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The intrahepatic transport of a number of anions is thought
to be mediated by the cytosoiic anion-binding protein ligandin
(Arias et ah , in Glutathione: Metabolism and Function, eds.
I. M. Arias & W. B. Jakoby, Raven Press, New York, 197 6,
pp. 175 -188). Ligandin also possesses enzyme activity and has
been reported to be identical to glutathione S-transferase B
(Habig_et al_. , Proc. Natl. Acad. Sci U. S. A. 71, 3879 3882),
one of at least 7 proteins in rat liver cytosol with transferase
activity. Each of these enzymes comprise two of three possible
monomers, Ya, Yb or Yc which have mol. wts. 22 000, 23 500
or 25 000 respectively. In this thesis bile acid-binding to
rat liver cytosol proteins has been investigated.
In hepatic cytosoi the major bile acid-binding activity was
associated with glutathione S-transferase activity. Transferase
activity was resolved into 7 peaks by cation exchange chromato¬
graphy; at least 4 of these peaks bound cholic acid and at least
3 of the transferases bound lithocholic acid. Examination of the
subunit compositions of different glutathione S-transferases
indicated that cholic acid-binding, lithocholic acid-binding and GSH:
1, 2-dichioro-4-nitrobenzene conjugating activity may be ascribed
(VI)
to different subunits.
The two major lithocholic acid-binding transferases were
purified and were designated LBa and LBb; they comprised
YaYa and YaYc subunits respectively. These two proteins
were identified by comparing their eiution volumes from CM-
Sephadex with those of purified Ligandin and glutathione S-transferase
B. Although ligandin and glutathione S-transferase B have been
reported to be identical they eiuted separately, as single peaks
of enzyme activity at volumes equivalent to LBa and LBb
respectively. This suggests that ligandin and glutathione S-transferase
B are not identical but separate proteins. LBa and LBb had
similar amino acid compositions and were both induced by
phenobarbitone. They may be coded by a single gene. Peptide
"mapping" suggested that a product-precursor relationship may
exist between LBa and LBb. The removal of 26 terminal amino
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The bile acids are a group of acidic sterols with a four ringed
cyciopentanophenanthrene structure (Fig. 1.1). Bile acids are based
on cholanic acid and the individual acids differ in the number of
hydroxy! groups on the rings; for example, cholic acid has hydroxyl
groups at the 3, 7 and 12 positions, chenodeoxycholic acid and
deoxycholic acid have hydroxyl groups at the 3 and 7 and 3 and 12
positions respectively, and lithocholic acid has one hydroxyl group at
the 3 position. Neither the methyl, hydroxyl nor carboxyl groups are
situated in the same steric plane as the steroid ring: the methyl
groups are jS -oriented while the hydroxyl groups and the carboxyl side
chain are a-oriented. Bile acid molecules can be divided into two
distinct regions; first, the polar hydroxyl and carboxyl groups and
secondly, the non-polar steroid ring and methyl groups.
Physiological functions of the bile acids
Bile acids have three major physiological functions.
First they solubilize biliary cholesterol (Admirand & Small,
1968; Neiderhiser & Roth, 1968; Dam & Hegardt, 1971) and emulsify
















Figure 1.1 Structural formulae of cholesterol, cholanic acid,
cholicacid, chenodeoxycholic acid, deoxycholic acid and lithocholic
acid.
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1962; Hofmann, 1963). Bile acids also appear to enhance the process
of lipolysis hi vitro (Borgstrom, 1954) and in vivo (Borgstrom et al.,
1957). Although the mechanism of this process is not clear it has
been discussed in a review on the roles of bile acids in fat and
cholesterol absorption (Holt, 1972). Whilst it is possible that bile
acids may exert their effect on lipolysis by interacting directly with
pancreatic lipase it is more probable that bile acids increase
lipolysis in the gut through emulsifying the substrate. Sarda &
Desnuelle (1958) demonstrated that lipolysis occurs at an oil-water
interface and therefore emulsification of large triglyceride droplets
into a small stable droplet emulsion would increase the interface
available for the reaction. Holt (1972) also suggested that the
emuisification properties of bile acids may help remove the products
of lipolysis from the interface reducing product inhibition of the
reaction. The emuisification activity of bile acids depends on their
amphipathic properties. They are surface-active in water and at
low concentrations are most densely distributed at the airrwater
interface. At a certain critical concentration, when bile acid
molecuies are densely crowded together at the interface and the
surface activity has reached a maximum , the excess bile acid
molecules, which must enter the bulk phase, spontaneously
aggregrate to form small clusters of molecules called micelles.
This critical bile acid concentration is called the critical micellar
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concentration(C. M. C.) and it has been calculated to be 0.75-2.0 mM
(Holt, 1972). The micelle is about 10 nm in diameter and is discoid
in shape. It comprises 4-20 bile acid molecules, oriented with
non-polar areas in the centre of the aggregate and the polar groups
exposed to the aqueous phase (Hofmann & Small, 1967; Carey & Small,
1972). The solubilization of biliary cholesterol as well as the
digestion products of dietary lipid occurs by formation of mixed
micelles in which lipid molecules interdigitate between detergent
molecules (Small, 1970). In the rat, the concentration of bile salts
in the liver tissue is 0.14-0. 28 mM (Greim & Popper, 1971).
Bile acids therefore cross the hepatocyte as single molecules, not as
micelles.
The second physiological role which has been ascribed to bile
acids is the stimulation of bile flow. A linear relationship has been
demonstrated between the rate of bile acid secretion into bile and bile
flow (Wheeler, 1972; Javitt, 1976a, b). Because of their choleretic
activity bile acids are determinants of bile flow and they therefore
facilitate the removal of many endogenous and exogenous substances
from the body by excretion into bile. Sperber (1959) proposed
that the choleretic effect of bile acids results from their
active transport across the canalicular membrane.
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The osmotic gradient thereby established allows water to pass
across the canalicular membrane into bile. Active transport
of any solute should therefore promote bile flow.
The third physiological role of bile acids may be to
regulate the size of the body cholesterol pool. Since
bile acids are quantitatively the major products of cholesterol
catabolism, the formation of bile acids and their ultimate
elimination in the faeces represents a major mechanism of
cholesterol degradation and elimination from the body
(Siperstein & Chaikoff, 1952; Elliott & Hyde, 1972; Danielsson
& Sjovall , 1975). For an animal to be in cholesterol balance
the rates of cholesterol supply and removal must be equal.
Cholesterol supply involves both dietary intake and cholesterol
acquired from endogenous synthesis; cholesterol removal involves
both the catabolism of cholesterol to bile acids and the secretion
of cholesterol into the gut with their ultimate excretion into the
faeces. When the rates of supply and removal are equal the cholesterol
pool remains constant. There is evidence which suggests that
hepatic cholesterol synthesis is in part regulated by bile acids
in the enterohepatic circulation (the enterohepatic circulation is
described on pp. 14-17). However, the mechanism of this effect
is not well understood. First, the external diversion of bile flow
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leads to a striking increase in the rate of cholesterol synthesis in
the liver (Eriksson, 1957; Myant & Eder, 1961). Second, the fact
that feeding the bile acid binding resin cholestyramine also
results in increased hepatic cholesterol synthesis suggests that
the bile acid component in bile is responsible for the increase
in synthesis (Huff_etal., 1963). Third, interference with the
enterophepatic circulation of bile acids as a result of ileal
bypass operations also results in a striking increase in cholesterol
synthesis in the liver (Borgstrom, 1960; Moutafis & Myant, 1968).
The bile acids are an integral part of cholesterol catabolism and
anabolism; it has been suggested that the net effect of the bile
acids on cholesterol metabolism is to maintain a balance in
which synthesis and absorption tend to equal excretion and
degradation under diverse physiological conditions (Wilson, 1972).
Bile acid synthesis
Bile acids are synthesised from cholesterol in the liver.
Synthesis involves five separate modifications of the cholesterol
molecule, (a) introduction of a-hydroxyl groups at positions
12 and/or 7; (b) alteration of the orientation of the 3-hydroxyl group
from /3 to a ; (c) saturation of the double bond between C5 and 6;
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(d) cleavage of the side chain between the carbon atoms 24 and 25 and
(e) oxidation of the terminal carbon atom of the side chain to form
a carboxylic acid group.
In rat liver the two major synthetic pathways result in the
formation of cholic acid and chenodeoxvcholic acid. These bile
acids are formed by pathways which are initiated by modifications
to the steroid ring structure of the cholesterol molecule and are
followed by modifications to the side chain. The first two
reactions in both pathways are common and therefore a branch
point exists before cholesterol degradation is committed to either
cholic acid synthesis or chenodeoxycholic acid synthesis.
Cholic acid is the major bile acid in rat liver (70 %
of total) (Okishio & Nair, 1966). The first step in the conversion
of cholesterol into either cholic acid or chenodeoxycholic acid is
the formation of 7a-hydroxycholesterol. This reaction is
catalysed by cholesterol 7a-hydroxylase, a cytochrome P-450
dependent enzyme system present in the microsomal fraction
of the liver, which requires oxygen, reduced nicotinamide adenine
dinucleotide phosphate (NADPH) and a thiol cofactor (Scholan &
Boyd, 1968; Grimwade et al., 1973). This reaction is rate-
iimiting; procedures, such as biliary drainage, which result in an
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increase in the rate of bile acid synthesis also result in an increase
in the activity of the cholesterol 7 a-hydroxylase enzyme system
(Danielsson et al., 1967; Boyd _et al_., 1969). The regulation
of bile acid synthesis has been reviewed by Boyd & Percy-Robb
(1971) and Danielsson St Sjovall (1975); it is widely accepted that
bile acids control the rate of their own synthesis through a
feedback inhibition mechanism which alters the activity of the
cholesterol 7a-hydroxylase enzyme system, possibly by inducing
the synthesis of a component of this enzyme system. The mechanism
of such an effect is unknown.
Bile acid metabolism and degradation
After synthesis the bile acids are conjugated with either
taurine or glycine through an amide bond at carbon atom 24.
Vessey & Zakim (1977) showed that in the guinea-pig the enzymes
responsible for conjugation are located in the microsomal fraction
of the liver. The two conjugates of cholic acid, glycocholic acid
and taurocholic acid, are shown in Fig. 1.2. The ratio of taurine-
conjugated to glycine-conjugated bile acids in normal human bile
is approximately 1:3 and in rat bile 20:1. These ratios are species









Figure 1.2 Structural formulae of cholic acid, cholyl glycine and
cholyl taurine.
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Conjugated bile acids possess several physiological advantages
over their unconjugated counterparts. They are more polar and
are therefore secreted, by the liver, into bile more rapidly than
unconjugated bile acids (O'Mgiille et al., 1965). Although free
bile acids precipitate from solution, as the insoluble protonated
acids, at pH's which lie close to neutrality (Dowling & Small, 1968)
conjugated bile acids are resistant to precipitation, as protonated
acids, at the pB of the upper gut (pH about 6.5); conjugated bile acids
are therefore more effective promoters of absorption within the
intestine than their unconjugated counterparts (Schiff _et al_., 1972).
Conjugated bile acids also appear to be less toxic to the intestinal
mucosa. For example, cholic acid ( 8 mM) caused a 99%
inhibition of glucose transport by segments of jejunum, whereas
equivalent concentrations of glycocholic acid or taurocholic acid
produced no inhibition (Pope et al., 1966). Further, Teem & Phillips
(1972) reported that deoxycholic acid, but not conjugated deoxycholic
acid, produced gross morphological damage to the jejunum.
The conjugated bile acid is commonly called a bile .salt whilst
the unconjugated form is referred to as a bile acid. However,this
terminology is not used rigorously. The terms bile salts and bile
acids to describe conjugated and unconjugated bile acids are commonly
interchanged. In this thesis the unconjugated bile acids will be
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referred to as bile acids and the conjugated bile acids as bile salts.
In dilute solutions (below their G.M.C. 's), the free bile acids choLic,
chenodeoxycholic and deoxycholic have pKa values about 5, their
glycine conjugates about 3.7 and their taurine conjugates about
1.5(Heaton, 1972). At physiological pH's, therefore the majority
of both conjugated and unconjugated bile acids will be present
largely as sodium salts.
Apart from conjugation with the amino acids taurine or glycine,
bile acids can react with sulphuric acid. This occurs in the liver
and the kidney and results in the formation of a sulphate ester with
the 3a-hydroxyl group (Palmer, 1971; Cronholm et al., 1972). The
intracellular location of enzymes responsible for this reaction is
not known. The ratio of sulpha ted to non-sulpha ted bile acid varies
with the bile acid; lithocholic acid is the most completely sulphated
bile acid (Makino et al., 1974; Stiehl, 1974). The sulphation process
does not appear to be affected by conjugation since both bile salts and
bile acids are suiphated (Stiehl et al., 1977). Bile acid sulphates
differ in excretion and toxicity from non-sulphated bile acids
(Stiehl _et al_., 1977). The introduction of an SO^H group into the bile
acid molecule improves its water solubility. Once excreted into bile
the polar suiphated bile acids are poorly absorbed from the small
intestine. They pass into the colon and the majority of the suiphated
bile acids are lost in the faeces (Cowen_et ai., 1975). Sulphation
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is therefore of special importance in helping to eliminate the
potentially toxic bile acid, lithochoiic acid, from the body. In
patients with cholestasis, which results in increased serum
concentrations of bile salts, elimination of bile salts in the
urine may be considerable (Back, 1973; Norman & Strandvik,
1974; Stiehl et al., 1975; Van Berge Henegouwen & Brandt, 1976).
A major part of such bile salts are present in the urine as
sulphate esters (Makino_et al_., 1974; Stiehl, 1974).
Bile salts can be degraded by aerobic and anaerobic
bacteria in the small and large intestine. Two types of
bacterial action are important in bile acid metabolism (Lewis &
Gorbach, 1972). First, the main initial reaction is the
deconjugation of bile salts to produce the respective free acid.
Several strains of bacteria , including Streptococcus faecalis,
Bacteroides fragilis, Clostridium perfringens and Bifidobacterium
adolescentis, produce a cholanyl glycine hydrolase which catalyzes
the deconjugation of bile salts (Shimadajst al_., 1969; Aries & Hill,
1970; Lewis & Gorbach, 1972). The specificity of this reaction
is not absolute and most organisms found to deconjugate a specific
bile salt will, under suitable conditions, deconjugate others presented
to them (Drasar_et al_., 1966; Dickenson_et aj_., 1971). Secondly,
the two primary bile acids, cholic acid and chenodeoxycholic acid,
may subsequently be dehydroxylated at the 7 position to form the
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secondary bile acids deoxycholic acid and lithochoiic acid (Lewis &
Gorbach, 1972). As the rat eats its own faeces it normally possesses
bacterial colonisation of the small gut. Bacterial modification
of bile acids is therefore quantitatively important in the rat. In the
rat half the cholic acid pool is dehydroxylated each day and up to
one third of the bile salt pool is deconjugated each day (Lindstedt
& Samuelsson, 1959; Heaton, 1972).
Bile acid enterohepatic circulation
After conjugation in the liver, the bile salts are secreted into
bile and pass down the bile duct into the third part of the duodenum.
During passage down the small intestine the bile salts promote the
digestion of dietary fat and in the rat a proportion of the bile salts
will be deconjugated by intestinal bacteria to form free bile acids.
The bile salts and bile acids are reabsorbed largely at the terminal
ileum (Dietschy, 1968; Lack & Weiner, 1971) and return to the liver
in the portal blood bound to albumin (Rudman & Kendall, 1957;
Burke ^_taJ_., 1971). The bile salts and acids are extracted from
the blood by the hepatic parenchymal cells (O'Maille_et aL , 1967),
transported across the hepatocyte and resecreted against a concen¬
tration gradient into the bile canaliculi (O'Maille et ad., 1965).
Figure L 3 Diagramatic representation of the enterohepatic
circulation of bile acids.
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This recycling system, in which bile salts are circulated between
the liver and the intestine, is called the enterohepatic circulation.
It effectively conserves bile salts and bile acids and enables the body
to make maximum use of this group of substances. A diagramatic
scheme of the enterohepatic circulation in the rat is shown in
Fig. 1.3. This differs from the enterohepatic circulation in man
in that the rat does not possess a gallbladder. The human gallbladder
has a capacity of about 40 ml and can concentrate bile acids to about
0. 2 M_ (Lindstedt, 1957; Abvarre jet ah, 1969; Vlahcevic
et_al_., 1970). It is theoretically capable of storing 8 mmol of bile
acid, which is equivalent to the total bile acid pool. The possession
of a gallbladder, with its large storage capacity, therefore
enables man to secrete bile in response to the ingestion of food
more effectively than the rat.
The bile acid pool is continually depleted by faecal excretion
and repleted by hepatic synthesis. In normal man the bile acid pool
is 2 - 4 g and it loses, and is replaced with 500 - 700 mg (15 - 20%)
of the total) per day. Since the bile acid pool circulates
5-15 times a day, approximately 30g of bile acid are transported
across the liver and are reabsorbed from the gut. This
demonstrates that about 9b% of the bile salts and bile acids
are reabsorbed during each cycie of the pool (Brunner et al., 1972;
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Heaton, 1972). In the rat the pool is about 20mg and about 200mg
of bile salt and bile acid are transported across the liver each
day (Cronholm & Sjovall, 1967). Maintenance of an adequate bile
acid pool is dependent upon efficient absorption by the ileum,
return to the liver in portal blood, removal from the blood
by the liver and secretion into bile. These transport processes
are very efficient and except for a small quantity of bile acid in
the systemic circulation the bile acid pool is restricted to the
enterohepatic circulation (Ng & Kofmann, 1977).
Hepatic transport of bile acids
This thesis is principally concerned with the intrahepatic
transport phase of the enterohepatic circulation. The hepatic
transport of bile acids includes three steps: uptake across the
sinusoidal membranes of the parenchymal cell, intracellular
transport and secretion across the canalicular membrane into
bile. Little is known about the molecular mechanisms of these
steps.
Several studies have investigated the kinetics of bile acid
uptake. 0'Mailie_et aL (1967) have shown that in dogs both
taurocholic acid and cholic acid are efficiently removed by the
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liver after intravenous injection. By applying the Fick principle, to
determine the total hepatic blood flow, they showed that about 90%
of the taurocholate and 80% of the cholate was extracted from the
blood during a single passage through the liver. Smallwood et al.
(1974) injected a bolus of radiolabelled bile acids into the
portal vein of rats and showed that radioactivity appeared in
bile within 30 s and the maximal excretion rate was
reached within 3 min. They showed that cholic acid was
transported into bile more quickly than chenodeoxycholic acid.
Similar experiments by Strange et al. (1979c) demonstrated that
lithocholic acid excretion into bile was slower than that of the
tri- or di-hydroxy bile acids.
Studies in dogs suggest that bile acid uptake from plasma
is saturable and therefore carrier-mediated (Glasinovic et al., 1975).
Bile acid uptake has also been studied in the isolated perfused rat liver
(Reichen & Paumgartner, 1975) and isolated rat liver ceils
(Schwartz et al., 1975). These also indicate that a carrier-
mediated transport mechanism, located in the sinusoidal membrane,
is responsible for uptake (Reichen & Paumgartner, 1975).
The process is specific for bile acids (Paumgartner & Reichen,
1975, 1976) and is Na+ dependent (Schwartz et al., 1975; Reichen
& Paumgartner, 1976). The demonstration of competitive
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inhibition between the uptake of different bile acids suggests that
they share a common pathway which is different from that by which
organic anionic dyes enter the hepatocyte (Paumgartner & Reichen,
1975).
Uptake of bile acids and biie salts from the plasma is
probably not rate limiting as their hepatic uptake capacity
(Vmax) is 5 - 10 times greater than their maximal secretion rate
(Tm) (Wheeler, 1972; Glasinovic et_aL, 1975; Reichen &
Paumgartner, 1976). The difference between the capacity of
the hepatic uptake and secretion processes has given rise to the
concept of hepatic storage of bile acids and salts (Heaton, 1972;
Wheeler, 1972; Reichen & Paumgartner, 1975).
Secretion of bile acids into bile is also probably carrier-
mediated as it is saturable (O'Maille et al., 1967). However
the Tm of bile acids exceeds the usual demands imposed by the
enterohepatic circulation (Q'Maille etal., 1965, 1967; Wheeler,
1972). This is greater than the Tm for other organic anions
(Wheeler et al., 1960 ; 0'Maille_et ai., 1966). Bile acids are
excreted across the canalicular membrane into bile against a
large concentration gradient. In the rat, the concentration of biie
salts in the liver tissue is 0.14 - 0.28 mM (Greim & Popper,
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1971) while in bile it is 16 mM (Kiaasen, 1971). The excretion
process is energy requiring and is postulated to be regulated by
the membrane-bound enzyme (Na+- K+)ATPase (Erlinger et al.,
(1970).
The existence of bile acid carriers in the sinusoidal and
canalicular membranes has been supported by the identification
of bile acid-binding sites in liver surface membranes (Accatino
& Simon, 1976). Characterisation of these binding species showed
that their binding kinetics were similar to the uptake process in
the intact liver. Further,Gonzalez et al., (1979) demonstrated that
in rats administered cycloheximide, a drug which inhibits protein
synthesis, both the number of bile acid receptors in liver surface
membranes and the bile acid Tm were decreased. However, although
the sinusoidal and canalicular membranes are morphologically
distinct it is not clear whether these surface membranes receptors
originate from the sinusoidal or canalicular membranes. Accatino
& Simon (1976) suggested that they were present in both membranes
but since the canalicular membrane represents only 13% of the total
hepatic surface membranes the majority of the receptors were
present in the sinusoidal membrane.
Comparatively little is known about how bile acids traverse
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the hepatocyte. It is not clear whether they cross it in free
solution or are transported from the sinusoidal membrane to the
canalicular membrane bound to a carrier protein. Strange
et al. (1976, 1977a) demonstrated the presence, in rat liver
cytosol, of proteins which can bind cholic acid, chenodeoxycholic
acid and lithocholic acid. Subsequent partial purification of
two lithocholic acid-binding proteins showed that these both
possessed glutathione S-transferase activity (Strange et al., 1977b).
Although neither of the two proteins was identified it was suggested
that one may be the well-described, non-specific, anion-binding
protein, ligandin, which also possesses glutathione S-transferase
activity (Kaplowitz et al., 1973). The physiological role of these
binding proteins is not clear. However, the interaction of bile acids
with subcellular organelles in the liver has recently been studied
with a view to determining how bile acids cross the liver and how
the cytosolic binding proteins effect bile acid transport (Strange etal.,
1979a, b, c). These studies showed that the bile acids were
non-specifically distributed (partitioned) between nuclei, microsomes,
mitochondria or free solution and that only cytosol contained saturable
bile acid-binding sites. Further these workers constructed a
compartmental model for bile acids in the liver which indicated
that 90% of the cholic acid conjugates and 99% of the
lithocholic acid in the liver would be bound to nuclei, microsomes,
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mitochondria or cytosolic proteins with 10% and 1%, respectively,,
in free solution. Strange et al. (1979b) considered ways
in which bile acids may be passively transported across the liver cell.
A comparison between the observed cholic acid transit time, across
the liver into bile, and the calculated transit time it would have if
it diffused across the hepatocyte (a) in free solution, (b) bound to
protein or (c) bound to phospholipid, suggested that bile acids may
diffuse across the liver in free solution. Strange et al. (1979c)
suggested that the physiological role of the cytosolic binding proteins
is to restrict the amount of bile acid available for partitioning into
subcellular organelles.
Origin of the term ligandin
A large number of compounds, including bilirubin, bromo-
sulphophthalein and indocyanine green, are transported across the
hepatocyte and may be bound to cytosolic proteins. The hypothesis that
cytosolic proteins are involved in the hepatic transport of various
anions has largely originated from the work of Arias and his
colleagues. They first described the presence of the anion-binding
proteins, X, Y & Z by gel-exclusion chromatography of a mixture
of hepatic cytosol and either bilirubin or bromosulphophthalein
(Levi_et_al., 1969b). This resulted in the elution of 3 peaks of
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protein-bound anion; these fractions were called X (eluted in the
void volume), Y (mol, wt. approx. 45 000) and Z (mol. wt. approx.
12 000). The binding component in the Y fraction , initially called
Y protein, bound a wide variety of organic anions including
bilirubin, bromosulphophthalein and indocyanine green. It was
subsequently reported that Y protein was identical to the Azodye
carcinogen-binding protein (/3-ABP) described by Ketterer et al.
(1967) and the Corticosteroid Binder I described by Singer et al.
(1970). The protein was therefore called ligandin because of
its binding properties (Litwack et al., 1971).
Ligandin and the glutathione S-transferases
Habig et al. (1974a) reported that ligandin, prepared by the
method of Arias and his colleagues, was identical to glutathione
S-transferase B since both proteins had the same specificity for
substrates and for ligands, both proteins had similar physicochemical
properties, both proteins were induced by phenobarbitone treatment
and both proteins reacted similarly to antibody produced against
ligandin. There are at least 7 glutathione S-transferases in rat
liver cytosol; they each catalyse the conjugation of glutathione to a
number of electrophilic compounds. As examples, the reaction
between glutathione and l-chloro-2, 4-dinitrubenzene and between
24
Figure 1.4 The reactions between (i) GSH and i-chloro-2,
4-dinitrobenzene and (ii) GSH and 1, 2-dichloro-4-nitrobenzene.
Both reactions are catalysed by glutathione S-transferase enzymes.
Reaction (i) results in the formation of HC1 and of S-(2, 4-dinitrophenyl)-
glutathione. Reaction (ii) results in the formation of HC1 and of
S -(2 - chloro - 4 -ni trophenyl )glu ta thione.
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glutathione and 1, 2-dichloro-4-nitrobenzene are shown in Fig. 1.4.
The conjugation of glutathione with various electrophilic compounds
is the first step in the synthesis of the mercapturic acids. The
thioesters formed by the reaction catalysed by the glutathione
S-transferases are subsequently converted in separate stages by
(a) removal of the $-glutamyl moiety through the action of a
^-glutamyl transferase, (b) removal of the glycine moiety through
the action of a dipeptidase and (c) N-acetylation of the cysteine
conjugate by an acetyl -CoA linked acetylase to form a
N-acetylcysteine thioether, which is the mercapturic acid (Fig. 1.5)
(Barnes et al., 1959; Bray et al., 1959; Boyland & Chasseaud,
1969: Habig et al., 1974b).
Attempts to classify the glutathione S-transferases on the basis
of their substrate specificity have resulted in the use of such terms
as aryl transferase, alkyl transferase, araikyl transferase, alkene
transferase and epoxide transferase (Boyland & Chasseaud, 1969).
However the overlapping catalytic abilities of individual members of
this enzyme group has prevented their being definitively classified
solely by substrate specificity. For example, transferases
E, D. C, B, A and AA can all catalyse the conjugation of glutathione
with l-chloro-2, 4-dinitrobenzene. The Commission on Biochemical


























Figure 1.5 Synthetic pathway of the mercapturic acids. The
initial step is catalysed by the glutathione S-transferases.
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EC 2.5.1.18. The rat liver enzymes are basic proteins, which have
pi values greater than 7.1. They can be separated by cation-exchange
chromatography and they have been classified by their elution order.
Habig e_t al_. (1974b, 1976a) designated the transferases by their
order of elution from CM-ceilulose as E, D, C, B, A and AA and
have described the abilities of these transferases to conjugate
glutathione with a variety of substrates. This nomenclature is
not entirely comprehensive as an additional cytosolic enzyme,
glutathione S-transferase M, was omitted from the CM-ceilulose
chromatography as it was removed by preliminary purification
steps (Jakoby et al., 1976b). Recently a separate glutathione
S-transferase has been reported in the microsomal fraction of rat
liver indicating that these enzymes are not restricted to the cytosol
(Morgenstern et al., 1979).
The glutathione S-transferases are a group of enzymes which
are functionally similar and,in addition to their overlapping
substrate specificities,they also exhibit overlapping binding activities
towards a large number of non-substrate ligands which possess
hydrophobic moieties (Ketley et al. , 1975). They have similar
molecular weights (approx. 46 000) and each comprises two subunits
(Jakob y_et al_., 1976b). Bass_etal_. (1977a) have examined the proteins
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in the Y fraction, obtained by gel-exciusion chromatography of hepatic
cytosoi, using discontinuous SDS/poiyacrylamide gei electrophoresis
and found 3 major monomeric bands: Ya (mol. wt. approx. 22 000),
Yb (moi. wt. approx. 23 500) and Yc (mol. wt. approx. 25 000).
Since all the cytosolic transferases elute in the Y fraction this
finding raised the possibility that certain glutathione S-transferases
possess common subunits. Support is given to this hypothesis
by the observation that antisera raised against transferase A
cross-reacted with transferase C and vice versa (Habig_et al_.,
1974b).
Ligandin: one protein or two?
The most widely studied glutathione S-transferase is ligandin
from rat liver. Preparation of purified ligandin has been
described by several groups using different purification techniques
(Morey & Litwack, 1969; Habig et al., 1974a; Kamisaka et al.,
1975; Tipping et al_., 1976). Present evidence shows ligandin to be
a basic protein (pi 8.7-9.0) which comprises 4.0-4.5% of the total
protein in rat liver cytosoi; it has a mol. wt. of 47 000 and consists
of two subunits Ya (mol. wt. 22 000) and \c (mol. wt. 25 000)
(Bhargava et al., 1978; Ketterer_et al_., 1978). However, there is
now doubt whether the different purified preparations of ligandin
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contain only one protein or indeed if they comprise the same protein.
These doubts arise partly because of the wide range of pi values
(8.4-9.8) obtained by different groups (Litwack et al., 1971;
Jakoby et al., 1976b) and also because these preparations exhibit
properties compatible either, with their containing contaminating
glutathione S-transferases or, with their modification during
storage to a mixture of ligandin and other proteins (Habig et al., 1974b;
Ketterer_et al_., 1976a; Listowsky et al., 1976). For example,
Bass_et al_. (1977a) and Carne et al. (1979) have demonstrated
that ligandin can be further resolved by ion-exchange chromatography
into dimeric proteins comprising YaYa and YaYc monomers.
Physiological importance of the glutathione S-transferases
The physiological importance of these enzymes is emphasised
by their high concentration (in rat liver the enzyme group accounts
for a total of 10% of the cytosolic protein ) and their wide
distribution throughout the animal kingdom (Jakoby, 197 8).
Furthermore, glutathione S-transferase enzymes are not restricted
to the liver and activity has been reported from a number of other
tissues including small intestine (Clifton & Kaplowitz, 1977), kidney
( Boyland & Williams, 1965; Clifton et al., 1975; Hales et al., 1978)
and erythrocytes (Marcus_et al_., 1978). Bassetal. (1977b) have
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studied the tissue distribution of iigandin in the rat using
radioimmunoassay. They found ligandin in a number of different
organs, including liver, kidney, proximal and distal small-
intestinal mucosa, testis, ovary, adrenals, salivary glands,
stomach and pancreas.
At least four physiological functions have been proposed
for the glutathione S-transferases as a result of their enzyme
activity and their ability to bind, covalently and non-covaiendy,
certain compounds. First, circumstantial evidence obtained
from phylogenetic studies (Levine_et ai., 1971), investigations
into neonatal jaundice (Levi et al., 1969a, 1970) and induction
of ligandin by drugs (Reyes_et al., 1969, 1971) led to the
hypothesis that ligandin is involved in the hepatic uptake of a large
number of anions. Further, Jakoby et al. (1976b) suggested that,
since all the glutathione S-transferases tested (C, B, A and AA)
bound non-covalentiy, different non-substrate ligands, all the
glutathione S-transferases were involved in hepatic anion
transport. Second, glutathione S-transferases catalyse the first
step in the synthesis of the mercapturic acids and are therefore
involved in the excretion of potentially harmful electrophilic
compounds from the body (Chasseaud, 1976; Jakoby et al., 1976a).
The glutathione S-transferases appear to catalyse two main types
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of reaction : replacement (substitution), typified by the conjugation
of GSH with aikyl, aryl or aralky halides; and addition,typified by
the conjugation of GSH with epoxides (Chasseaud, 1976). The
ability of the transferases to conjugate GSH with a large number of
electrophilic compounds results in their being involved in the
excretion of potentially harmful compounds from the body
(Chasseaud, 1976; Jakoby et_ai., 1976a). GSH conjugates have
the requisite physicochemical properties for biliary excretion
(Chasseaud, 1974) and generally will, together with their
metabolites, be present in bile in relatively high concentrations.
For example, the GSH, cysteinylglycine, cysteine and N-
acetylcysteine (mercapturic acid) conjugates of the corresponding
hydrocarbon expoxides have been detected in the bile of rats
treated with certain polycyciic hydrocarbons (Boyland & Sims,
1962, 1964a, b). Thirdly, the glutathione S-transferases are
considered to reduce the susceptibility of the liver to carcinogenesis
through both their catalytic activity and their ability to bind,
covalently, toxic compounds thereby protecting the nucleus from
potential carcinogens (Jakoby & Keen, 1977; Smith ejjaL, 1977).
Fourthly, in addition to its glutathione S-transferase activity,
ligandin has been reported to possess other types of enzyme activity.
The reactions which ligandin is able to catalyse are therefore not
restricted to mercapturic acid metabolism. Ligandin has been
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shown to have 3-oxo steroid A - A isumerase activity (Benson
£t_aL , 1977) and glutathione peroxidase activity (Proshaska
& Ganther, 1977).
Bile acids studied in this thesis
This thesis is concerned with cholic acid and lithocholic
acid-binding proteins in rat liver cytosol which could be
involved in the intrahepatic transport of these bile acids. Cholic
acid was used for investigation since it is quantitatively the most
important bile acid in the rat (Gkishio & hair, 1966). Litho¬
cholic acid was chosen for study for several reasons; rat liver
cytosol contains more binding sites for lithocholic acid than for
other bile acids and binding can be studied under non-
equilibrium conditions (Strange et al., 1977a). However,
Strange et al. (1977a) have shown that both cholic acid and
chenodeoxycholic acid can competitively inhibit lithocholic acid
binding to cytosolic proteins. This suggests that rat liver cytosol
contains general bile acid-binding proteins rather than a number
of binding sites which are each specific for a particular bile acid.
Lithocholic acid is therefore regarded as a convenient ligand which
is probably handled by the same proteins as are the other bile acids.
Lithocholic acid also has toxic properties and Palmer (1964)
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demonstrated that it can lyse human erythrocytes in vitro .
Hoisti (1960) reported that rabbits which were given iithocholic
acid daily (40 nmol/kg body weight) deveioped cirrhosis of the
liver within 3 months and Fischer et al. (1974) and Stiehl
et ai. (1977) have confirmed that it is hepatoxic to a variety
of mammalian species including the rat. Lithocholic acid
appears to be most toxic to species which are unable to form
sulphated derivatives (Gadacz et al., 1976). In addition Javitt
& Emerman (1968) reported that lithochoiic acid has cholestatic
properties inhibiting the biliary secretion of taurochoiic acid.
Whilst lithocholic acid is present in very low concentrations
in the rat the hepatic mechanisms involved in handling this
potentially toxic substance and removing it from the blood are of
sufficient clinical importance to merit investigation.
Objectives of the thesis
The aim of this thesis was to characterise further the
interaction of cholic acid and lithocholic acid with rat liver cytosol.
Cytosolic proteins were investigated to determine whether choiic
acid and lithochoiic acid were bound by all the glutathione
S-transferases , only certain glutathione S-transferases or proteins
which did not have transferase activity. The subunit compositions
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of the enzymes were investigated to see if certain binding properties
or enzyme characteristics could be ascribed to the presence of
particular suburbts.
Experiments were performed to characterise and identify
the two previously described lithocholic acid-binding proteins.
Their amino acid compositions, isoelectric points and monomeric
compositions have been determined. The effect of phenobarbitone
on their concentrations has been investigated because pheno¬
barbitone has been reported to increase the synthesis of ligandin
(Reyes_et al_., 1971; Fleischner et al., 1972; Arias et al., 1976).
Further, glutathione S-transferase B was prepared by the procedure
of Habig_et al. (1976a) and ligandin by that described by
Arias et al_. (1976) and these two purified proteins have been
compared with the lithocholic acid-binding proteins. The relationship





Cholicacid, (3a, 7a, 12a-trihydroxy-5/3-cholan-24-oic
acid) and lithocholic acid (3a-hydroxy-5/3-cholan-24-oic acid)
were from Maybridge Chemical Co., Tintagel, Cornwall, U.K..
3
[2,4-^H] Cholic acid (14 Ci/mmol) from New England Nuclear,
14
Dreieichenhain, West Germany and [24- C] Lithochohc acid
3 14
(59 Ci/mol), [ H] water (5 Ci/ml) glycerol tri[l- C] palmitate
(50 Ci/mol) from the Radiochemical Centre, Amersham, Bucks,
U.K. were used. Butan-l-ol, hydrogen peroxide and pyridine of
/
AristaR grade, acrylamide, NN -methylenebis-acryiamide,
NNN^^-tetramethylethylenediamine , ammonium persulphate,
ammonium sulphate, ninhydrin, di-sodium hydrogen orthophosphate,
sodium dihydrogen orthophosphate, sodium chloride, sodium hydroxide,
sucrose, acetone, ammonia solution, anisaldehyde, chloroform,
diethyl ether, isopropyl ether, ethanol, formic acid, glacial
acetic acid, hydrochloric acid, iso-octane, methanol and sulphuric
acid of AnaiaR grade, triton X-100 and toluene of scintillation grade,
2-mercaptoethanol, 2, 2,4-trimethylpentane, di-iso-propyl ether,
sodium dihydrogen citrate and sodium dodecyl sulphate (SDS) of
laboratory grade and Folin & Ciocalteu's phenol reagent were
obtained from B.D.H. Chemicals Ltd., Poole, Dorset, U.K..
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The 1, 2-dichloro-4-nitrobenzene was from Eastman Kodak Co.,
Rochester, N.Y., U.S.A. and was twice recrystallized from
ethanol before use. Reduced glutathione (GSH), rat albumin,
bovine serum albumin, ovalbumin, a-chymotrypsinogen A,
a-chymotrypsin, trypsin, ribonuclease A, 1,4-bis[2(5-phenylo-
xazolyl)] benzene (POPOP), 2,5-diphenyloxazole (PPO),
TEAE-cellulose and Coomassie brilliant blue G were from
Sigma Co. Ltd., Poole, Dorset, U.K.. CM-Sephadex C-50,
QAE-Sephadex A-50, Sephadex G-100 and Blue Dextran
2000 were from Pharmacia Fine Chemicals Ltd., London
W5 5SS, U.K.. CM-celluiose (Whatman CM52) and DEAE-
cellulose (Whatman DE52) were purchased from Whatman Ltd.,
Maidstone, Kent, U.K. and Bio-Gel A-0.5 m (200-400 mesh) was
from Bio-Rad Laboratories Ltd., Bromley, Kent, U.K.
Pierce-Durrum DA X2 and DC-LA ion-exchange resins were
obtained from Pierce & Warriner U.K. Ltd., Chester, Cheshire,
U.K.. Sodium phenobarbitone was from Evans Medical Ltd.,
Speke, Liverpool, U.K.. Human immunoglobulin (IgG) and
albumin were obtained from the Protein Fractionation Centre,
Scottish National Blood Transfusion Association, Edinburgh,
Scotland, U.K.. Poly(ethylene glycol) (mol. wt. 25 000) was
from Union Carbide, Southampton, Hants, U.K. and Spectrapor
dialysis membrane (mol. wt. cut off of 12 000 - 14 000) was from
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Spectrapor, Spectrum Medical Industries, Los Angeles, C.A. ,
U.S.A.. Disodium phenoltetrabromophthalein sulphonate
(bromosulphophthalein) was from Hynson, Westcott and
Dunning Inc. , Baltimore, Maryland, U.S.A. and pH 7-9 and
9-11 Ampholines were from LKB Instruments Ltd., Selsdon,
South Croydon, Surrey, U.K.. The staphylococcus aureus
V8 protease, thermolysin, mercaptoethanesuiphonic acid,
L-amino guanidinopropionic acid, L-norleucine and the
amino acid standards for high-voltage paper electrophoresis
("wonder mix" which comprised lysine, histidine, arginine,
glycine, valine, alanyl glycine, 0-dinitrophenyl lysine, taurine,
cysteic acid, aspartic acid, glutamic acid and xylene cyanol FF)
were a gift from Dr. R. P. Ambler, Department of Molecular
Biology , University of Edinburgh, Edinburgh.
Buffers
Several buffers were used repeatedly. The composition and
the temperatures at which they were prepared are listed in Table 2.1.
All the buffers used, with the exception of buffers F, I and J were
prepared at room temperature (20°C).
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Table 2.1 Buffer compositions
Buffer pft Temperature Composition
buffer prepared
A 7.5 20°C lOOmM -sodium phosphate
B 6.5 20°C lOOmM -sodium phosphate
C 7.4 20°C 20mM-sodium phosphate containin,
D 7.4 20°C lOmM-sodium phosphate
E 6.7 20°C lOmM-sodium phosphate




H 6.8 20°C 125mM-Tris/HCl
I 8.1 4°C lOmM-Tris/KCl
J 8-8 4°C lOmM-Tris/HCl





This was performed in a Packard Tri-Carb liquid scintillation
spectrometer (Model 3255) using a toluene: triton X (2:1 v/v) based
scintillant containing 2, 5-diphenyloxazole (PPO), 4g/l and
1,4-di(2-(5-phenyloxazolyl))-benzene (POPOP), 0.2 g/1. Portions
of scintillant (5 ml) were mixed with 100^il aqueous sample in
polyethylene vials and were counted with a standard deviation
of less than 1%. Samples were checked for quenching by the
14 3
addition of an internal standard ([ C] glycerol palmitate or [ H]water).
The counting efficiency was determined by counting known
3 14
amounts of [ H] cholic acid and [ C] lithocholic acid and was found
to be 60% and 85% respectively.
Glutathione S-transferase activity
This was measured at 37°C by the method of Habig et al.
(1974b). The conjugation of GSH with either 1, 2-dichloro-4-
nitrobenzene or i-chloro-2, 4-dinitrobenzene was followed at
340 nm in buffers A and B respectively with a LKB Reaction Rate
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Analyzer (Model 8600). Both the reaction between GSH and
1, 2-dichloro-4-nitrobenzene and the reaction between GSH and
l-chloro-2, 4-dinitrobenzene were initiated by the addition of
GSH. Reaction rates were corrected for the small amount
(less than 5% of total rate) of non-enzyme-catalysed conjugation
of GSH with l-chloro-2, 4-dinitrobenzene.
Protein determination
Protein concentrations were determined by the method of
Lowry et al. (1951) with bovine serum albumin as the standard.
Protein concentrations in samples eluted from columns were
calculated from the extinction values at 280 nm.
Bromosulphophthalein assay
Bromosuiphophthalein concentrations were measured by the
absorbance values at 580 nm following addition of NaGH (100 pi;
10 M_) to 250 pi portions of column fractions (Levi et al., 1969b).
Sodium determination
Na concentrations in column fractions were measured
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by flame photometry using an IL 343 photometer (Instrumentation
Laboratory (L.K.)Ltd., Altringham, Cheshire, U.K.).
Bile acid purity
The bile acids were shown to be 99% pure by thin
layer chromatography (t.l. c.) before use. The chromatograms
were developed in a stationary phase (20 cm x 20 cm x 0.25 mm)
consisting of silica-gel G (Merck Darmstadt : F254) by ascending
chromatography. The solvent system used was iso-octane/
isopropyl ether/acetic acid (2:1:1, by vol.) (Hamilton & Muldrey, 1961).
Portions (10|il; approx. 1 |iCi) of the radiolabeled bile acids
and non-radiolabeled bile acids (about 10 pg) were applied
to the plates, at an "origin" 1 cm from the bottom of the plate,
and the chromatograms were developed until the solvent front
reached 1 cm from the top of the plate (O'Moore & Percy-Robb,
1973).
The purity of the non-radiolabeled bile acid samples was
assessed by staining the developed plates with acetic acid/
sulphuric acid/anisaidehyde (100:2:1, by vol.) and scanning the
stained chromatograms at 580 nm with a vitatron TLD 100
Flying spot densitometer (Fisons Scientific Apparatus,
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Loughborough, Leics., U.K.) as described by O'Moore &
Percy-Robb (1973). The purity of the radiolabeled bile acid
samples was assessed by cutting 40 slices (each 0.5 cm high
x 2.0 cm wide) from the developed chromatograms and measuring
the radioactivity contained in each silica-gel slice by liquid
scintillation spectrophotometry.
Animals
Male Wistar rats (230 - 290 g) fed ad libitum, from the
Animal Breeding Research Organisation, Bush Estate, Milton
Bridge, Midlothian, Scotland, U.K., were used. Phenobarbitone -
treated rats were given subcutaneous injections of sodium
phenobarbitone in sterile water (0.5 ml; approx. 100 mg/kg body
weight) for 7 successive days and were killed on the eighth day.
Phenobarbitone administration resulted in a 30-50% increase in
liver weight compared with untreated animals.
Preparation of Cytosol
Rats were anaesthetised with ether and the livers perfused
in situ through a portal vein cannula with approx. 20 ml of ice cold
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buffer C containing 250 mM sucrose, until blood free. The liver
was removed, homogenized in 20 ml of the perfusion buffer and
centrifuged (30 min, 4°C, 18 000 g) in a MSE Highspeed 18
(MSE Scientific Instruments, Manor Royal, Crawley, Sussex, U.K.).
The supernatant was decanted off, recentrifuged (120 min, 4°C, 100 OOOg)
in an MSE Superspeed 50 and after removal of the lipid layer
the clear supernatant was stored on ice.
Analysis of cholic acid-binding by equilibrium gel-exclusion
chromatography
Strange et al. (1976, 1977a) showed that although cholic
acid-binding by rat liver cytosol was observed under equilibrium
conditions (equilibrium dialysis) cholic acid-binding by rat liver
cytosol could not be analysed under non-equilibrium conditions by
gel-exclusion chromatography (zonal gel filtration) since the
putative protein: cholic acid complex(es) readily dissociated during
chromatography. Cholic acid-binding was therefore investigated
using an equilibrium chromatographic method. The use of
equilibrium chromatography was initially devised by Hummel &
Dreyer (1962) and its use has been reviewed by Wood & Cooper
(1970). Equilibrium chromatography avoids the problem of
dissociation since the column is eluted with a constant concentration
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of hgand and therefore the ligand-protein compiex(es) are
constantly surrounded by "free" ligand during chromatography.
Samples for analysis were concentrated by dialysis against
poly(ethylene glycol) until they had a protein concentration
greater than 7 mg/ml. They were then dialysed against 2
changes, each of 2 litres, of buffer C (16h, 4°C). Portions (3 ml)
of cytosol (approx. 80 mg of protein) or individual glutathione
S-transferase enzyme peaks (80 or 20 mg of protein), which were
obtained by ion-exchange chromatography (see pp. 46-47)
were diluted with an equal volume of buffer C containing
3
20 nM [ H] cholic acid (300 d.p.s./ml). After incubation (60 min,
4°C) the mixture was applied to a Bio-Gel A-0.5 m column
(2.5 cm x 38 cm) which was equilibrated and eluted (20.5 ml/h) at
4°C with buffer C containing 10 nM [\l] choiic acid (150 d.p.s./ml).
Fractions of 3.4 ml were collected and analysed for protein,
glutathione S-transferase activity and radioactivity. The void
volume, determined using Dextran Blue, was 75 ml and the salt
volume, determined by using NaCl was 195 ml. The elution volume
3
of [ H] cholic acid was 200 ml. The elution volumes of immuno¬
globulin G (mol. wt. 180 000); albumin (mol. wt. 67 000);
ovalbumin (mol. wt. 45 000); myoglobin (mol. wt. 17 800) and
ribonuclease A (mol. wt. 12 700) were plotted against the logarithm
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of their mol. wt. and the straight line obtained was used to
estimate the moL. wt. of the bile acid-binding proteins.
Separation of the glutathione S-transferases in cytosol
Q
Cytosol, from two livers, was dialysed (4 C, 9 h) against
two changes, each of 2 litres, of buffer D. The dialysed solution
(12 ml; approx. 325 mg of protein) was eluted (4°C, 16 ml/h)
from a column of CM-Sephadex (2.2 cm x 15 cm) which was
equilibrated with buffer D. The fraction volume was 2.7 ml.
After 70 ml had been eluted, the glutathione S-transferases
which were retained by the ion-exchanger were eluted with a
continuous 0-80 mM NaCl gradient in buffer D (Strange et al.,
1977b). Fractions of 2.7 ml were collected and analysed for
glutathione S-transferase activity by measuring the conjugation
of GSH with either l-chloro-2, 4-dinitrobenzene or 1, 2-dichloro-
4-nitrobenzene.
The fractions which eiuted (130-180 ml) from CM-Sephadex
were of particular interest and were subjected to further
chromatography. These fractions were combined and concentrated
o
to about 5 ml by dialysis, at 4 C, against poly(ethylene glycol).
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After concentration this fraction was dialysed against 2 changes,
each of 2 litres, of buffer F. This solution was applied to a
DEAE-Sephadex column (2.2 cm x 15 cm) which was equilibrated
and eluted (20 ml/h, 4°C) with buffer F. A continuous 0-500 mM
ISaCl gradient in buffer F was established after 95 mi eluted from
the column (Strange et al., 1977b). Fractions of 3.3 ml were
collected and analysed for glutathione S-transferase activity.
Analysis of lithocholic acid-binding by cytosol
The lithocholic acid-binding capacity of cytosol was studied
by gel-exclusion chromatography. 500 nmol Lithochoiic acid
14
and 5.1 nmol [ C] lithocholic acid (0.3 jaCi) were added to
5 ml portions (40 mg of protein) of cytosol and mixed by inversion.
After incubation (60 min, 4°C), the mixture was eluted (22.2 ml/h),
using buffer G, from a Bio-Gel A-0.5 m column (2.5 cm x 38 cm).
Fractions of 3.7 ml were collected and analysed for protein,
glutatione S-transferase activity and radioactivity. The void volume,
determined using Dextran Blue, was 75 ml, the salt volume,
determined using NaCl was 195 mi and the elution volume of
14
[ C] lithocholic acid was 230 ml.
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The lithochoiic acid-binding activity of different glutathione
S-transferases was studied by CM-Sephadex chromatography.
Cytosol (12 mi; approx. 325 mg of protein) was dialysed (4°C, 9h)
against 2 changes, each of 2 litres, of buffer D and the dialysed
material was then incubated (60 min, 4°C) with 20 nmol
14
[ C] lithochoiic acid (1.2 jiCi). This mixture was eluted from
CM-Sephadex as described.
Discontinuous SPS/polyacrylamide gel electrophoresis
This was performed at room temperature (20°C) in the
presence of 0.1% (w/v) sodium dodecyl sulphate (SDS) using
vertical slab gels (0.075 cm x 16.5 cm x 18 cm) in an
IN/96 electrophoresis apparatus obtained from Raven Scientific
Ltd., Haverhill, Suffolk, U.K.. The electrophoretic system used
was that described by Laemmli (1970). This comprised a 14 cm
long resolving gel of either 11.5% or 16.5% (w/v) polyacrylamide
containing buffer G and a 1 cm high stacking gel of 3% (w/v)
polyacrylamide containing buffer H which was formed on top of the
resolving gel. Samples were prepared for electrophoresis by
heating at 85°C for 10 min in an aqueous solution containing 1%
(w/v) SDS, l%(v/v) 2-mercaptoethanol, 0.002% (w/v) bromophenol
blue and 10% (w/v) sucrose as described by Maizel (1971).
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Portions (40 jji; 5-30 fig of protein) of these mixtures were run
through the stacking gel at 6 W and through the resolving gel at
2W - 4W. Electrophoresis was stopped when the bromophenoi
blue dye marker had reached 0.5 - 3.0 cm from the end of
the resolving gel. The gels were stained (2h, 20°C) in a
0.2% (w/v) solution of Coomassie brilliant blue in water/methanol/
acetic acid (50:50:7, by vol.) and destained in water /methanol/
acetic acid (88:5:7, by vol.). After slicing, the gels were scanned
at 580 nm using a Vitatron TLD 100 Flying spot densitometer
from Fisons Scientific Apparatus, Loughborough, Leics.,
U.K.. Fig. 2.1 shows an SDS/polvacrylamide gel of whole
hepatic cytosol from normal and phenobarbitone-treated rats.
Fig. 2.2 shows the densitometric scan obtained from the gel
slice of the normal rat cytosol shown in Fig. 2.1.
The Ya, Yb and Yc monomers present in the Y fraction
(Bass _et ai_., 1977a) were identified as follows. Cytosol
(3 ml, 40 mg of protein) was eluted (4°C, 22 ml/h) from a column
of Bio-Gel A-0.5 m (2.5 cm x 38 cm). The fraction volume
was 3.7 ml. The void volume (Dextran Blue), was 75 ml and
the salt volume (Na"*"), was 195 ml. The 3 fractions which




Figure 2.1 Discontinuous SDS/poiyacrylamide gel electrophoresis
of cytosol and "Y fractions" from normal and phenobarbitone-treated
rats. The samples were applied to the gel (11.5% resolving gel) from
left to right; 1, cytosol from a normal rat (60 pg of protein);
2, cytosol from a phenobarbitone-treated rat (60 pg of protein);
3, "Y fraction" from a normal rat (2.5pg of protein) and
4, "Y fraction" from a phenobarbitone-treated rat (2.5 pg of protein).
The samples were applied at the top and were run towards the anode
(bottom). The position of the bromophenol blue dye marker is
indicated (B. B.).
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Figure 2.2 SDS/polyacrylamide gei scan of hepatic cytosoi from
normal rats. The gel pattern obtained from normal rat cytosoi
in Fig. 2.1 (track 1) (11.5% resolving gel) was scanned at 580 nm
using a Vitatron TLD 100 Flying spot densitometer. The top of
the gel is on the left and the direction of electrophoresis





Figure 2. 3 Plot of mol. wt. of marker proteins against their
electrophoretic mobility. Portions of rat albumin (A), ovalbumin
(O), a-chymotrypsinogen (a-C), myoglobin (M), lysozyne (L)
and ribonoclease A (R) were prepared for electrophoresis
and samples (approx. 5 y.g of protein) of each were applied
to SDS/polyacrylamide gels (11.5% resolving gel). The
electrophoretic mobility of each protein was compared with the
bromophenoi blue marker dye and its relative mobility plotted
against its log. mol. wt. The relative mobilities of the Ya, Yb
and Yc bands are indicated.
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(elation volume 124 - 136 ml) were combined and a portion
(approx. 20 p.g of protein) of this preparation was examined
by discontinuous SDS/polyacrylamide gel electrophoresis.
Densitometry of the electrophoretic pattern demonstrated that
85% of the total protein present was recovered in 3 bands
(Ya, Yb and Yc). The mol. wt. of the Ya, Yb and Yc
bands were calculated by comparing their electrophoretic
mobilities against rat albumin (mol. wt. 67 000), ovalbumin
(mol. wt. 45 000), a -chymotrypsinogen (mol. wt. 25 000),
myoglobin (mol. wt. 17 800), lysozyme (mol. wt. 14 300)
and ribonuclease A (mol. wt. 12 700). The relative mobility
of each protein compared with the bromophenol blue "tracking-dye"
was calculated and plotted against the logarithm of the mol. wt.
(Fig. 2.3). The graph was found to be linear as reported
by Shapiro et al. (1967). From this graph the mol. wt. of
Ya, Yb and Yc was estimated as 22 000, 23 500 and
25 000 respectively, which is in good agreement with the values
of 23 000 (Ya), 24 000 (Yb) and 25 000 (Yc) reported by Bass
et al. (1977a).
Subunit composition of the glutathione S-transferases
Before discontinuous SDS/polyacrylamide gel electrophoresis,
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the glutathione S-transferases were partially purified. Two
portions of cytosol (each 5 ml; approx. 180 mg of protein)
were eluted (22 ml/h) with buffer C, from the Bio-Gel column
(2.5 cm x 38 cm). The enzyme-containing fractions which eluted
between 124 - 136 ml were combined (about 85% of the protein
in this mixture migrated with the Ya, Yb and Yc monomer
bands). Ammonium suiphate was added to the combined
enzyme-containing eluate and the precipitate, formed between
55-85% saturation, was collected, redissolved in 12 mi of buffer
D and dialysed against 2 changes, each of 2 litres, of the same
buffer (4°C, 15 h)(Dixon & Webb, 1964; Strange et al., 1977b).
The dialysed solution was eluted from CM-Sephadex as described
and the fractions which eluted from CM-Sephadex between 130-
180 ml were rechromatographed on DEAE-Sephadex as described.
Portions (10 jig of protein) of each enzyme-containing peak were
examined by discontinuous SDS/polyacryiamide gel electrophoresis
as described.
Polyacrylamide gel isoelectric focussing
This was performed using 6% (w/v) polyacrylamide slab gels
(12 cm x 11.5 cm x 0.2 cm) containing 12.5% (w/v) sorbitol and 0.3%
(w/v) ampholines pH7-9and 2% (w/v) ampholines pH 9-11 on
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an LKB 2117 Multiphor (8°C) with an LKB 2103 power supply
as described by Karlsson_et aL ,1973. The cathode electrode
solution was 1.0 M_ NaOH and the anode electrode solution
was a 0.1% (w/v) solution of ampholines pH 7 - 9. The gel
was run for 60 min to allow a pH gradient to form before the
samples (20 ^ii; approx. 25 ^ug of protein) were applied with
LKB eiectrofocussing strips (10 mm x 6.5 mm) (Vesterberg,
1973). The pH range obtained after electrophoresis (3h;
20 W - 30 W) was determined by taking 5 mm slices from the
gel after each run and eluting the carrier ampholines with
degassed deionised water. The pH's of these amphoiine-
containing solutions were measured at 20°C. The gels were then
o _
stained (60 min, 60 C) in a 0.1% (w/v) solution of Coomassie
brilliant blue in methanol/water (15:31, v/v) containing 0.15 M_
sulphosalicylic acid and 0.65 M_ trichloroacetic acid as described
(Karlsson et al., 1973). The gels were destained in water/ethanol/
acetic acid (66:26:8, by vol.).
Preparation of glutathione S-transferase B
This was prepared as described by Habig_et ai_. (1974b, 197 6a)
and Table 2.2 presents a summary of the purification procedure.
Livers from 2 rats were frozen in a beaker placed in a mixture of
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Purification procedure for glutathione S-transferase B
Rat liver removed and frozen at -72°C for 30 min.
1
Liver homogenised in distilled H-0 for 30 sec. and centrifuged
(10,000 g, 60 min.)
1
Supernatant applied to DEAE-cellulose equilibrated with
10 mM Tris-HCl buffer pH 8.1 and eluted with same buffer
I
Void volume fractions combined and solid (NH^ SO^ added until
90% saturation
Solution centrifuged (10,000 g, 45 min.) and pellet dissolved in
10 mM sodium phosphate buffer pH 6. 7 and dialysed against
2 litres of the same buffer for 16h
Dialysed material applied to CM-cellulose equilibrated with
lOmM sodium phosphate buffer pH6.7 and eluted with the same
buffer.
CM-cellulose eluted with a continuous 0-80 mMNaCl gradient, in
the 10 mM sodium phosphate buffer pH6.7, and the protein
fractions eluted between 46 mM - 53 mM [Na+3 combined
and dialysed against 2 litres Iff mM sodium phosphate buffer
dH 7.4 for 16 h. ~
Table 2. 2 Purification scheme for glutathione S-transferase B.
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solid CO and ethanol (approx. -72°C). After 30 min the frozen
o
livers were removed, added to 40 mi of distilled water (4 C) and
crushed with a pestle. This preparation was blended for 30 s
in a Sunbeam liquidiser Model PB-P (Sunbeam Corporation Ltd.,
Maribyrnong, Victoria, Australia) and the resulting solution
was centrifuged (I h, 4°C, 10 OOOg) in an M.S.E. Highspeed 18
centrifuge. The lipid layer was removed and 16 ml of the
supernatant applied to a DEAE-cellulose column (2.2 cm x 15 cm)
which was equilibrated and eluted (22 ml/h, 4°C) with buffer I.
The enzyme-containing fractions, eluted between 29 - 65 ml,
were combined. Solid (NH^)^SO^ was added, with stirring, at
20°C until 90% saturation was reached (Dixon & Webb, 1964).
After standing (30 min, 20WC), the solution was centrifuged
(10 000 g, 45 min, 20°C). The supernatant was discarded,
the precipitate redissolved in 10 mi of buffer E and the solution
dialysed (16 h, 4°C) against 2 litres of the same buffer. The
diaiysed solution was applied to a CM-cellulose column (2.2 cm
x 15 cm) equilibrated and eluted (22 ml/h, 4UC) with buffer E.
The fraction volume was 3.7 ml. After 120 mi of eluant had been
collected a continuous 0 -80 mM iNaCl gradient in the same buffer
was initiated (Habig_et al_., 1974b). Five peaks of enzyme activity,
able to catalyse the conjugation of GSH with l-chloro-2,
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4-dinitrobenezene, were eiuted at Na concentrations of 15, 37,
50, 59 and 70 mM. Only the enzyme-containing peaks elated at
Na+concentrations of 37 and 59 mM were able to catalyse the
conjugation of GSH and 1,2-dichloro-4-nitrobenzene indicating
that these peaks contain transferases C and A respectively
(Hafaig_et al_., 1974b). The enzyme-containing peak which eiuted
between these transferases, at a Na+ concentration of 50 mM ,
is glutathione S-transferase B (Habig et al., 1974b).
Preparation of ligandin
Ligandin was prepared essentially by the method of Arias
et al. (1976) and Table 2.3 presents a summary of the
purification procedure. After perfusion in situ with approx. 20 mi
of ice-cold buffer D, 100 g of liver was homogenised in 300 ml of
buffer D containing 250 mM sucrose. The homogenate was
centrifuged (100 000 g, 90 min, 4°C) in an M.S.E. Superspeed 50
ultracentrifuge and the resulting supernatant dialysed against
5 litres of buffer J (16 h, 4°C). The dialysed material (80 mi)
was eiuted (25 ml/h) from a column of TEAE-cellulose
(2.5 cm x 100 cm) equilibrated with buffer J. The first protein
peak, eiuted between 350 - 500 ml, was combined, concentrated
to 10 mil by dialysis against poly(ethylene glycol) and redialysed
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Purification procedure for ligandin
Rat livers perfused in situ with 10 mM sodium phosphate
buffer pH7.4, removed and homogenised in the same buffer
containing 250 mM sucrose.
Homogenate centrifuged 100,000 g for 90 min.
Supernatant dialysed against 5 litres of 10 mM Tris-HCl buffer
pH 8. 8 for 16 h
I
Dialysed material applied to TEAE-cellulose equilibrated and
eluted with 10 mM Tris-HCl buffer pH8. 8
1
Void volume fractions combined, concentrated to 10 ml and
redialysed against 2 litres of 10 mM sodium phosphate buffer
pH 7.4 for 16 h
Bromosulphophthaiein added to the dialysed material and the
mixture eluted from Sephadex G-100.
Fractions containing protein-bound bromosulphophthaiein combined,
concentrated to 5 ml and redialysed against 2 litres of 10 mM
Tris-HCl buffer pH8.8 for 16 h
Dialysed material applied to QAE-Sephadex equilibrated and
eluted with 10 mM Tris-HCl buffer pH8.8
Void volume fractions combined and dialysed against 2 litres of
10 mM sodium phosphate buffer pH7.4 for 16 h
Table 2.3 Purification scheme for ligandin.
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(16 h, 4°C) against 2 litres of buffer D. The resulting solution was
incubated (60 min, 4°C) with 20 mg of bromosulphophthalein and eluted
(24 ml/h) with buffer D from a column of Sephadex G-100 (2.5 cm x
100 cm) (Kirsch et al., 1975). The six fractions (elution volume
265-300 ml; approx. mol. wt. 45 000) containing the maximum
amount of protein-bound bromosulphophthalein were combined and
concentrated to approx. 5 ml of dialysis against poly(ethylene
o
glycol). After dialysis (16 h, 4 C) against 2 litres of buffer J
this solution was eluted (30 ml/h) from a column of QAE -Sephadex
A-50 (1.5 cm x 60 cm) equilibrated with buffer J. Fractions eluted
between 30 - 60 ml contained ligandin (Bass_et al_., 1977a).
Purification of the two lithocholic acid-binding proteins LBa and LBb
The lithocholic acid-binding proteins LBa and LBb were
purified essentially as described by Strange et al. (1977b)
and Table 2.4 presents a summary of the purification procedure.
Solution 1 Cytosol from 20 livers was dialysed (4°C, 18 h)
against 2 changes, each of 5 litres, of buffer D. The dialysed
solution (250 ml, approx. 1 g of protein) was eluted (5o ml/h) from
a CM-Sephadex C-50 column (4.4 cm x 20 cm) with buffer D and
8.9 ml fractions were collected. A continuous 0-80 mM NaCl
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Purification procedure for LBa and LBb.
Rat livers perfused in situ with lOmM sodium phosphate buffer pH7.4
containing 250mM sucrose, removed and homogenised in the same buffer.
1
Homogenate centrifuged 18,000^ for 30min and the supernatant
recentrifuged 100,000£for 120min.
I
Supernatant dialysed against 2 changes, each of 2 litres, of lOmM sodium
phosphate buffer pH7.4 for 18h.
I
Dialysed material applied to CM-Sephadex equilibrated with lOmM
sodium phosphate buffer pH7.4 . CM-Sephadex eluted with a 0-80mM NaCl
gradient, in the lOmM sodium phosphate buffer pH7.4, and the protein
fractions eluted between 25m M - 75mM [Na+] combined.
~i
Solid (NH^SC^ added to the combined fractions and the material
precipitated between 55% - 85% saturation combined, centrifuged
(50,000g, 30min) and the pellet dissolved in lOmM sodium phosphate buffer
|
Redissolved material eluted from Sephadex G-100 with lOmM sodium
phosphate buffer. Fractions containing glutathione S-transferase
activity combined and dialysed against 2 changes, each of 20mM
Tris-HCI buffer pH8.6 j
Dialysed material applied to DEA E-Sephadex equilibrated and eluted with
20mM Tris-HCI buffer pH8.6
Void volume fractions combined and dialysed against 2 changes, each of
2 litres, of lOmM sodium phosphate buffer pH7.4 for 18h.
Dialysed material applied to CM-Sephadex equilibrated with lOmM
sodium phosphate buffer pH7.4 . CM-Sephadex eluted with a 0-80mM NaCl
gradient in the lCmM sodium phosphate buffer pH7.4 and the fractions
eluted between 35mM - 45mM and 54mM - 61mM [Na+J separately
combined.
Table 2.4 Purification scheme for LBa and LBb.
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gradient, in the same buffer, was initiated after eiution of 530 ml;
the fractions which eiuted between 25-75 mM Na+ (eiution volume
550 - 610 ml) were combined, giving Solution 1 (Fig. 2.4).
Solution 2 Solid (NH^SO^ was added (20°C), with
stirring, to solution 1 until 55% saturation was achieved
(Dixon & Webb, 1964). This solution was left standing for 30 min
(20°C) before the precipitate was removed by centrifugation
(5000 g, 15 min, 20 JC) and discarded. More (NH^^SO^ was
added to the resulting supernatant until 85% saturation was
obtained. This solution was also left standing for 30 min (20°C)
before centrifugation (50 000 g, 30 min, 20°C) in an M.S.E.
Superspeed 50 ultracentrifuge. The supernatant was discarded and
the precipitate redissolved in 10 ml of buffer D (Solution 2).
Solution 3 The redissoived material was applied to a
Sephadex G-100 column (2.5 cm x 95 cm) which was equilibrated
and eiuted (31 ml/h) with buffer D. The void volume (Dextran
Blue), was 200 mi and the salt volume (Na+), was 480 mi. Fractions
of 5.2 ml were collected. The 7 fractions (eiution volume 265
- 301 mi) which contained most glutathione S-transferase activity
(measured with GSH and l-chloro-2, 4-dinitrobenzene) were
combined and dialysed (4°C, 18 h) against two changes, each of
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Elution volume (ml)
Figure 2.4 Purification of LBa and LBb (preparation of Soiution 1).
Cytosoi (250 mi, approx. ig of protein) was eiuted from a
CM-Sephadex coiumn (4.4 cm x 20 cm) as described). Fractions of
8.9 mi were collected and the A (•) and the Na+ concentrations
2oL)
(■) determined. The fractions which contained 25 - 75 mM
[Na+] were combined, giving Soiution 1.
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Elution volume (ml)
Figure 2.5 Purification of LBa and LBb (preparation of Solution 3).
The protein fraction in Solution i which precipitated between 55 - 85%
ammonium sulphate saturation was collected and dissolved in 10 ml
of buffer D, giving Solution 2. This solution was eiuted from a
Sephadex G-100 column (2.5 cm x 95 cm). Fractions of 5.2 ml were
collected and the A (•) and glutathione S-transferase activities2ou
(4) were measured. Fractions which eiuted 265 - 301 ml were
















Figure 2. 6 Purification of LBa and LBb (preparation of Solution 4).
Solution 3 was eluted from a DEAE-Sephadex column (2.2 cm x 15 cm)
as described. Fractions of 3.4 mi were collected and the (•)
and the Na+ concentration (!) were determined. The glutathione
S-transferase activity was measured with l-chioro-2, 4-dinitrobenzene
(A) and 1, 2-dichloro-4-nitrobenzene (o) as substrates. Fractions
eluted between 14 - 38 ml were combined and diaiysed as described,
giving Solution 4.
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Figure 2.7 Purification of LBa and LBb (resolution of the two proteins).
14
Solution 4 was eluted with [ CJlithocholic acid from a column of
CM-Sephadex (2.2 cm x 20 cm) as described. Fractions of 3.4 ml
were collected and the A „ (•), Na+ concentration (■), radioactivity
(O) and glutathione S-transferase activi ty, with l-chloro-2,
4-dinitrobenzene as substrate (A), were measured. Fractions which
eluted between 115 - 133 ml (LBa) and 156 - 173 ml (LBb) were
combined.
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2 litres, of buffer F (Solution 3) (Fig. 2.5).
Soiution 4 Soiution 3 was applied to a column (2.2 cm
x 15 cm) of DEAE-Sephadex A-50 equilibrated and eluted at 4°C
with buffer F. The flow rate was20.4 ml/h and the fraction volume
3.4 mi. A continuous 0-200 mM NaCl gradient was established
in buffer F after 110 ml was collected. Fractions eluted between
14 - 38 ml were combined and dialysed (4°G, 18h) against
two changes, each of 2 litres, of buffer D giving Solution 4
(Fig. 2.6). Solution 4 was incubated (4°C, 60 min) with 17 nmoi
14
[ CJlithochoiic acid (50 jii; 1 ^iCi) and applied to a column
(2.2 cm x 20 cm) of CM-Sephadex C-50 equilibrated and eluted
with buffer D. The flow rate was 20.4 mi/h and the fraction
volume 3.4 mi. A continuous 0.80 mM NaCl gradient was
established in buffer D after 80 ml was collected (Fig. 2.7).
The fractions eluted between 115 - 133 ml and 156 - 173 mi
were separately combined and diaiysed against two changes, each of
2 litres, of 50 mM ammonium acetate buffer, pH 8.5. These contained
LBa and LBb respectively.
Analysis of amino acid compositions
To allow a direct comparison between the amino acid compositions
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of the two purified lithocholic acid-binding proteins, LBa and LBb,
to be made, the different steps invoived in the analyses were performed
simultaneously, on both proteins, under identical conditions.
Portions (0.7 mg of protein) of LBa and LBb were evaporated
to dryness under vacuum in a desiccator, over H^SO^, at room
temperature. These samples were hydrolysed at 105°C in evacuated
sealed Pyrex glass tubes with 0.4 ml of 6M_ HC1 for 24 h or 96 h as
described by Ambler & Brown (1967). After hydrolysis the glass
tubes were opened and the samples were desiccated under vacuum,
over NaOH pellets. The dried samples were then redissoived in
0.35 ml 200 mM trisodium citrate/HCl buffer, pH 2.2,containing
0.5 mM L-amino guanidinopropionic acid and 0.5 mM L-norieucine
as internal standards.
The amino acid compositions were determined using a
Beckman-Spinco Model 120-C Amino Acid Analyser (Benson &
Patterson, 1965). This analyser employs two ion-exchange columns:
one column (0.9 cm x 5.0 cm, which contained Pierce-Durram DA-X2
ion-exchange resin) separates the basic amino acids and ammonia
and the other column (0.9 cm x 50 cm, which contained Pierce - Durram
DC-A ion-exchange resin) separates the acidic and the neutral amino
acids. To enable the complete amino acid compositions (basic amino
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acids plus acidic and neutral amino acids) of LBa and LBb to be
determined both hydrolysed proteins were divided into two 0-15 ml
portions. One portion was eluted (70 ml/h, 53°C) from the short
column (0.9 cm x 5.0 cm) with 116 mM trisodium citrate buffer,
pH 5.2. The other portion was applied to the long column (0.9 cm x
50 cm) which was first eluted (70 ml/h, 53°C) with 67 mM trisodium
citrate/HCl buffer, pH 3.28, for about 1 h (until proline, glycine and
alan ine had eluted) and was then eluted (70 ml/h, 53°C) with 67 mM
trisodium citrate/HCl buffer, pH 4.25. The recoveries of the basic
amino acids, which eluted from the short column (0.9 cm x 5.0 cm)
and the neutral and acidic amino acids which eluted from the long
column (0.9 cm x 50 cm) were checked by comparing the elution
of the two internal standards. L-amino guanidinopropionic acid was
used to check the amino acid recovery from the short column
(0.9 cm x 5.0 cm); it eiuted between NH^ and arginine. L-norleucine
was used to check the amino acid recovery from the long column
(0.9 cm x 50 cm); it eluted between leucine and tyrosine. The
recoveries were found to be 85-98%.
Certain amino acids (asparagine, giutamine, cysteine
cystine and tryptophan) are destroyed during acid hydrolysis.
Asparagine is converted to aspartic acid and giutamine is converted
to glutamic acid during acid hydrolysis. These two amino acids are
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responsible for the NH^ produced by chemical hydrolysis of proteins.
However since no distinction was made between the aspartic acid (Asp.)
originally present in LBa and LBb and the asparagine (Asn.) which has
been subsequently converted to aspartic acid during hydrolysis the
aspartic acid recovered from the long column (0.9 cm x 50 cm) during
analysis was designated Asx, rather than Asp. Likewise the glutamic
acid recovered during analysis of LBa and LBb was designated Glx,
rather than Glu.
Since cysteine and cystine are acid-labile, the amounts of these
amino acids in LBa and LBb were determined after first oxidising
the proteins with performic acid (Hirs, 1967; Schroeder, 1968).
Oxidation with performic acid converts both cystine and cysteine to
cysteic acid and methionine to methionine sulphone. Cysteic acid, unlike
cystine and cysteine, is not destroyed during hydrolysis in 6 M_ HC1 and
therefore the content of cystine and/or cysteine was determined by
measuring the cysteic acid content after performic acid oxidation.
Portions (0.7 mg of protein) of LBa and LBb, which had been
evaporated to dryness, were treated with 0.4 ml 22 M_ performic acid
(120 min, 0°C) and the reaction products were desiccated.
These samples were then hydroysed with 0.4 ml 6 M HC1 (24h,
105°C) before being desiccated and the dried products dissolved
in 0.2 mi 200 mM trisodium citrate/HCl buffer, pH 2.2, containing
0.5 mM L-amino guanidinopropionic acid and 0.5 mM L-norieucine.
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A portion (0.15 mi; approx. 0.3 mg of protein) of the redissolved
material was eluted from the long column (0.9 cm x 50 cm) of the
Amino Acid Analyser. Cysteic acid is the first amino acid to elute
from the long column.
The tryptophan content of LBa and LBb was determined by
hydrolysis with 3 M_ mercaptoethanesulphonic acid (Penke et al., 1974).
Portions (o.7 mg of protein) of LBa and LBb, which had been
evaporated to dryness, were treated with 0.4 ml of 3 M_ mercapt¬
oethanesulphonic acid for 24 h. These hydrolysates were then
desiccated under vacuum, over ^2^2 anc* dissolved 0.35 ml
200 mM trisodium citrate/HCl buffer, pH 2.2, containing 0.5 mM
L-amino guanidinopropionic acid and 0.5 mM L-norleucine. Two
0.15 ml portions were analysed. One portion was eluted from the
short column and one portion was eluted from the long column of the
Amino Acid Analyser as described. Tryptophan eluted from the
long column after phenylalanine.
The results from different analyses were corrected to minimize
the effect of pipetting inaccuracies. This correction factor was applied
to the recoveries of all the analyses and was the ratio of the sums of
the recoveries of glycine, alanine, leucine, a spar tic acid (Asx),
glutamic acid (Glx), phenylalanine, lysine and arginine to the sum of these
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amino acids in the 24 h sampie (Ambier & Brown, 1967). These
amino acids were chosen since they are stable during hydrolysis
and their recoveries after different analyses should be similar.
No corrections were made for the hydrolytic loss of serine and
threonine, nor were corrections made for the increased recovery
of valine and isoleucine with prolonged hydrolysis.
Peptide "mapping" of LBa and LBb by limited proteolytic digestion
in the presence of SDS
The method used was that described by Cleveland et al. (1977).
The two purified lithocholic acid-binding proteins (approx. 1 mg of
protein/ml) were each heated to 95°C, for 2 min, in the presence
of 0.2%(w/v) SDS and 1 mM EDTA. These mixtures were cooled
(37°C, 10 min) and proteolytic digestions were carried out at 37°C,
by addition of various amounts of either a-chymotrypsin or
staphylococcus aureus V8 protease (10 jil containing 14, 1.4,
0.14, 0.014 or 0.0014 jjg of protein) to portions (50|ii approx.
50|ig of protein) of the purified lithocholic acid-binding proteins
(LBa and LBb). After 45 min, 2-mercaptoethanoi, SDS, sucrose and
bromophenol blue were added to final concentrations of 1%, 2%, 10% and
0.002% respectively and the digestions terminated by heating (95°C, 10 min).
Portions (50 |il)of the digest, containing 25 jig of digested lithocholic
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acid-binding protein and 7.0 - 0.0007 jig of either of the proteolytic
enzymes, were analysed by discontinuous SDS/poiyacryiamide gel
electrophoresis using a 3% stacking gel and 16.5% poiyacryiamide
resolving gel as described. For controls either a-chymotrypsin
or staphylococcus aureus V8 protease were incubated alone at the
highest concentration used for digestion (140jig/ml) and 7.0 jig of
the proteolytic enzyme was applied to the gel.
Peptide "mapping" of LBa and LBb by total proteolytic digestion
Portions (0.5, 1.0 or 1.5 mg) of the lithocholic acid-binding
proteins LBa and LBb were dried under vacuum in a desiccator over
H^SO^. The two proteins were prepared for proteolysis by oxidation
with performic acid (120 min, 0°C) and the reaction products
desiccated under vacuum. The two proteins were dissolved in
100 j_il 0.1 M_NHg before 0.3 ml of 200 mM ammonium acetate
buffer, pH 8.5, was added and the pH adjusted to 9-10 with
0.1 M_NH .
O
Digestion of LBa and LBb was carried out at 37°C for 6 h
with either trypsin, chymotrypsin or thermolysin using a
protein/proteolytic enzyme ratio of 50:1 (w/w) (Bhargava et al.,
197 8). After digestion the reaction mixture was lyophilised and
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stored under vacuum at room temperature.
The freeze-dried digestion products were examined by
high-voitage electrophoresis after dissolution of the freeze-dried
powder in 100yul 0.1 This solution was centrifuged
(4 000 g, 2 min, 20°C) and the supernatant applied to Whatman
3 MM paper. Pieces of Whatman 3 MM chromatography paper
(56 cm long, 25 - 42 cm wide) were used throughout. High-voltage
paper electrophoresis was carried out in apparatus similar
to that described by Michi (1951). The buffer systems and coolants
at pH 6.5, 3.5 and 2.0 were as described by Ambler (1963). In
all the runs (45 min at 3000 v) a parallel separation of a mixture
of amino acids including arginine, histidine, E-DNP-lysine,
aspartic acid, glutamic acid ana xylene cyanol FF ("Wondermix")
and a spot of red Pentel pen was performed on the same paper
(Milstein & Milstein, 1968). After each run the paper was examined
under ultraviolet light (340 nm) before ninhydrin treatment, as the tryptophan-
containing peptides fluoresce (Ambler, 1963). Peptides were
visualised by dipping the paper in 0.2%(w/v) ninhydrin solution in
acetone to which had been added (just before use) 3% (v/v) collidine.
The paper was then dried at room temperature, for 5 min, and then
heated, at70°C, for 10 min.
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The multidimensional tryptic peptide "maps" of LBa and LBb
were formed by a combination of electrophoresis and chromatography.
All the steps involved in the "mapping" were performed simultan¬
eously on both proteins under identical conditions. A diagramatic
representation (which is not drawn to scale) of the procedures involved
in constructing these "maps" is shown in Fig. 2.8. In the first
dimension the soluble peptides were separated into the basic,
neutral and acidic peptides by high-voltage paper electrophoresis at pH 6.5.
During electrophoresis at pH 6.5 the basic peptides migrate towards
the cathode, the acidic peptides migrate towards the anode and the
neutral peptides migrate as a single band which is slightly displaced
from the origin (towards the cathode) by endosmosis. The basic
and acidic peptides, which were partially resolved by electrophoresis
at pH 6.5, were separated in the second dimension by electrophoresis
at pH 3.5. This was carried out by cutting these peptides from the
electrophoresis paper after the first dimension, rotating them through
90° and sewing them onto fresh paper so that migration in the second
dimension was at right angles to that in the first. The basic peptides
from LBa and LBb were sewn onto a single piece of chromatography
paper in a "tail-to-tail" orientation which resulted in the production
of inverted repeat V-shaped patterns after migration in the second dimension.
The acidic peptides from LBa and LBb were also sewn onto a single
piece of chromatography paper in a "tail-to-tail" manner and were
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Figure 2. 8 Scheme for constructing the multi -dimensional peptide
"maps" of LBa and LBb. For the sake of simplicity the diagram only
shows the construction of a multi-dimensional "map" for a single
protein. The peptide "maps" of LBa and LBb were constructed
in parallel. The tryptic digests of LBa and LBb were separated in the
first dimension (1) by electrophoresis at pH 6.5 into the basic,
neutral (N) and acidic peptides. These were further separated by
(2) electrophoresis at pH 3.5 and (3) descending chromatography
using butan-l-ol/acetic acid/water/pyridine (15:3:12:10, by vol.)
as shown. The diagram is not drawn to scale.
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separately subjected to electrophoresis at pH 3.5. Since after
electrophoresis at pH 6.5 (the first dimension) the neutral peptides,
from LBa and LBb, migrated as single spots, they were sewn onto
chromatography paper and separated by electrophoresis at pH 3.5
in the same orientation as the first dimension. This resulted in the
neutral peptides being resolved into a single column after the second
dimension. The neutral peptides were then further separated by
descending chromatography using butan-i-oi/acetic acid/water/
pyridine (15:3:12:10 by vol.) for 16 h in a third dimension. This
was carried out at right angles to the direction of migration of the
two high-voltage paper electrophoresis runs (Fig. 2.8).
Peptide nomenclature
To facilitate the comparison between the tryptic digests of
LBa and LBb each peptide spot, obtained after the two and three
dimensional "mappings" was assigned a number. The peptides
in the acidic, basic and neutral "maps" were designated A, B and
N respectively. The peptides which appeared to be common to both
proteins were then numbered first, according to their mobility
in the pH 6.5 electrophoretic system (the most acidic ones were
numbered first). The unique peptides which were found in only one
protein were numbered second. The peptides were then designated
a or b according to their protein of origin. Using this nomenclature
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the peptides in the acidic peptide "map" of LBa and LBb, which
migrated furthest from the origin towards the anode, during
electrophoresis at pH 6.5 were designated Ala and Alb in the final
two dimensional "map". Likewise, in the basic peptide "map",
the peptides from LBa and LBb which, after the first dimension,
were recovered nearest the anode (i.e. migrated least) were
designated Bla and Bib in the final two dimensional "map". In
the peptide "map" which was constructed using descending
chromatography in the final dimension (the neutral peptide
"map") the peptides were numbered according to their mobility;
the peptides which migrated least, and were found nearest




Aims of the experiments
In this thesis the interactions between choiic acid and rat liver
cytosol and between iithochoiic acid and rat liver cytosol were
investigated. Choiic acid-binding was studied by an equilibrium
method using gel-exclusion chromatography. Lithochoiic acid-
binding was studied by non -equilibrium methods using gel-exclusion
chromatography and ion-exchange chromatography. Two
lithochoiic acid-binding proteins from rat liver cytosol have
previously been described and both proteins were shown to have
glutathione S-transferase activity (Strange et al., 1977b). Cytosolic
proteins were studied to determine whether choiic acid and
lithochoiic acid were bound by all the glutathione S-transferases ,
only certain glutathione S-transferases or by proteins which had no
transferase activity. The subunit compositions of the transferases
were investigated to see if a particular monomer could be responsible
for bile acid-binding activity. Further, experiments were also
performed to characterise and identify the two previously described
iithochoiic acid-binding proteins which also possessed glutathione
S-transferase activity. In this thesis these two proteins were called
LBa and LBb .
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Cholic acid-binding to liver cytosol
The binding cf choiic acid to cytosolic preparations was studied
using an equilibrium method (see pp. 44-46). Using this method
3
cystoiic proteins were incubated with [ H] choiic acid and applied
to a gel-exclusion column which had previously been equilibrated
with the same ligand. A constant "baseline" of radioactivity
was therefore eluted from the column; the concentration of
3
[ H] choiic acid eluted at the beginning of each run (pre-void
volume, 0-70 ml) was equal to that eluted at the end of each run
3
(post-salt volume, 230-300 ml). Protein-bound [ HJcholicacid
eluted as a peak of radioactivity which was observed above this
"baseline" level. In cases where choiic acid-binding was observed
3
the [ H] choiic acid which was in free solution in the test sample,
eluted from the column at the salt volume as a trough of radio¬
activity, since the concentration of the free ligand in these samples
was less than the concentration of the ligand with which the column
was equilibrated. In these instances, the areas of the "trough" and
"peak", although inverted, should have been equal since the rate at
which the ligand was applied to the column was constant throughout
each experiment. Under these circumstances, the binding proteins
3
picked up more [ H]choiic acid as they passed down the column,
until they were in equilibrium with the free ligand given by the
equilibrium solution (eluting buffer).
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Figure 3.1 Elution pattern of cytosol from Bio-Gel equilibrated
3
with [ H] choiic acid. Rat Liver cytosol (approx. 150 mg of
protein) was dialysed against buffer C (4°C, 18 h, 2 litres)
3
and eiuted from a Bio-Gel column equilibrated with [ H] choiic acid
as described. Fractions (3.4 ml) were collected and the A^g^ (■)»
the radioactivity (•) and glutathione S-transferase activity with
1-chloro-2,4-dinitrobenzene (A) were measured. The solid
















Figure 3. 2 Bio-Gel moi. wt. calibration curve. The moi. wt.
of the cholic acid-binding component(s) (■), and the glutathione
S-transferases (GSAT) in rat liver cytosol were estimated by
comparing their elution volume from the Bio-Gel A-0.5 m column
(2.5 cm x 38 cm) with the elution volumes of standards (20 mg
of protein), immunoglobulin G (IgG), rat albumin (A), ovalbumin
(O), myoglobin (M) and ribonuclease A (R).
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The elution pattern of cytosol from a Bio-Gel column
3
equilibrated with [ H] cholic acid (Fig. 3.1) demonstrated that
bound cholic acid coeluted with glutathione S-transferase
activity. The mol, wt. of the binding component(s) was
3
determined by comparing the elution volume of bound [ H] cholic acid
with that of various protein standards. Fig. 3.2 shows that both
glutathione S-transferase activity and choiic acid-binding activity
eluted from Bio-Gel with proteins of moi. wt. about 43 000.
However, since several distinct enzymes, of similar mol. wt.,
have glutathione S-transferase activity the enzyme mixture was
further examined for cholic acid-binding activity.
Cholic acid-binding to individual glutathione S-transferase enzymes
A partial separation of the transferases in liver cytosol was
achieved by a combination of CM-Sephadex and DEAE-Sephadex
chromatography as described on pp. 46-47.
CM-Sephadex resolved rat liver cytosol into 5 peaks of
glutathione S-transferase activity (measured by the conjugation
of l-chloro-2, 4-dinitrobenzene and GSH) (Fig. 3.3). These peaks
were designated 1-5 by their elution volumes; peak 1, 15-40 ml;
peak 2, 43-85 ml; peak 3, 91-115 ml; peak 4, 130-180 mland peak 5,
197-241 ml. Enzyme activity in peak 4 included a shoulder
Elution volume (ml)
Figure 3. 3 Elution pattern of cytosol from normal rats from
CM-Sephadex. Rat liver cytosoi (approx. 325 mg of protein) from
normal rats was dialysed against buffer D and eluted from a column
(2.2 cm x 15 cm) of CM-Sephadex C-50. Fractions (2.7 ml) were
collected and the Na+ concentrations (■) determined. Glutathione
S-transferase activity was also measured using l-chioro-2, 4-
dinitrobenzene (A) or 1, 2-dichloro-4-nitrobenzene (O) as substrate.
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indicating the presence of at least two enzymes.
Peaks 1, 2 and part of peak 4 (elution volume 155-180 ml)
were able to catalyse the conjugation of GSH with 1, 2-dichloro-
4-nitrobenzene. A small peak, containing 1, 2-dichloro-4-
nitrobenzene:GSH conjugating activity, was eiuted between peaks
3 and 4 (elution volume 115-130 mi). Enzyme activity in peak 4
was partially resolved by CM-Sephadex chromatography since the
initial fractions (elution volume 130-154 ml) were unable to
catalyse the conjugation of GSH with 1, 2-dichloro-4-nitrobenzene
whereas the later fractions (elution volume 155-180 mi), were able
to catalyse the conjugation of GSH with both l-chloro-2, 4-dinitrobenzene
and 1, 2-dichloro-4-nitrobenzene.
The combined elution profile of the 1-chloro -2, 4-dinitrobenzene:
GSH and 1, 2-dichloro-4-nitrobenzene:GSH conjugating activities from
CM-Sephadex demonstrated the presence of at least 7 glutathione
5-transferases in hepatic cytosoi; 6 were able to catalyse the
conjugation of l-chloro-2, 4-dinitrobenzene and GSH.
The glutathione S-transferases which eiuted from CM-Sephadex
in peak 4 (elution volume 130-180 ml) were further resolved by DEAE-



















Figure 3.4 DEAE -Sephadex chromatography of peak 4. Cytosol
was eiuted (20.4 ml/h, 4°C) from a CM-Sephadex coLumn (2.2 cm
x 15 cm) and peak 4 (eiution volume 130-180 mi) was combined and
concentrated. After dialysis against buffer I, peak 4 was eiuted
(20.4 ml/h, 4°C) from a DEAE-Sephadex coiumn (2.2 cm x 15 cm)
Fractions (3.4 mi) were collected and the glutathione S-transferase
activity with 1-chioro-2, 4-dinitrobenzene (A) and 1, 2-dichioro-4-
-L.
nitrobenzene (O) and the Na' concentration (■) were measured.
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designated 4(i) (elation volume 20-53 mi) and 4(ii) (eiution volume
127-153 ml). Peak 4(i) was able to catalyse the conjugation of
GSH with only 1-chloro-2,4-dinitrobenzene whilst peak 4(ii)
was able to catalyse the conjugation of GSH with both l-chloro-2,
4-dinitrobenzene and 1, 2-dichloro-4-nitrobenzene. On the basis of
substrate specificity, peak 4(i) probably elutea from CM-Sephadex
in the initial fractions of peak 4 (130-154 ml) and peak 4(ii) in
the later fractions of peak 4 (155-180 mi). In this thesis the
transferases were defined as peaks 1, 2, 3, 4(i), 4(ii) and 5 by their
eiution order from the ion-exchangers CM-Sephadex and DEAE-
Sephadex as shewn in Table 3.1.
Peaks 1, 2, 3, 4(i), 4(ii) and 5 were individually combined
and analysed for cholic acid-binding activity by an equilibrium
chromatographic method as described. Binding by peaks 1, 3,
4(i) and 5 was associated with enzyme activity (Fig. 3.5a & b).
Cholic acid-binding by peak 1 was not restricted to enzyme containing
fractions, but was also found in fractions with the same eiution volume
as rat albumin (110 mi). Peak 1 also contained a component of mol.
wt. about 17 000 which bound cholic acid. This may be the low
mol. wt. lithocholic acid-binding protein previously described by
Strange et al. (1977a). No cholic acid-binding was demonstrated
in peaks 2 or 4(ii) despite the recovery cf substantial enzyme activity.
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Table 3.1 Nomenclature used to define the glutathione S-transferase
containing peaks. The glutathione S-transferases from rat liver cytosol
were initially resolved by CM-Sephadex chromatography into 5 peaks
of GSH:l-chioro-2,4-dinitrobenzene conjugating activity (Fig. 3.3).
These enzyme-containing peaks were designated 1-5 by their
elution order from CM-Sephadex. Peak 4 was further resolved
into 2 peaks of GSH:i-chloro-2, 4-dinitrobenzene conjugating activity
(Fig. 3.4). These enzyme-containing peaks were designated 4(i)
and 4(ii) by their elution order from DEAE -Sephadex.
Peak Elution volume from Elution volume from












Figure 3.5a Eiution pattern of individual glutathione S-transferase
3
peaks from Bio-Gel equilibrated with [ H]cholic acid. The transferase
peaks 1, 2 and 3 obtained after ion-exchange chromatography were
concentrated and dialysed against buffer C. They were then eluted
(20.5 ml/h, 4°C) from a Bio-Gel A-0.5 m column (2.5 cm x 38 cm)
3
equilibrated with [ H] cholic acid; peak 1, a; peak 2, b and peak 3, c.
Fractions (3.4 ml) were collected and the A (■), radioactivity (•)2oU
and glutathione S-transferase activity with 1-chioro-2,4-dinitrobenzene
(A) were measured. The solid horizontal line represents the
radioactivity in the eluting buffer.
Conjugationagl tath ewi hl-chloro-2,4-diniti benzenelA/mp rl)
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Figure 3.5b Eiution pattern from Bio-Gel of the individual glutathione
3
S-transferase peaks equilibrated with [ H] cholic acid. The transferase
peaks 4(i), 4(ii) and 5 obtained after ion-exchange chromatography
were concentrated and diaiysed against buffer C. They were then
eluted (20.5 ml/h, 4°C) from a Bio-Gel A-0.5 m column (2.5 cm x 38 cm)
3
equilibrated with [ H] cholic acid; peak 4(i), d; peak 4(ii), e and
peak 5, f. Fractions (3.4 ml) were collected and the A (1),2o(J
the radioactivity (•) and glutathione S-transferase activity with
l-chloro-2, 4-dinitrobenzene (A) were measured. The solid horizontal
line represents the radioactivity in the eluting buffer.
97
Cholic acid-binding, other than that found in the albumin -
containing fractions from peak i, therefore, appears to be
associated with proteins which coeiute with giutathione S-transferase
activity. The oniy transferase which has previousiy been reported
to bind cholic acid is ligandin (Tipping_et ah , 1976).
Lithochollc acid-binding to liver cytosol
Gel-exclusion chromatography of a mixture of cytosol and
lithochoiic acid from a calibrated Bio-Gel column, demonstrated
the presence of two types of binding species (Fig. 3.6). The
larger binding component (moi. wt. about 43 000) eluted with
giutathione S-transferase activi ty whilst the smaller binding component
had a mol. wt. of about 17 000. The 43 000 moi. wt. component bound
0. 67±0.09 jimol lithochoiic acid/g supernatant protein (mean±S.E.M.,
n = 3) and the 17 000 mol. wt. component 1.67±0«10 pmol lithochoiic
acid/g supernatant protein (mean* S. E. M., n = 3).
Lithochoiic acid-binding to the glutathione S-transferases
To identify the iithocholic acid-binding glutathione S-transferases,
cytosoi (12 mi; approx. 325 mg protein), which had been dialysed against
o 14
buffer D, was incubated (60 min, 4 C) with [ C] lithochoiic acid
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Figure 3. 6 Elution pattern of cytosoi and [ CJlithochoiic acid
from Bio-Gei. Rat iiver cytosoi (approx. 40 mg of protein) was
o 14
incubated (60 min, 4 C) with [ C]iithochoiic acid (0.3^iCi, approx.
0.5 jimoi) and eiuted from a Bio-Gei A-0.5 m coiumn (2.5 cm x
38 cm). Fractions (3.7 ml) were collected and the radioactivity
(•) and glutathione S-transferase activity with l-chioro-2, 4-dinitro-
benzene (A) were measured. The eiution volumes of Dextran Blue
(BD), immunoglobulin G (IgG), rat albumin (A), ovalbumin (OA),
myoglobin (M), ribonuclease (R) and Na+ (Na) are shown.
99
(luCi; 16 nmoi) and the mixture eluted from a CM-Sephadex column
14
(2.2 cm x 15 cm). Preincubation of cytosol with [ C]iithocholic
acid did not alter the transferase elution pattern from CM -Sephadex .
The radioactivity eluted with enzyme activity in peaks 1 and 3 and also
with the initial fractions of peak 4 (elution volume 130-154 ml,
peak 4(i)) (Fig. 3.7).
14
Elution of [ C]lithocholic acid alone from the CM-Sephadex
column resulted in elution of the radioactivity between 20-40 ml
suggesting that at least some of the lithocholic acid associated with
peak 1 may be in free solution. The presence of a 43 000 mol. wt.
binding component in these fractions was shown as follows;
cytosol was eluted from the CM-Sephadex column and the fractions
from peak 1 were combined and dialysed against two changes, each
o
of 2 litres, of buffer C (16 h, 4 C). A portion of this solution
o 14
(40 mg of protein) was incubated (60 min, 4 C) with [ C]lithocholic
14
acid (luCi; 16 nmol) and eluted from the Bio-Gel column. [ CJLitho-
cholic acid eluted with a component of 43 000 mol. wt.
(binding capacity 38 nmol/g of protein) and also with a component
of 17 000 mol. wt. (binding capacity 120 nmol/g of protein). The
higher mol. wt. binding component eluted with glutathione S-transferase
activity. Although a relatively smaller amount of lithocholic acid was




Figure 3.7 Elution pattern of cytosoi and [ CJlithocholic acid
from CM-Sephadex. Rat liver cytosoi (approx. 325 mg of protein)
14
was diaiysed against buffer D, incubated with [ CJlithocholic acid
and eluted from CM-Sephadex as described. Fractions (2.7 mi) were
collected and the radioactivity (•) and Na+ concentrations (!) were
determined. Glutathione S-transferase activity was also measured
using l-chloro-2, 4-dinitrobenzene (A) or 1, 2-dichloro-4-nitrobenzene
(O) as substrates.
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the transferase peak 1 which was obtained after CM-Sephadex
chromatography (elution volume from CM-Sephadex 15-40 ml) than
was associated with the 17 000 moi. wt. binding component which
was obtained from whole cytosol this difference may only reflect
loss of the component during dialysis (membrane cut off 12 000 -
14 000). When this experiment was repeated using samples from
the peak 3 transferase and the peak 4 (i) transferase (Table 3.1)
the 17 000 mol. wt. component was not present; radioactivity was
associated only with glutathione S-transferase activity. Peaks 3 and
4(i), which eluted from the CM-Sephadex column on the NaCl gradient
at Na+ concentrations of 40 mM and 57 mM , contain the two previously
described lithocholic acid-binding proteins (Strange et al., 1977b).
Subunit composition of the glutathione S-transferases
The glutathione S-transferases were partially purified by a
combination of gel-exclusion chromatography and ammonium sulphate
fractionation before being separated by CM-Sephadex and DEAE-
Sephadex chromatography. The partial purification is described
on pp. 55-56. It involved eluting cytosol from a Bio-Gel column and
combining the fractions which contained maximum transferase activity.
Ammonium sulphate was added to the enzyme containing eiuate and the
fraction which precipitated between 55-85% saturation was combined. This
fraction was eiuted from CM-Sephadex and the transferase peaks 1-5 were
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Table 3.2 Elation characteristics, subunit compositions and choiic
acid-binding by glutathione S-transferases from rat liver cytosoi.
The glutathione S-transferases in rat liver cytosoi were separated
by a combination of CM-Sephadex and DEAE-Sephadex chromatography.
Their monomer composition was determined by SDS/poiyacryiamide
gei electrophoresis and their ability to bind choiic acid by an equilibrium
chromatographic method.
Peak Elution volume Elution volume Percentage Choiic
(ml) from (mi) from subunit acid































individually pooled. The subunit compositions of peaks I, 2, 3 and 5
were determined after CM-Sephadex chromatography. Peak 4 was
further resolved into peaks 4(i) and 4(ii) by DEAE-Sephadex
chromatography before analysis. Portions (10-20 jig of protein) of
each transferase peak (1-5) were analysed by discontinuous
SDS/polyacrylamide gel electrophoresis. The gels were scanned
at 580 nm, as described, and the percentage monomer composition
of each peak was calculated (Table 3.2). Peak 1 probably comprises
a mixture of transferases since it contains mainly unequal amounts
of the Yb and Yc monomers. ' Peak 2 appears to comprise a YbYb
dimer. Peak 3 comprises a YaYa dimer. Peak 4(i) appears to comprise
a YaYc dimer and peak 4(ii) a YbYb dimer. Peak 5 probably comprises
a YcYc dimer. Although peaks 2 and 4(ii) eluted differently from
CM-Sephadex both appeared to comprise a YbYb dimer.
Effect of phenobarbitone on the glutathione S-transferases
Habig et al. (1974b, 1976a) have prepared 6 of the glutathione
S-transferases and termed them E and D (eiuted together) and C,
B, A and AA by their order of eiution from CM-ceiluiose. Transferases
B, A and AA elated with a NaCl gradient. On the basis of eiution
volume, substrate specificities and cholic acid-binding activity,
either of the two iithocholic acid-binding proteins (LBa and LBb) eiuted
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in peaks 3 and 4(i) could be ligandin.
Phenobarbitone administration has been reported to increase the
concentration of hepatic ligandin (Arias et al., 1976) and the effect
of this agent on the elution profile of the glutathione S-transferases
from CM-Sephadex was studied (Fig. 3.8). A comparison of the
eiution profiies obtained from normal rats (Fig. 3.3) and from
phenobarbitone -treated rats (see p. 43 ) (Fig. 3. 8) shows that the
elution volumes of the glutathione S-transferase peaks were not
changed by phenobarbitone treatment. Transferase activity
in peaks 1 and 2, measured using either l-chioro-2 , 4-dinitrobenzene
or 1, 2-dichloro-4-nitrobenzene was unaffected by phenobarbitone
treatment. Transferase activity in peak 3 was increased approx.
3.5-fold when measured using 1-chioro-2, 4-dinitrobenzene as the
substrate and transferase activity in peak 4 towards both substrates
was increased approx. 2-fold. Transferase activity in peak 5,
however, measured with i-chioro-2, 4-dinitrobenzene and, GSH
was similar in both groups of animals. The enzyme activities
in both the first and second parts of peak 4 were increased by
phenobarbitone treatment.
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Figure 3. 8 Elution pattern from CM-Sephadex of cytosol from
phenobarbitone-treated rats. Rat liver cytosoi (approx. 325 mg of
protein) from phenobarbitone-treated rats was dialysed against
buffer D and eluted from a column (2.2 cm x 15 cm) of CM -Sephadex
C-50. Fractions (2.7 ml) were collected and the Na+ concentrations
(■) were determined. Glutathione S-transferase activity was also
measured using 1-chloro-2, 4-dinitrobenzene (A) or 1, 2-dichioro-
4-nitrobenzene (O)as substrates.
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Effects of phenobarbitone on the subunit composition of the glutathione
S-transfe rases
The subunit composition data in Tabie 3.2 suggested that
transferase peaks 3, 4(i) and 4(ii) comprise YaYa, YaYc and YbYb
respectiveiy. The effect of phenobarbitone on the concentration of
these bands was studied.
Equai portions of cytosoi (approx. 325 mg of protein) from controi
and phenobarbitone-treated rats were chromatographed on columns of
CM-Sephadex. Electrophoresis of portions (15 ^il approx. 10 p.g of
protein) of fractions of peak 3 (91, 96, 99, 103, 107, 115 and 118 mi)
obtained from controi animals demonstrated that the concentration
of the Ya band across the peak increased with enzyme activity;
70% of the protein migrated with the Ya band in the fraction which
contained most enzyme activi ty (Fig. 3.9). This provides further
evidence that a YaYa dimer is responsible for the enzyme activity
in peak 3 (Fig. 3.3) and is in agreement with the results in Table
3.2. Phenobarbitone-treatment resulted in a 3-fold increase in
the amount of the Ya monomer. Only small amounts of the Yb and
Yc monomers were found in control animals, the amounts of these




Figure 3.9 Examination of the subunit composition of peak 3
using SDS/poiyacrylamide gel electrophoresis. Peak 3 was prepared
by CM-Sephadex chromatography of hepatic cytosol. The fractions
which eluted at 91, 96, 99, 103, 107, 115 and 118 ml across peak 3
were collected and 25 |il (approx. 15 |ig of protein) was taken for
electrophoresis. The samples were applied from left to right:
whole hepatic cytosol and fractions eluted at 91, 96, 99, 103, 107,
115 and 118 ml. The origin is at the top of the gel and samples
were run down towards the anode. The Ya (mol. wt. 22 000),
Yb (mol. wt. 23 500) and Yc (mol. wt. 25 000) bands are
indicated.
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For normal rats, electrophoresis of purtions (15 |il, approx.
15 jig of protein) of fractions from peak 4 (136, 141, 147, 157, 165
and 173 ml) (Fig. 3.10) demonstrated a change in the Ya, Yb, Yc
subunit composition (Fig. 3.11). The initial fractions contained
primarily Ya and Yc, in equai concentrations, whilst the later
fractions contained predominantly Yb. The Yb content changed
from approx. 16% (elution volume 136 ml) to 55%(elution volume
173 ml) of the total Ya Yb Yc protein; this suggested that a "Va Yc
dimer is responsible for the enzyme and lithocholic acid-binding
activities in the initial fractions of peak 4 (peak 4(i)), and a YbYb
dimer for the enzyme activity in the iater fractions (peak 4(ii)) and
agrees with the data in Table 3.2. After phenobarbitone treatment
the concentration of the Ya, Yb and Yc bands were each increased
approx. 2-fold in ail the fractions across peak 4 (Fig. 3.11). The
concentration of other bands was unchanged. Phenobarbitone
treatment therefore appears to induce both of the two partially
resolved glutathione S-transferases in peak 4.
Peak 3 and the initial fractions of peak 4, which contain the
two lithochoiic acid -binding proteins LBa and LBb, are both
induced by phenobarbitone treatment and could therefore be ligandin.
Ligandin has been described as a YaYc dimer (Daniei e_t al_., 1977;




Figure 3.10 SDS/poiyacrylamide gel electrophoresis of peaks 3
and 4. Peaks 3 and 4 were prepared by CM-Sephadex chromatography;
the three fractions which eiuted in peak 3 with maximum enzyme activity
were combined and fractions which eiuted at 136, 141, 147, 157, 165
17 3 ml across peak 4 were collected and 25 jil (approx. 20 p.g of
protein) was removed from each fraction and prepared for electro¬
phoresis. The samples were applied from left to right: whole hepatic
cytosol, the 3 combined fractions (eiuted 99-107 ml) from peak 3,
and fractions eiuted at 136, 141, 147, 157, 165 and 173 ml. The
origin is at the top of the gel and samples were run down towards the
anode. The Ya (mol. wt. 22 000), Yb (mol. wt. 23 500) and Yc




Figure 3.11 Phenobarbitone induction of peak 4 proteins. Peak 4
was prepared by CM-Sephadex chromatography of whole cytosol.
Electrophoresis of samples (25|ii) from fractions which eluted
at 136, 141, 147, 157, 165 and 173 from both phenobarbitone-treated
and untreated rats was performed as described. The relative
concentration in the peak 4 fractions of Ya (A— A), Yb (■— ■)
and Yc (•—•) in untreated rats and Ya (A A), Yb (□ □) and
Yc (O O) in phenobarbitone-treated rats was determined by
densitometry ana expressed as a percentage of the total protein
in each fraction.
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peak 4. However, Bass_etaJ_. (1977a) have shown that their preparation
of iigandin contained predominantly YaYa protein which is consistent
with it being eluted in peak 3 while Carne_et al_. (1979) prepared
ligandin which could be resolved into a YaYa protein and a YaYc protein.
The identity of the two bile acid-binding proteins LBa and LBb was
therefore further investigated by preparing independendy ligandin
(see Table 2.3) and glutathione S-transferase B (see Tabie 2.2) and
studying the elution behaviour of the two purified proteins from
CM-Sephadex.
Elution of ligandin and glutathione S-transferase B from CM-Sephadex
Chromatography of ligandin from CM-Sephadex resulted in
elution of a peak (85-120 ml) of protein and enzyme activity
(measured with l-chloro-2, 4-dinitrobenzene and GSH) at a Na^
concentration of 40 mM (Fig. 3.12). Glutathione S-transferase
B was eluted (130-155 ml) from CM-Sephadex as a single peak of
protein and enzyme activi ty (measured with l-chloro-2, 4-dinitrobenzene
and GSH) at a Na+ concentration of 57 mM (Fig. 3.12). The glutathione
S-transferase activity of ligandin and glutathione S-transferase B using
1, 2-dichioro-4-nitrobenzene was less than 0.3% of that with 1-chloro-
2,4-dinitrobenzene. When either ligandin or glutathione S-transferase
o 14
B was incubated (4 C, 60 min) with [ C]lithocholic acid (luCi; 16 nmol)
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Figure 3.12 CM-Sephadex chromatography of glutathione
S-transferase Band ligandin. Glutathione S-transferase Band iigandin
were prepared and 5 ml (approx. 1 mg) of each preparation was
eluted (16.0 ml/h) from CM-Sephadex C50. Fractions (2.7 ml) were
collected and the Na+ concentration (1) determined. The results from
the separate chromatography of the two protein preparations are combined.
GSH: l-chioro-2, 4-dinitrobenzene conjugating activities in the eluate
from chromatographed ligandin (A) and glutathione S-transferase B
(A) are shown.
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before elation from CM-Sephadex , single peaks of radioactivity elated
with the protein peaks indicating that both iigandin and glutathione
S-transferase B bind lithocholic acid.
Subunit composition of .LB a and LBb
The two iithocholic acid-binding proteins, LBa (ligandin) and
LBb (glutathione S-transferase B), were prepared as described
(Table 2.4). SDS/polyacrylamide gel electrophoresis of portions
(15 gg of protein) of the two binding proteins showed that the LBa
protein migrated as a single band, which was identified as the Ya
monomer and the LBb protein migrated as two bands, identified
as the Ya and Yc monomers (Fig. 3.13). In both cases there was
no evidence that any protein in either of the samples was excluded
\
from the resolving gel. Densitometry of the gel pattern obtained
from LBa indicated that 98-99% of the sample applied migrated with
the Ya monomer. Densitometry of the gel pattern obtained from
LBb indicated that the Ya and Yc monomers contained equal amounts
of protein. No other protein bands were detected even when the





Figure 3.13 SDS/poiyacrylamide gel electrophoresis of the
two iithocholic acid-binding proteins (LBa and LBb). LBa and
LBb were purified and prepared for SDS/polyacryiamide gel
electrophoresis. Portions of each protein (15 pg) were applied
to the gels (11.5% polyacrylamide resolving gel) and were run
from the cathode (top) to the anode (bottom). Purified protein
which eluted from CM-Sephadex at a Na concentration of
40 mM (LBa) was applied to the left hand side of the gel and
protein which eiuted at a Na+ concentration of 57 mM (LBb)
was applied to the right hand side of the gel.
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Isoelectric focussing of LBa and LBb
Thin-layer polyacrylamide gel isoelectric focussing of portions
(25 p.g of protein) of LBa and LBb was performed as described
(pp. 56-57). This showed that each focussed as single bands
in the pH 7-10 range. There was no evidence, in either preparation,
that protein was excluded from the polyacrylamide gel at the point
of application. Densitometry of the gel pattern obtained from
either binding protein failed to demonstrate the presence of other
protein bands. The pi for LBa was pH 8.7 and that for LBb pH 8.6
(Fig. 3.14).
Purity of LBa and LBb
The combination of SDS/polyacrylamide gel electrophoresis
and polyacrylamide gel isoelectric focussing indicated that the
preparations of LBa and LBb were highly puri fied . Although
LBa was not completely homogeneous at least 98% of the stainable
protein migrated as a single band when examined using the two
electrophoretic systems. SDS/polyacrylamide gel electrophoresis
indicated that LBb comprises two non-identical monomers; at least
99% of the protein migrated with the two monomeric bands. Isoelectric








Figure 3.14 Thin-layer polyacrylamide gel isoelectric focussing
of LBa and LBb. LBa and LBb were prepared as described and portions
of each protein (25 jig) were applied to the gels using electrofocussing
strips (in the photograph LBa is on the left hand side and LBb is on
the right hand side). After electrophoresis (3 h) the pH range obtained
was determined by eiuting the carrier-ampholines from gel slices
as described. The pH at the cathode (top) was 9.9 and at the anode
(bottom) 6.7.
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sample from LBb migrates as a single band.
Amino acid compositions
The amino acid compositions of LBa (ligandin) and LBb
(glutathione S-transferase B) were determined to see whether the
two proteins possessed similar compositions, and could therefore
be coded for by the same gene(s), or different compositions, and
could therefore be the products of separate genes. To enable
this comparison to be made the two proteins were simultaneously
subjected to identical analytical procedures.
Table 3.3 presents the quantitative data obtained from the amino
acid analysis of LBa and LBb. No significant differences between the
compositions of the two proteins were detected. The largest differences
observed between the two proteins, after the 24 h HC1 hydrolysis,
were in the recoveries of leucine and lysine. However the differences
were within the 3% error limits which Schroeder (1969) suggested was
the precision of the method when carrying out duplicate determinations.
Both proteins contained large amounts of aspartic acid(Asx),
glutamic acid (Glx), alanine, leucine and lysine; in both cases these
amino acids accounted for more than 50% of the total amino acids
recovered from the hydrolysate. No glucosamine or galactosamine
was recovered from either LBa or LBb.
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Amino acids recovered after hydrolysis (/j. mol)
LBa LBb
24 h 96 h Ox Mesa 24 h 96 h Ox Mesa
Lys 0.185 0.186 0.191 0.188
His 0.030 0.025 0.028 0.027
Arg 0.110 0.112 0.114 0.118
nh3 0.304 0.401 0.318 0.381
Asx 0.183 0.186 0.190 0.186 0.182 0.185 0.193 0.191
Thr 0.057 0.039 0.054 0.053 0.059 0.041 0.055 0.054
Ser 0.085 0.039 0.083 0.083 0.084 0.045 0.079 0.081
Glx 0.220 0.233 0.221 0.222 0.219 0.240 0.226 0.221
Pro 0.106 0.101 0.093 0.099 0.110 0.106 0.097 0.095
Gly 0.097 0.100 0.103 0.102 0.095 0.096 0.103 0.099
Ala 0.143 0.153 0.151 0.140 0.146 0.150 0.149 0.146
i Cys 0.018* 0.019*
Val 0.102 0.124 0.115 0.089 0.099 0.121 0.117 0.090
Met 0.058 0.057 0.053* 0.060 0.059 0.058 0.054* 0.062
He 0.090 0.60 0.089 0.087 0.087 0.058 0.090 0.087
Lue 0.249 0.245 0.234 0.271 0.256 0.255 0.243 0.262
Tyr 0.071 0.062 0.082 0.073 0.064 0.079
Phe 0.080 0.079 0.077 0.080 0.082 0.078 0.078 0.078
Trp 0.002 0.002
Correction
1.00 1.05 0.96 0.98 1.00 0.98 1.07 1.03
Factor
Table 3. 3 Amino acid composition of LBa and LBb. Samples of
LBa and LBb were hydroiysed in either 6M - HC1 for 24 h and 96 h
or 3M -mercaptoethanesulphonic acid for 24 h (Mesa). Portions
of LBa and LBb were also treated with performic acid and the oxidixed
protein hydroiysed in 6M -HC1 for 24 h (Ox). The results obtained
are presented in jimol of amino acid recovered from the column.
Different samples were normalized on Gly, Ala, Leu, Asx, Glx, Phe,
Lys and Arg as described and the correction factor applied to each
sample is indicated. In the Ox samples Cys and Met were recovered
as cysteic acid and methionine sulphone and the corresponding
recoveries are marked with an asterisk (*).
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These are identifiable as they elute from the long column (0.9 cm
x 50 cm) of the Beckman-Spinco Amino Acid Analyser after the
acidic and neutral amino acids.
A comparison between the analysis of the 24 h and the 96 h
HCHhydrolysis of either protein revealed striking differences in the
recoveries of threonine, serine, valine and isoleucine. However,
in each case, the recoveries of these amino acids after 96 h
HC1-hydrolysis, from LBa and LBb, was similar and no obvious
differences between the two proteins were observed. The loss
of threonine from both LBa and LBb between the 24h hydrolysis
and the 96 h hydrolysis was 32%. Both proteins therefore lost
threonine to the extent of 11% per 24 h of hydrolysis. The loss
of serine from LBa and LBb between the 24 h hydrolysis and the
96 h hydrolysis was 54% and 46% respectively. LBa and LBb
therefore lost serine to the extent of 18% and 15% respectively
per 24 h of hydrolysis. In both instances the hydrolytic loss of
threonine and serine was greater than expected. Normally threonine
and serine are destroyed to the extent of 5% and 10% respectively
per 24 h of hydrolysis (Schroeder, 1969). However, this result may
only reflect the individual behaviour of different proteins.
A lower recovery of isoleucine was also obtained from the 96 h
hydrolysis than from the 24 h hydrolysis of either protein (33% loss
in both proteins). This was an unexpected result as the recovery
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of this amino acid normally increases with prolonged hydrolysis, and
the isoleucine content of proteins is normally calculated by extrapolation
to infinite hydrolysis time (Schroeder, 1969). This finding may be
due to the recovery of an additional peak, which eluted between methionine
and isoleucine, which was found in the 96 h hydrolysates. This peak was
found in both LBa and LBb and was provisionally identified as ailo-
isoieucine (Dr. R. P. Ambler, personal communication).
In both proteins the recovery of valine was found to increase
between the 24 h hydrolysis and the 96 h hydrolysis. This increase
was calculated as 22%and 23% for LBa and LBb respectively over
the 72 h period.
Performic acid treatment of LBa and LBb and subsequent
hydrolysis revealed no difference in the cysteine and/or cystine
content of the two proteins. However, since this approach does not
permit cysteine or cystine to be distinguished from each other, this
method does not remove the possibility that differences exist between
LBa and LBb in the oxidation state of these residues.
The use of mercaptoethanesulphonic acid to enable the tryptophan
content of the two proteins to be determined also revealed no
differences between the two proteins.
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Table 3.4 shows the amino acid compositions of LBa and LBb.
The results were calculated from the 24 h hydrolyses using the
mol. wts. which were determined by SDS/polyacryiamide gel
electrophoresis. They are expressed as moles of amino acid/44 000 g
protein for LBa and as moles of amino acid/47 000 g protein
for LBb. The actual moi. wt. of LBa and LBb calculated from the amino
acid values are 44 010 and 47 040 respectively (Asx, Glx and ^Cys
were assigned mol. wts. of 133, 147 and 121 respectively). Table
3.4 shows that the amino acid compositions of the two proteins were
very similar when expressed as a percentage of the total amino acids
recovered. However, small differences between LBa and LBb were
observed when the results were expressed as residues/mol of
transferase. These differences were most noticable in the case of
residues such as lysine, arginine, alanine and leucine, which were
present in large amounts. The results of Table 3.4 can only be
regarded as approximate since no corrections were made to the
data to allow for the loss of serine or threonine (by extrapolation
to zero hydrolysis time) or the increase in the recovery
of valine with prolonged hydrolysis (by extrapolation to
infinite hydrolysis time). These corrections were not made
since analyses were performed on samples from only
two different hydrolysis times. This provided insufficient
data to permit reliable extrapolations to be made. However the




Amount of amino acid
as % of total recovered Residues/mol
LBa LBb LBa LBb
Lys 9.8 10.0 38 41
His 1.6 1.5 6 6
Arg 5.8 6.0 22 25
Asx 9.7 9,5 38 39
Thr 3.0 3.1 12 13
Ser 4.5 4.4 17 18
Glx 11.7 11.5 45 47
Pro 5.6 5.8 22 24
Gly 5.1 5.0 20 21
Ala 7.6 7.7 29 32
5 Cys 1.0 1.0 4 4
Val 5.4 5.2 21 21
Met 3.1 3.1 12 13
lie 4.8 4.6 18 19
Leu 13.2 13.4 51 55
Tyr 3.8 3.8 15 16
Phe 4.2 4.3 16 18
Trp 0.1 0.1 - -
Total 386 412
Table 3.4 Amino acid composition of LBa and LBb. The data
presented in Table 3.3 were used to calculate the percentage amino
acid compositions of the two proteins and also the number of
moles of each amino acid per mol. of LBa or LBb as described.
The compositions were not corrected for the increased or decreased
recoveries of Ser, Thr, Val and lie.
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an estimate to be made of the number of peptides, which should be
obtained after proteolytic digestion of these two proteins. Further,
the amino acid compositions were determined to allow comparisons
to be made with the published data of Habig et al. (1974b),
Ketterer et al. (1975) and Kirsch et al. (1975).
The amino acid analyses did not reveal any major differences
between LBa and LBb and therefore both proteins may be the product
of the same gene(s). Further, the amino acid compositions and
SDS/poiyacrylamide gel electrophoresis data suggests that the
differences between the two proteins resides in only one of the two
subunits which LBa (YaYa) and LBb (YaYc) comprise. It is unlikely
that this difference is due to the oxidation state of the cysteine/cystine
residues in the two proteins since the subunit compositions were
unchanged when 2-mercaptoethanoi was either omitted, or its
concentration increased to 5% (v/v) in the electrophoresis sample
mixture. The difference between LBa (ligandin) and LBb
(glutathione S-transferase B) may however be the result of a
post-translational modification to either the Ya or Yc monomer or
both, rather than the two monomers being coded separately. The nature
of this postulated modification is not known but it is unlikely that it
is due to the addition of carbohydrate since no glucosamine or
galactosamine residues were recovered from the hydrolysates of either
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protein. LBa and LBb were therefore further examined for differences
in the primary structure of the two proteins.
Peptide "mapping" of LBa and LBb using SDS/polyacrylamide gels
Evidence for differences in the primary structure of these
two binding proteins was looked for by peptide "mapping". Peptide
"maps" were constructed by two different methods. The first
method used was that described by Cieveland et al. (1977) and
involved forming partial digests of LBa and LBb, the products of
which were large enough to be separated, according to size,by
SDS/polyacrylamide gel electrophoresis. The second method
used, was that described by Ambier (1963), involved allowing
the proteolytic digestion of LBa and LBb to continue to completion.
The digestion products were then separated, according to charge,
by high-voltage paper electrophoresis in either one or two dimensions.
"Cleveland gels" of LBa and LBb digestion products were
constructed following partial digestion with the proteolytic enzymes
chymotrypsin and staphylococcus aureus V8 protease. Limited
proteolysis of LBa and LBb with chymotrypsin followed by SDS/
polyacrylamide gel electrophoresis revealed two major digestion





Figure 3.15 Partial digestion of LBa and LBb with chymotrypsin.
Portions (50 jig) of the lithochoiic acid-binding proteins were digested
with varying amounts of a-chymotrypsin as described. After 45 min
digestion, the reaction mixtures were applied to an SDS/polyacrylamide
gel and run from the cathode (top) to the anode (bottom).
The samples applied (left to right) were; 1: Chymotrypsin (7 jig),
2-6: Lithochoiic acid-binding protein LBa (YaYa)(25 jig) and 0.0007 jig,
0.007 jig, 0.07jig, 0.7 jig, 7 jig chymotrypsin respectively, 7-11:
Lithochoiic acid-binding protein LBb (YaYc)(25 jig) and 7 jig, 0.7 jig,
0.07 jig, 0.007 jig, 0.0007 jig chymotrypsin respectively, 12:
Chymotrypsin (7 jig).
Chymotrypsin, treated in the same way as the lithochoiic
acid-binding proteins, was dissociated into its subunits (mol. wt.
approx. 17 000 and 11 000 respectively (Schroeder, 1968)) and was
used as a mol. wt. marker (channels 1 and 12).
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of the mobility of these two products with that of the subunits of
chymotrypsin showed them to have mol. wt. about 10 000 and
13 000. Figure 3.15 however, also revealed digestion products of
mol. wt. about 19 000 and 17 000 which are found in LBb but not in
LBa.
Limited proteolysis of LBa and LBb with staphylococcus
aureus V8 protease followed by SDS/poiyacrylamide gel electro¬
phoresis revealed three major digestion products which were
common to both proteins (Fig. 3.16). These had mol. wt. of
about 9000, 12 000 and 15 000. The recovery of these products
from LBa and LBb was different. The 9000 mol. wt. fragment
was recovered in highest concentration from LBa. The 12 000
mol. wt. fragment was recovered in highest concentration from
LBb. The 15 000 mol. wt. fragment was recovered in equal
amounts from both proteins. Figure 3.16 also revealed digestion
products of moi. wt. about 8500, 16 000 and 20 000 which were
found in the digests from LBa but not from LBb.
Although these two "Cleveland gels" revealed structural
differences between the two proteins, the gels also suggested that
these proteins possessed a degree of structural similarity since in
both the V8 protease and chymotrypsin digests LBa and LBb yielded
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Figure 3.16 Partial digestion of LBa and LBb with V8 protease.
Portions (50 jug) of LBa and LBb were digested with varying amounts
of staphylococcus aureus V8 protease as described. After 45 min
the digestion products were applied to an SDS/polyacrylamide gel and
run from the cathode (top) to the anode (bottom).
The samples applied (left to right) were ; 1, V8 protease
(7 jig); 2-6, LBa (25 jig) and 0.0007 jug, 0.007 jig, 0.07 jig, 0.7 jig,
7 jag V8 protease respectively; 7-11, LBb (25 jug) and 7 jig, 0.7 jig,
0.07 jig, 0.007 jig, 0.0007 jig V8 protease respectively; 12, V8
protease (7 jig).
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digestion products of similar moi. wt.. However the data obtained
from these "Cleveland gels" is only qualitative since the digests,
which were used for the comparisons, were not allowed to go to
completion. To enable a more definitive comparison between the
two proteins to be made LBa and LBb were analysed by two dimensional
peptide "mapping" procedures. In these experiments the proteolytic
digestions were allowed to go to completion and all the steps were
performed simultaneously on both proteins under identical conditions.
Peptide "mapping" of LBa and LBb using high-voltage paper electro¬
phoresis
Before preparing the multi-dimensional peptide "maps" LBa
and LBb were separately digested with thermolysin, chymotrypsin
and trypsin with a view to finding the proteolytic enzyme whose
specificity revealed the largest number of structural differences
between the two binding-proteins. The products from the 6 digests
were analysed in parallel by high-voltage paper electrophoresis
at pH 6.5 . Examination of these one dimensional peptide "maps"
indicated that thermolysin, chymotrypsin and trypsin each revealed
minor differences between LBa and LBb (Fig. 3.17). Although
different peptide "patterns" were observed it was not possible to





















Figure 3.17 One dimensional "map" of thermolysin, chymotrypsin
and trypsin digests of LBa and LBb. Portions of LBa and LBb ( 1 mg
of protein) were digested at 37°C with portions of thermolysin,
chymotrypsin or trypsin (20 pg of protein). After 6 h the digests were
freeze-dried. The lyophilised digests were then redissolved in 100 jil
of 0.1 M_NH and applied to Whatman 3MM chromatography paper from
O
left to right as follows; 1, thermolysin digest of LBb; 2, thermolysin digest
of LBa; 3, chymotrypsin digest of LBb; 4, chymotrypsin digest of LBa;
5, trypsin digest of LBb and 6, trypsin digest of LBa. These samples
were analysed by high-voltage electrophoresis at pH6.5. The origin
is marked and the cathode is at the top and the anode at the bottom
of the photograph. The peptides were divided into three groups which
were designated the basic, neutral and acidic peptides, according to
their electrophoretic mobility at pH 6.5 (Fig. 2.8).
To enable the two dimensional tryptic "maps" to be constructed,
these three groups were separated by cutting the paper after the first
dimension at the positions indicated.
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or whether both proteins produced the same number of peptides, some
of which had a different mobility from their counterparts in the other
protein, since the peptides in these one dimensional "maps" were
incompletely resolved. The electrophoretic mobility of the "difference
peptides" (or position where the peptide pattern differed in the
two proteins) was expressed in terms of the distance and direction
each migrated from the origin. These peptides were compared with
amino acid standards run in parallel. The basic amino acid markers,
lysine, arginine and histidine migrated 20 cm, 17.5 cm and 9.5 cm
respectively from the origin towards the cathode (—'VE) and were
therefore designated positions -20 cm, -17.5 cm and -9.5 cm
respectively. The "neutral" (monoaminomonocarboxylic) amino
acids migrated 2.5 cm from the origin towards the cathode (—VE) and
were therefore assigned the position -2.5 cm. The acidic amino acids,
glutamic acid and aspartic acid migrated 16 cm and 17. 8 cm
respectively, from the origin towards the anode (+VE) and were
designated positions +16 cm and +17.8 cm (Fig. 3.17).
High-voltage paper electrophoresis of the thermolysin digests
of LBa and LBb revealed differences in the pattern obtained from the
basic peptides (position on "map" - 15 cm) and the acidic peptides
(position + 15.5 cm). Differences in the LBa and LBb "map" patterns
were obtained after digestion by chymotrypsin. These differences
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were observed in the neutral peptides ("map" position -0.5 cm) and
further differences were observed in the acidic peptides (positions
+5.5 cm, +8.0 cm, +9.5 cm and +13 cm). Analysis of the tryptic
digests of LBa and LBb revealed a large number of differences
in the basic peptides (positions -17.5 cm, -15 cm, -10 cm and
-9.5 cm). A slight difference in the migration of the neutral peptides
(which produced a single broad band with a "map" position between
-2 cm and -3.75 cm) was also observed. The neutral peptides
which were obtained from LBa migrated 0.25 cm further from the
origin than the equivalent peptides from LBb. Further differences
were also observed in the pattern produced by the acidic peptides
at positions +2.5 cm and +5.0 cm. No differences were observed
in any digests between the tryptophan containing peptides (identified
by examination of the electrophoresis paper under U.V. light) obtained
from LBa or LBb. On the basis of these results trypsin was chosen
as the proteolytic enzyme to construct the two dimensional "maps"
of LBa and LBb since its specificity of action revealed the largest
number of structural differences between the two proteins.
Two dimensional peptide "maps" of LBa and LBb
The two dimensional peptide "maps" of LBa and LBb were
constructed by high-voltage paper electrophoresis at pH 6.5 in the
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first dimension and at pH 3.5 in the second dimension (Fig. 2.8).
After electrophoresis in the first dimension, of portions (1.5 mg of
protein) of the tryptic digests, the electrophoresis paper was cut,
as indicated in Fig. 3.17, into sections containing the basic peptides,
the neutral peptides and the acidic peptides. The cutting was
facilitated by running along with the 1.5 mg portions of LBa and LBb,
0.5 mg portions of LBa and LBb digests. These 0.5 mg portions
were stained, after electrophoresis, with ninhydrin and served as
markers enabling the peptides on the unstained paper to be divided
(into the "neutrals","basics" and "acidics") without cutting through
any peptides. The two pieces of paper containing the acidic peptides
from LBa and LBb were sewn on to a single piece of electro¬
phoresis paper end-to-end such that the least acidic peptides (which
were still at the original origin) from LBa and LBb were adjacent
and the direction of migration in the second dimension was at right
angles to the direction of migration in the first dimension. The basic
peptides from LBa and LBb were also sewn in a similar manner
onto a single piece of electrophoresis paper. This enabled these two
types of peptides from LBa and LBb to be directly compared and





Figure 3.18a Two dimensional "map" of the acidic peptides
from tryptic digests of LBa and LBb. The tryptic digests of portions
(1.5 mg of protein)of LBa and LBb were prepared as described. The
peptides were separated by high-voltage paper electrophoresis
at pH 6.5 in the first dimension and the acidic peptides were cut
out of the paper as described. These peptides were separated in
the second dimension by high-voitage electrophoresis at pH 3.5. The
peptides from LBa are on the right hand half of the "map" and the
peptides from LBb are on the left hand half of the "map" as
indicated (IT and 2T respectively). A diagramatic representation
of the "map" is shown in Fig. 3.18b.
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Figure 3.18b Diagramatic representation of the two dimensional
"map" of the acidic peptides from tryptic digests of LBa and LBb.
The acidic peptides from LBa and LBb were separated as described
in Fig. 3.18a. Definition of the symbols is given in the text.
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Fig. 3.18a shows the two dimensional "map" of the acidic
peptides from LBa and LBb and Fig. 3.18b shows a diagramatic
representation of the same "map". The peptide nomenclature,
which was devised to enable the multi-dimensional "maps" from
LBa and LBb to be compared, is described and is based on the
mobility of the peptides. In this nomenclature the peptides which
were common to both proteins were designated first and the
unique peptides designated second. Fig. 3.18b shows that at
least 5 peptide spots (Ala-A5a and Alb -A5b) appear to be common
to both proteins. LBb also appeared to contain several peptides
(A6b, A7b and A8b) which were not recovered from LBa .
However, although LBa did not produce any peptide spots which
were equivalent to A6b or A8b the significance of A7b is not clear
since it was obtained from the peptides which remained at the
origin, during electrophoresis at pH 6.5. Neither A5a nor A5b and
A7b, which each remained at the origin in the first dimension,
were well resolved. These peptides were recovered as elongated
smears along the axis and may not reflect real differences between
the proteins rather than the peptides adhering to the paper during
eiectrophore si s.
Fig. 3.19a shows the two dimensional map of the basic peptides




Figure 3,19a Two dimensional "map" of the basic peptides from
tryptic digests of LBa and LBb. The tryptic digests of portions
(1.5 mg of protein) of LBa and LBb were prepared as described.
The peptides were separated by high-voltage paper electrophoresis
at pH 6.5 in the first dimension and the basic peptides were cut out
of the paper as described. These peptides were separated in the
second dimension by high-voltage paper electrophoresis at pH 3.5.
The peptides from LBa are on the right hand half of the "map" and the
peptides from LBb are on the left hand half of the "map" as indicated
(IT and 2T respectively). A diagramatic representation of the "map"



















































((1)Electrophoresis at pH 6-5 ^ _
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Figure 3.19b Diagramatic representation of the two dimensional
"map" of the basic peptides from tryptic digests of LBa and LBb.
The basic peptides from LBa and LBb were separated as described
in Fig. 3.19a. Definition of the symbols is given in the text.
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of the same 'fnap'I The main bulk of peptides run diagonally across
the electrophoresis paper forming a "V"-shaped two dimensional
map. Although these are not well separated, differences in the
patterns produced by these peptides were observed. A
tentative identification of the peptides was made and 16 spots
from LBa and 18 spots from LBb were provisionally designated
Bla -B16a and Blb-B18b respectively. A marked difference between
LBa and LBb was observed in the peptides which lay outside the
main "V"-shape.
Two peptide spots were obtained from LBa (Bla and B5a) which
migrated relatively further in the second dimension than in the first
(when compared with the other peptides in the digest) and were
therefore not included in the general "V"-shaped peptide mass.
However LBb contained an additional peptide, giving a total of 3
peptide spots (Bib, B5b and B17b), which lay outside this "V"-shaped
pattern. There also appeared to be an additional peptide (B18b) in LBb
which was sandwiched between Bllb and B12b which was not observed
between Blla and B12a. Whilst it appears from the "map" that both
B17b and B18b are additional peptides which are not found in LBa
it is possible that both B5a and Blla each contain two unresolved
peptides which, due to the substitution of an amino acid, have been
resolved in LBb to produce the additional peptides. In either event,
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however, these peptides reveal structural differences between the two
proteins.
Three dimensional peptide "maps" of the neutral peptides from LBa
and LBb
The neutral peptides, obtained from LBa and LBb after electro¬
phoresis at pH 6.5, were also subjected to electrophoresis at pH 3.5
in the second dimension, as were the acidic and basic peptides (see Fig. 2.8).
However, since the first dimension resulted in the neutral peptides
running as a single band (Fig. 3.17) the second dimension produced
"maps" of LBa and LBb which comprised only single columns of peptides.
No differences in these neutral peptides of LBa and LBb were observed
but since the various peptides were poorly resolved after the second
electrophoretic run further separation of the neutral peptides was
achieved by descending chromatography in a third dimension (Figs. 3.20a
and b). Fig. 3. 20a shows the three dimensional "map" of the neutral
peptides from LBa and LBb and Fig. 3.20b shows a diagramatic
representation of the same "map". These show that at least 10 peptide
spots (Nla-NlOa and Nlb-NlOb) appear to be common to both proteins.
LBb also appeared to contain two peptides (Nllb and N12b) which were









Figure 3.20a Tryptic "map" of the neutral peptides from LBa and
LBb. The tryptic digests of portions (1.5 mg of protein) of LBa and
LBb were prepared. The single spot of neutral peptides obtained from
LBa and LBb after high-voitage paper electrophoresis at pH 6.5 (3.17)
were separated in a second dimension by high-voltage paper electro¬
phoresis at pH 3.5. These were further resolved by descending
chromatography using butan-1-ol/acetic acid/water/pyridine (15:
3:12:10, by vol.) for 16 h in a third dimension. The peptides from
LBa are on the right hand half of the "map" and the peptides from
LBb are on the left hand half of the "map" as indicated (IN and 2N
respectively). A diagramatic representation of the "map" is shown
in Fig. 3.20b.
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^Electrophoresis at pH 3-5 ^Electrophoresis atpH 35

































Figure 3. 20b Diagramatic representation of the tryptic "map"
of the neutral peptides from LBa and LBb. The neutral peptides from
LBa and LBb were separated as described in Fig. 3.20a. Definition
of the symbols is given in the text.
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The results from the three peptide "maps" shown in Figs. 3.18-
3.20 suggest that digestion of LBa with trypsin produced 31 peptides
and digestion of LBb with trypsin produced 38 peptides. If it is assumed
that LBa (YaYa) comprises two identical subunits then although only 31
peptide spots were observed each LBa molecule would produce 62
peptides. This would indicate that each LBa dimer contains a total of
60 tryptic cleavage sites. Since the specificity of trypsin is limited
to peptide bonds associated with the carboxyl groups of lysine and
arginine this suggests that LBa contains at least 60 arginine + lysine
residues per molecule. This is in agreement with the data in Table
3.4 which shows that LBa (YaYa) contains 38 lysine residues/mol
and 22 arginine residues/mol. However Table 3.4 also indicates that
LBb (YaYc) contains 3 extra lysine residues/mol and 3 extra arginine
residues/mol which suggests that tryptic digests of LBb should produce
6 more peptides than LBa. LBb in actual fact produced 7 extra peptides
which is in good agreement with what would be expected from the
amino acid compositions. The similarity of the peptide "maps"
from LBa and LBb suggests that these two proteins possess a great
deal of homology. Since LBb produced 7 extra peptides, which were
not recovered from LBa, LBb probably possesses an additional
sequence of amino acids. From the subunit compositions (Fig. 3.13)
it was calculated that this postulated sequence would comprise 26 amino
154
acids. This additional sequence does not result in the gross amino
acid compositions of LBa and LBb appearing significantly different.
This sequence therefore probably comprises amino acids whose
percentage composition is approximately the same as that of LBa




Hepatic transport of organic anions and ligandin
An important function of the liver is the removal of both
endogenous and exogenous anions from the blood and their excretion
into bile. Various anionic dyes have been used clinically to test this
ability of the liver; most commonly used are bromosulphophthalein
(Kaplowitz et ai., 1973) and indocyanine green (Kitazima &
Shibata, 1975). Because of its association with jaundice, bilirubin
clearance by the liver has been extensively studied and, to a large
extent, present understanding of hepatic anion transport has been
shaped by investigations into bilirubin transport. Bernstein et al.
(1966) showed that when radioactive bilirubin is injected intra¬
venously into rats, 60% of the injected bilirubin is found in the liver
supernatant and 40% in the liver particulate fraction. Gel-exclusion
chromatography of a mixture of rat liver cytosoi and bilirubin
demonstrated that 80% of the bilirubin in supernatant is bound to a
protein of mol. wt. 45 000 (Levi et al., 1969b; Arias et al., 1976).
This protein was called Y protein and since it also bound bromo¬
sulphophthalein and indocyanine green it was proposed that it was
involved in the intrahepatic transport of various anions. Phylogenetic
studies (Levine et ai., 1971) and investigations into neonatal jaundice
(Levi_et ad., 1969a, 1970) supported this hypothesis. Although the
involvement of Y protein in anion transport was not clearly defined,
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it was none-the-less generally assumed that it served as a general
carrier protein which transported anions from the sinusoidal membrane
to the canalicular membrane.
Litwack_et al_. (1971) reported that the Y protein, described by
Arias and his co-workers, was the same protein as a carcinogen-
binding protein, which had been isolated by Ketterer_et al_. (1967),
and a Cortisol-metabolite-binding protein, which had been purified
by Morey & Litwack (1969); the three protein preparations possessed
similar physicochemical and immuno-chemical properties. The three
groups renamed their respective proteins ligandin. The name
ligandin emphasised the widely held belief that this protein was
responsible for the intrahepatic transport of a large number of anions.
In addition to its anion-binding properties ligandin was subsequently
shown to possess enzyme activity (Kaplowitz et al., 1973) and Habig
et al. (1974b) reported that in the rat liver ligandin, prepared by the
method of Arias and his co-workers, is identical to glutathione S-transferase
B. There are at least 7 glutathione S-transferases in rat liver cytosol
and Ketley _et al_. (1975) have shown that transferases C, B, A and AA
were ail able to bind bilirubin and indocyanine green. These workers
suggested that although binding was not specific, ligands should possess
a hydrophobic moiety for binding to take place. Further, Ketley et al.
(1975) suggested that since the term ligandin was used to describe a
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protein with a wide range of binding affinities, ail the glutathione
S-transferases could therefore be called ligandins.
The reason for the large number of similar glutathione S-
transferases in rat liver cytosol is not clear. It is not known
whether each of the ionically distinct enzymes is the product of a
separate gene or whether several transferases are coded for by a
single gene. It appears likely that at least several of these enzymes
are coded for by a single gene since transferases A and C have
similar amino acid compositions and antisera raised against either
enzyme cross-reacts with the other transferase (Habig et al., 1974b).
This possibility is supported by the observation that although there are
7 transferases they each comprise 2 of only 3 possible monomers
(Bass et al., 1977a). An analogy may exist between the situation in
human liver, where 5 ionically distinct transferases were purified which
were postulated to have arisen as a result of an in vivo deamidation
of a single gene product, (Habig et al., 1976a).
The major group of anions transported by the liver are the bile acids.
In man and rat the liver transports 30 g and 200 mg of bile acids and bile
salts per day respectively. Since the bile acids possess a hydrophobic
moiety, the perhydrocyciopentanophenanthrene ring structure, it is
likely that certain glutathione S-transferases would bind this group
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of compounds. Strange_et ah (1977b) have purified two iithochoiic
acid -binding proteins from rat liver cytosol. Although neither protein
was identified, both possessed glutathione S-transferase activity.
These two proteins may be involved in bile acid transport across the
hepatocyte.
Aims of the study
The aims of this thesis were to ; (1), determine whether any of
the transferases bound the quantitatively important primary bile acid,
choiic acid; (2), determine whether the proteins which bound choiic
acid and lithocholic acid possessed a common subunit (Ya, Yb or Yc);
(3), identify the two purified lithocholic acid-binding proteins and
(4), determine whether these two proteins could be the product of
a single gene or whether they are coded separately and therefore
represent isoenzymes.
Bile acid binding by glutathione S-transferases
The experiments described show that at least 7 peaks of glutathione
S-transferase activity in hepatic cytosol can be resolved by CM-Sephadex
chromatography; of these 6 were able to catalyse the conjugation of
GSH with l-chioro-2,4-dinitrobenzene. These 6 were designated
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peaks 1, 2, 3, 4(i), 4(ii) and 5 according to their order of eiuticn
from CM-Sephadex. The cholic acid-binding activity of these 6
enzyme-containing peaks was examined by an equilibrium
chromatographic method which showed that peaks 1, 3, 4(i) and
5 bound the bile acid. Although only ligandin has previously been
reported to bind cholic acid (Tipping et al., 1976), these
experiments show that at least 4 transferases bind this bile acid.
The lithocholic acid-binding activity of the glutathione S-transferases
was examined by a non-equilibrium chromatographic method which
showed that peaks 1, 3 and 4(i) bound lithocholic acid. These
experiments show that 3 of the enzyme-containing peaks bind both
bile acids. However, although these results suggest that peak 5
possesses only cholic acid-binding activity the cholic acid and
lithocholic acid-binding data are not directly comparable since the
lithocholic acid binding was studied under non-equilibrium conditions
which would fail to demonstrate binding in instances where the
protein: iigand interaction was weak and the compiex dissociated
during chromatography.
Since certain transferases may be coded for by a single gene
the various enzyme peaks were examined by electrophoresis to
determine whether certain functions of the various transferase peaks
could be ascribed to a particular monomer. Discontinuous SDS/
polyacrylamide gel electrophoresis indicated that cholic acid-binding
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was associated with the Ya and Yc monomers. The enzyme-containing
peaks which bound lithochoiic acid ail possessed the Ya monomer
and the peaks which catalysed the conjugation of GSH with I, 2-
dichloro-4-nitrobenzene (peaks I, 2 and 4(ii) all possessed the Yb
band.
Identification of the lithochoiic acid-binding proteins LBa and LBb
Peaks 3 and 4(i) contain the two lithochoiic acid-binding proteins
described by Strange et al. (1977b). Both these peaks comprise proteins
which could be ligandin on the basis of substrate specificity,
phenobarbitone induction, subunit composition and anion-binding.
To identify these proteins, glutathione S-transferase B and ligandin were
prepared. Glutathione S-transferase B was purified by the method of
Habig et al. (1974b, 1976a) and ligandin by the procedure described by
Arias et al. (1976) and Bass_etal. (1977a). Examination of these two
proteins by CM-Sephadex chromatography showed that both ligandin and
glutathione S-transferase B eiuted separately as single peaks of protein
and enzyme activity at volumes equivalent to peak 3 and peak 4(i)
respectively. This indicates that ligandin and glutathione S-transferase
B, prepared by published procedures, are not identical proteins, as
reported by Habig et al. (1974b), but are separate proteins. Ligandin
and glutathione S-transferase B both bind lithochoiic acid and appear to
be identical to LBa and LBb respectively.
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Identification of the glutathione S-transferases
The glutathione S-transferases have previousiy been classified
by their order of elution from CM-celiulose (Habig et al., 1974b;
Jakoby et al., 1976a, b). A comparison between the CM-celluiose
data and the CM-Sephadex eiution profile suggests that transferases
D and E elute in peak 1, transferase C in peak 2, ligandin in peak 3,
transferase B in peak 4(i), transferase A in peak 4(ii) and transferase
AA in peak 5 (Table 4.1).
The presence of transferase C in peak 2 and transferase A in
peak 4(ii) is supported by the substantial GSH:1, 2-dichloro-4-nitrobenzene
conjugating activity found in these two peaks (Habig et al., 1974b).
The cholic acid-binding experiments therefore showed that ligandin
and glutathione S-transferase B, as well as glutathione S-transferase AA
and one or more of the transferases in peak 1 can bind cholic acid. Ligandin,
glutathione S-transferase Band one or more of the transferases in peak
1 can also bind lithocholic acid.
The identity of the transferase which eiuted from CM-Sephadex
between peaks 3 and 4(i) is not known. However, since it was only
able to catalyse the conjugation of GSH with 1, 2-dichloro-4-nitrobenzene
it is unlikely to be either transferase E, D, C, B, A or AA as Jakoby
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Table 4.1 Proposed identification of the transferase peaks
peak elution volume (ml) from glutathione S-transferase(s)
CM-Sephadex contained in the peak
1 15-40 D, E
2 43-85 C
3 91-115 "ligandin" (LBa)




et al. (1976a, b) have shown that these are all able to catalyse the
conjugation of GSH with l-chioro-2,4-dinitrobenzene. This group of
workers have reported that during the preparation of these transferases
(Table 2.2) an enzyme which was able to catalyse the conjugation of
GSH with menaphthyi sulphate was discarded during DEAE-cellulose
chromatography (Pabst et al., 1973). This enzyme was designated
transferase M (Habig et al., 1974b) and has been described by Giliham
(1971, 1973). Although it is not known whether transferase M can
conjugate GSH with 1-chloro 2, 4-dinitrobenzene, this enzyme may
account for the GSH:1, 2-dichloro-4-dinitrobenzene conjugating
activity observed between peaks 3 and 4(i). These results suggest
that although 7 ionicaliy distinct glutathione S-transferases can be
separated by ion-exchange chromatography there are a total of at
least 8 transferases in rat liver cytosoi.
The use of the term iigandin
The name ligandin was originally used to describe three apparently
homogeneous protein preparations which were considered to be one
protein (Litwack et al., 1971). The subunit composition of the 3
original preparations of ligandin is not known, although initially it
was thought that iigandin comprised two identical monomers (Litwack
etal. , 1971). However, the subsequent use of discontinuous SDS/
polyacrylamide gel electrophoresis has shown different preparations
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of ligandin to contain either YaYa (Bass et al., 1977a) or YaYc
dimers (Bhargava et al., 1978) or even a mixture of these
(Carne et al., 1979). Since Bhargava _etal_. (197 8) essentially
used the purification procedure described by Arias et al. (1976)
it is surprising that their ligandin comprised a Ya Yc dimer ;
however the pH of the buffer used in their ion-exchange chromatography
steps was reduced (from pH8.8 to pH 8.6) and purification was carried
out in the presence of phenylmethyisulphonyl fluoride. The YaYa
and YaYc dimers are very similar and this change in the pH of the
eluting buffer may have been sufficient to result in purification
of a YaYc dimer rather than the YaYa dimer. The use of the
term iigandin in the absence of subunit compositions is therefore
not definitive. The term ligandin should perhaps be abandoned and
the proteins redefined according to their subunit composition as either
YaYa protein or YaYc protein. In this thesis, ligandin is defined
as YaYa protein (or LBa) since the preparation of ligandin, by
the method of Arias_et ah (1976), gave this protein. Although the
use of the Arias preparation to define ligandin may appear arbitary,
the work of Arias and his colleagues has played a central part in the
description and identification of iigandin in the literature; Arias
was a co-author with Litwack et al. (1971) when the term iigandin
was coined and he was also a co-author with Habig et al. (1974b) when
iigandin was reported to be identical to glutathione S-transferase B.
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Ligandin, a microheterogeneous protein?
It has been proposed by Ketterer and his colleagues that
ligandin is a protein which exhibits "microheterogeneity". This
suggestion is based on the finding that apparently pure preparations
of iigandin can be resolved into two proteins. Ketterer et al. (1976b)
reported that these two proteins had identical amino acid compositions
and yielded similar peptide "maps". Carne et al. (1979) have
subsequently shown that the two proteins comprised YaYa and YaYc
dimers . Ketterer and his colleagues therefore refer to ligandin
as YaYa, YaYc or a mixture of the two proteins (Carne et al., 1979).
However, the majority of the experiments which this group have carried
out with ligandin, since they resolved the two proteins, have been
performed using the YaYa protein (Carne et al., 1979). It is not
clear what Ketterer and his co-workers mean by "microheterogeneity".
They may mean that the 2 proteins are interconvertable; presumably
the separate chromatography of either pure YaYa or YaYc protein
on CM-Sephadex would result in the elution of 2 enzyme-containing
peaks with YaYa and YaYc composition. The eiution of a homogeneous
preparation of either YaYa or YaYc protein from CM-Sephadex as
2 protein-containing peaks could also possibly occur as a purification
artifact. However, ligandin and glutathione S-transferase B eiuted
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as single peaks from CM-Sephadex. These results suggest that
iigandin and glutathione S-transferase B are separate proteins and that
they can be prepared to a degree of purity such that they elute from
CM-Sephadex as single peaks of protein. Further, the subunit
composition of these two proteins was unchanged after storage for
5 months at -10°C suggesting that the two proteins are not
interchangeable during storage.
Other workers have described ligandin preparations which do
not demonstrate this type of "microhetergeneity". In the present
study and in that of Bass_et ai. (1977a) ligandin, prepared by the
method of Arias_et ai_. (1976), was shown by discontinuous SDS/
poiyacrylamide gel electrophoresis to contain predominantly the
Ya monomer; indicating that the dimeric protein comprises a YaYa
dimer. Although small amounts of the Yc monomer were detected
in both studies there was no support for the suggestion that the
presence of the Yc monomer indicates "microheterogeniety"
rather than an impurity in an incompletely purified protein preparation.
Alternatively, Ketterer and his colleagues may have used the term
"microheterogeneity" to describe a putative carbohydrate
modification since many glycoproteins exhibit heterogeneity. This
inherent variation is due to differences in the carbohydrate content,
rather than the amino acid sequence, of these proteins. Therefore,
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whilst a particular glycoprotein will have a unique amino acid sequence
it may have different carbohydrate chains added to it, after synthesis,
giving rise to different "forms" of a single gene product. This
variation results because carbohydrate side chains do not have their
structure defined by a template in a way comparable with the genetic
coding of a polypeptide sequence. Instead, they are formed by the
stepwise addition of sugar residues catalysed by specific giycosyl
transferases (Marshall, 1974). The specificity of this process is
dependent on the sequential availability of activated monosaccharides
and individual transferases. For example, a -antitrypsin is
referred to as a microheterogeneous glycoprotein since it contains
varying amounts of sialic acid (Jeppsson et al., 1978; Carrell &
Owen, 1979). This variation gives rise to charge differences between
different "forms" of a ^-antitrypsin which only become apparent on
electrophoresis at a pH near the isoelectric point of the protein. However,
since there is no evidence in the literature to suggest that either YaYa
or YaYc protein is a glycoprotein, the existence of a carbohydrate-
based"microheterogeneity" to explain the recovery of both YaYa and
YaYc proteins in certain iigandin preparations is purely speculative.
Use of terms LBa and LBb
In this thesis the two purified iithocholic acid-binding proteins
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which eluted in peaks 3 and 4(i) are referred to as LBa and LBb
respectively, rather than ligandin and glutathione S-transferase B.
Using this nomenclature it appears that ligandin purified by the
method of Arias et al. (1976) contains LBa, iigandin purified by
the method of Carne et al. (1979) contains both LBa and LBb and
glutathione S-transferase B prepared by the method of Habig et al.
(1974b, 1976a) contains LBb. These results suggest that "ligandin"
prepared by particular groups of workers either contains two
proteins (and is therefore only partially purified) or a single protein,
in which case the preparations made by different groups may not
comprise the same protein.
LBa and LBb; are they genetically distinct?
The relationship between LBa and LBb is not clear. It is unlikely
that they arise as a result of non-specific degradation since they can be
prepared separately from each other and yield sharply defined monomer
bands. Since these 2 proteins are functionally similar they may
represent different "forms" of a single protein. The occurrence of
multiple molecular "forms" of a protein can arise for a number of
reasons; first, different "forms" can arise at synthesis. This usually
results from the transcription of at least two structural genes which
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code for functionally similar proteins. These proteins therefore are
separately translated and do not share a common synthetic pathway.
Since these proteins are functionally similar, but genetically distinct,
they represent isoenzymes. Second, differences may be introduced
after synthesis (post-ribosomai). In this instance a single
structural gene is transcribed and the resulting protein species, which
is formed after translation, is subsequently modified to produce a
mixture of proteins which may include the original precursor protein.
As these proteins are not genetically distinct,but share a common
synthetic pathway, they do not represent isoenzymes. Since both
LBa and LBb are physically similar these two transferases were
examined to determine whether they could be coded for by the same
gene.
A comparison between amino acid compositions is the simplest
way to determine whether two functionally related proteins are
isoenzymes or not. This procedure however is unlikely to detect
significant differences between proteins which although distinct are
evolutionarily closely related. The amino acid compositions of LBa
and LBb were therefore determined and the amino acid recoveries
from the two proteins (Table 3.3) are very similar. This is in
agreement with the findings of Carne et al. (1979) who were unable














Lys 36 40 34
His 6 6 5
Arg 22 24 21
Asx 37 40 36
Thr 11 14 12
Ser 18 18 15
Glx 46 44 42
Pro 20 20 19
Gly 21 20 19
Ala 31 30 28
i Cys 4 6 4
Val 25 18 16
Met 8 14 15
lie 18 20 18
Leu 50 50 46
Tyr 13 16 15
Phe 17 18 17
Trp 9 2 7
Total 392 400 369
Table 4. 2 The amino acid compositions which have been published
for glutathione S-transferase B (Habig et al., 1974b) and for
"ligandin" (Ketterer_et al_., 1975; Kirsch_et al., 1975). The total
number of amino acids which each group calculated to be present
is indicated.
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of these two proteins. The amino acid compositions presented
in Table 3.4 are in good agreement with the data which Habig
_et ai_. (1974b) have reported for glutathione S-transferase B and
which Ketterer et ai. (1975) and Arias and his workers
(Kirsch_et ai_., 1975) have reported for "ligandin" (Table 4.2).
The only significant difference between the amino acid compositions
calculated for LBa, LBb and the data reported by the other groups
of workers was in the recovery of tryptophan. However, since this is a
residue which is destroyed during hydrolysis these differences may
only represent methodological rather than real differences. The
similar amino acid compositions and the fact that both LBa and LBb
were induced in phenobarbitone-treated rats suggests that these two
transferases may have arisen as the result of a post-synthetic
modification of a single gene product.
Multiple protein "forms"; covalent and non-covalent modifications
of a single gene product
The multiple molecular "forms" of proteins, which are presumed
to have been synthesised from an identical genetic code and therefore
arise as the result of a post-synthetic modification, can be divided
into two groups. First, the multiple "forms" may possess non-covalent
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differences in their structure or secondly, they may possess covaient
differences in their structure. The second type of post-synthetic
modification would appear to be the more likely explanation for the
differences between LBa and LBb since non-covalent modifications,
such as the binding of various molecules (e.g. coenzymes, prosthetic
groups, fatty acids, hormones, nucleic acids or membrane fragments),
the non-specific aggregation of subunits or the formation of "stable"
conformational variants,are unlikely to account for the different
subunit compositions of the two proteins because the SDS present
denatures the protein preventing binding and minimising aggregation.
Peptide "mapping" using "Cleveland gels" also revealed structural
differences between the two proteins and further supported the
hypothesis that if LBa and LBb represented different "forms" of a
single gene product then they arose from covaient modifications.
This second category includes a large number of different
post-synthetic modifications such as ; a) deamidation, b) oxidation
of methionine or cysteine, c) reduction of cystine, d) mixed disulphides,
e) decarboxylation, f) modification of prosthetic groups, g) cleavage
of peptide bonds, h) differences in carbohydrate content, i) phosphor¬
ylation or sulphation. Although each of these possibilities was not
thoroughly explored certain modifications appeared unlikely to
account for the electrophoretic differences which were observed
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between LBa and LBb. In particular it is unlikely that deamidation,
decarboxylation, phosphorylation or sulphation would account for the
difference in size (mol. wt. 3 000) between the Ya and Yc subunits.
Nor does it appear likely that the differences between LBa and LBb
result from the formation of mixed disulphides or different oxidation
states of equivalent methionine or cysteine residues since no
differences were observed in the subunit composition when the
concentration of 2-mercaptoethanol was varied between 0-5% (v/v)
during preparation of the two proteins for SDS/polyacrylamide gel
electrophoresis. Further,the amino acid analyses presented in Table
3. 3 did not suggest the presence of any carbohydrate groups
(i.e. glucosamine or galactosamine) and so it was thought unlikely
that a carbohydrate-modification could account for the difference
between the two proteins. Several groups have determined the
amino acid composition of their "ligandin" preparations (LBa and/or
LBb) (Table 4.2) and no data has been published suggesting the presence
of either a prosthetic group, sialic acid residues or other carbohydrate
groups which may account for the difference between LBa and LBb.
It was therefore thought, on the basis of the limited amount of data
available, that the most likely explanation for the differences between
the two binding proteins is that LBb contains an additional sequence of
amino acids (approx. 26 residues) which is not found in LBa. Two and
three dimensional peptide "maps" were therefore constructed using
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high-voltage paper electrophoresis. These showed that the tryptic
digests of LBa produced 31 different peptides suggesting that the YaYa
dimer yields 62 peptides and contains 60 tryptic cleavage sites.
LBb produced an additional 7 peptides suggesting that the YaYc
dimer yields 69 peptides and contains 67 tryptic cleavage sites.
Although none of the peptides were sequenced, both proteins produced
peptides which possessed similar mobilities during electrophoresis
and chromatography, suggesting that the peptides obtained from LBa
are also present in LBb. The similar peptide "maps" obtained from
LBa and LBb suggests that the two proteins possess a large amount
of sequence homology and that the Ya monomeric band of the two
proteins is identical. If the difference between the two proteins
resides in a hypothetical carbohydrate group the same number of
peptides should have been obtained from LBa and LBb. The data
therefore, supports the hypothesis that the difference between LBa
and LBb is due to the Yc subunit in LBb containing an additional amino
acid sequence which contains 7 tryptic cleavage sites. However, the
Ya and Yc monomers have not been dissociated and separately
analysed and therefore the existence of the putative additional amino
acid sequence in the Yc subunit has not been exhaustively investigated.
It is not known whether this putative extra amino acid sequence
contained in Yc is located at the "N" or "C" terminus or is situated
elsewhere in the monomer, as an inserted sequence. Further in the
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absence of extensive sequence data the possibility that Ya and Yc are
coded for by two closely related structural genes (which have diverged
from a common ancestral gene) cannot be excluded but the pheno-
barbitone induction and the two and three dimensional peptide
"maps" are consistent with the hypothesis that these two subunits,
which are found in LBa and LBb, are the product of a single gene.
A product-precursor relationship may exist between LBa and LBb
similar to that described for penicillin amido-/?-lactamyhydrolase.
A comparison between the DNA sequence of the gene coding for this
protein and the amino acid sequence of the active enzyme demonstrated
that penciliin amido-/3-lactamhydroiase is synthesised as a 286
amino acid precursor (mol. wt. 28 900) from which 23N terminal amino
acids are removed to produce the mature enzyme (mol. wt. approx.
27 000) (Ambler & Scott, 197 8; Sutcliffe, 1978). An analagous
situation may exist between the Ya and Yc monomers of the two
lithocholic acid-binding proteins. These two proteins may be coded
for by a single gene and synthesised as a YcYc precursor (mol. wt.
50 000) which is subsequently converted into either YaYc (moi. wt.
47 000) or YaYa (mol. wt. 44 000) protein by the successive cleavage
and removal of approx. 26 terminal amino acids. The subunit
compositions indicate that peak 5 (transferase AA) comprises a YcYc
dimer. This may be the putative precursor protein.
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Are several glutathione S-transferases the product of a single gene?
Jakoby et al. (197 8) reported that in the rat liver the glutathione
S-transferases have similar physical properties and overlapping
substrate specificities. Jakoby and his colleagues have purified 5
of these enzymes (transferases E, C, B, A and AA) and shown
that the amino acid compositions of transferases C and A and B and AA
are similar (Table 4. 3) (Habig et al., 1974b, 1976a). However,
significant differences exist between the alanine and valine content of these
2 groups of transferases (Habig et al., 1974b, 1976a). The compositions
suggest that transferases B and AA may be the product of a single gene
and transferases C and A may also be coded for by a single but
separate gene. Habig et al. (1974b) have reported that both transferases
C and A cross react with antisera raised against each other, supporting
the hypothesis that these 2 enzymes are the product of a single gene.
It is not clear which, if either, of these 2 transferases (A and C)
represents the precursor, but the subunit compositions, which indicates
that both these enzymes comprise YbYb dimers, suggests that the
postulated post-synthetic modification involves minor structural
changes such as deamidation, decarboxylation , oxidation of methionine
or cysteine or reduction of cystine. Although the possibility of a
non-covaient modification of transferase A and/or C cannot be
excluded from this list of possible post-synthetic modifications it appears
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Moles of amino acid/45000g transferase
Transferase AA A B C
Amino Acid
Lys 34 34 36 35
His 7 6 6 6
Arg 26 21 22 21
Asx 41 45 37 44
Thr 8 13 11 12
Ser 12 20 18 17
Glx 47 42 46 41
Pro 25 22 20 22
Gly 23 19 21 21
Ala 33 20 31 20
iCys 2 6 4 6
Val 31 11 25 12
Met 10 10 8 10
lie 14 22 18 19
Leu 49 45 50 45
Tyr 19 23 13 22
Phe 15 20 17 22
Trp 2 6 9 6
Total 398 385 392 381
Table 4.3 The amino acid compositions which have been
published for glutathione S-transferase C, B, A and AA (Habig
et_al_., 1974b, 1976a). The total number of amino acids calculated
for each transferase is indicated.
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unlikely, since the enzymes were thoroughly dialysed before
chromatography. The amino acid composition of transferase E
has not been determined but since it is immunologically distinct
from transferases A, B and C (Habig et al., 1974b) it may
be coded for separately from these enzymes. The work of
Jakoby and his colleagues suggests that in the rat there are at least
3 genes which code for the glutathione S-transferases but that their
products have similar amino acid compositions. The subunit
compositions indicate that these genes code for proteins of
25 000, 23 500 or 22 000 mol. wt. Certain of the Ya, Yb, Yc bands
are likely to contain more than one gene product since together
transferases A, B and C possess ail three monomer bands but
transferase E, which the immunological study of Habig et al.(1974b)
indicated was coded separately, probably comprises Yb and/or Yc
monomers.
In the human liver 5 ionicaliy distinct glutathione S-transferases
have been isolated (Habiget al., 1976b). These proteins had different
amino acid compositions and were immuno-chemicaily distinct from the
rat liver transferases. Since these enzymes had apparently identical
amino acid compositions and were immunologically indistinguishable
from each other, it was proposed that these are coded for by a single
gene. However, since the subunit compositions have not been determined
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it is not known whether the postulated post-synthetic modification
is similar to the LBa:LBb or the transferase A:transferase C situation
in the rat liver.
Identity of the 17 000 mol. wt. bile acid-binding protein
The identity of the low mol. wt. (approx. 17 000) choiic acid-
binding component (Fig. 3.5a(a)) is not clear and the results do not
indicate whether this binding species is identical to the low mol. wt.
lithocholic acid-binding component (Fig, 3.6). However, it appears
likely that the low mol. wt. choiic acid-binding component is identical to the
aminoazode-binding protein A (mol. wt. 14 000) which Ketterer
et al. (1976a) have shown also binds choiic acid. Further, since
Ketterer_et al. (1976a) showed that this protein bound a large number
of steroids (including deoxycholic acid and tau rodeoxychoiic acid),
it is likely that this protein also binds lithochoiic acid. Several
other groups of workers have also studied low mol. wt. binding
proteins; for example, Z protein (Levi_et al., 1969a; Mishkin_et ai_.,
197 2 ; Mishkin & Torcotte, 1974a, b; Kamisaka et al., 1975;
Warner & Neims, 1975), fatty acid-binding protein (Ockner et al.,
1972) and squalene and sterol carrier protein (Grabowski_et_ai., 1976).
Since the various preparations all bind a number of common iigands
it has been suggested that a general non-specific low mol. wt. binding
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protein may exist which has binding properties similar to
"ligandin" (LBa) (Ketterer et al., 1976a). These preparations
may therefore all be able to bind cholic acid and lithocholic acid.
Physiological significance of bile acid-binding by cytosolic proteins
The physiological importance of biie acid-bindi ng by the
glutathione S-transferases is not clear. The various physiological
functions which have been ascribed to the glutathione S-transferases
have been discussed. These functions can be divided into three
groups based on the three types of activity which these proteins
possess. First, they have enzyme activity and catalyse the
conjugation of GSH to various electrophiiic compounds. Secondly,
they can bind non-covalently a number of hydrophobic non-substrate
ligands. Thirdly, it has been shown that certain transferases can bind
covalently an aminoazo-dye metabolite and l-chloro-2, 4-dinitrobenzene.
In the most recent review article on the glutathione S-transferases
Jakoby (1978) considered the physiological importance of the non-covaient
binding activity of the transferases. He proposed that on a quantitative
basis the major ligand for the transferases was bilirubin and therefore,
in this context, one of the major functions of the transferases was to
keep bilirubin in solution inside the hepatocyte in the same way that
albumin solubilises bilirubin in the plasma. Further Jakoby (197 8)
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suggested that since at least transferase E has been identified in
association with hepatic plasma membranes, the transferases could
participate at the sinusoidal surface of the hepatocyte, in mediating
the influx of anions into the ceil and that they may be responsible
for a facilitated diffusion process.
Recently, Arias and his co-workers investigated the physiological
role of "ligandin" (LBa) in bilirubin transport by the liver
(Wolkoff et al., 1979). They studied the kinetics of bilirubin uptake
in isolated perfused rat livers from normal, phenobarbitone and
thyroidectomized animals; the concentration of "ligandin" was
increased 25% and 100% in the thyroidectomized and phenobarbitone
treated rats respectively. These experiments showed that the net
uptake of bilirubin by the livers of animals which possessed increased
levels of ligandin was significantly greater than the uptake in control
animals. Their work supports the hypothesis that "ligandin" is involved
in the uptake of bilirubin but offers no data about the role of the other
transferases. More specifically, Wolkoff et al. (1979) constructed
a com partmental model for the hepatic transport of bilirubin and they
proposed that the physiological role of "ligandin" is to control the
efflux of bilirubin from the hepatocyte back to the plasma rather than
to control the influx of bilirubin from plasma to the hepatocyte.
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The hepatic transport of bilirubin has received much attention
since failure to excrete bilirubin results in jaundice. However,
the size of the bile acid pool is at least 10 times that of bilirubin
and as bile acids must traverse the liver at least 5-10 times per
day the liver transports 50-100 times more bile acid than bilirubin
per day. The quantitatively most important function of the glutathione
S-transferases therefore may be to assist bile acid transport. It is
not clear what role these enzymes play in bile acid transport.
Strange _et ai. (1979b) have calculated that the bile acids cross the
hepatocyte in free solution; they are probably not transported across
the liver bound to carrier proteins since the bile acid transit time
across the liver appears to be too rapid for the bile acids to diffuse
across the hepatocyte bound to protein. The transferases may be
involved in the hepatic transport of bile acids in a non-carrier
manner. Certain transferases may influence the uptake of bile acids
by the liver either by controlling influx, as proposed by Jakoby (1978)
for transferase E, or by controlling efflux, as proposed by Wolkoff
et ai. (1979) for "ligandin". These enzymes may be either an
integral part of the bile acid-binding sites in liver surface membranes
which were described by Accatino & Simon (1976) or may directly
interact with those sites. Alternatively the bile acid-binding activity
of the transferases may indirectly assist bile acid transport. Strange
et al. (1979b) showed that bile acids partition into subcellular
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organelles and it is possible that the transferases keep bile acids in
the cytosol and so restrict their partitioning into membrane lipid,
thereby promoting their rapid excretion into bile. This cytosolic
binding (storage) capacity may be important in dealing with the
transiently high concentrations of bile acids which are transported
as a bolus across the liver following reabsorption from the gut
after a meal. In this case the transferases would keep the bile acids
in solution thereby helping to prevent precipitation of the less
soluble bile acids (the mono- and di-hydroxy bile acids) and by
restricting the partitioning of the bile acids into the subceiluiar
organelles prevent possible disruption of membranes through the
detergent activity of the bile acids.
The 17 000 mol.wt. bile acid-binding components) may have
similar physiological functions in the hepatocyte as those which have
been proposed for the bile acid-binding glutathione S-transferases.
However, if the bile acid-binding components) is identical to the
squalene and sterol carrier protein, which binds several bile acid
precursors including 7 a-hydroxy-4-choiesten-3-one, then the
possibility exists that choiic acid and lithocholic acid could
competitively inhibit the binding of bile acid precursors to the carrier
protein. As this protein is postulated to carry the intermediates in
the conversion of cholesteroi to the bile acids to their relevant
enzymes in the synthetic pathway, it is evident that through
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competitive inhibition between the bile acids and their precursors, bile
acids could modify the rate of their own synthesis. Whilst such a
mechanism would not be of major importance in the regulation of
bile acid synthesis, since the cholesterol 7 a-hydroxylase step
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Partial Purification of Two Lithocholic Acid-Binding Proteins from
Rat Liver 100000# Supernatants
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1. The partial purification of two lithocholic acid-binding proteins from liver lOOOOOg
supernatants is described. 2. Gel-filtration, (NH4)2S04 fractionation, Ca3(P04)2
fractionation and ion-exchange chromatography were used. 3. Both proteins exhibited
glutathione S-transferase activity; one may be the non-specific anion-binding protein
ligandin. 4. Glutathione S-transferase activity of one of the binding proteins was inhibited
by lithocholic acid.
The removal of anions from plasma and their
excretion into bile is an important function of the
liver. Ligandin, a non-specific anion-binding protein
present in hepatic lOOOOOg supernatants, may be an
important component of the uptake ofmany different
anions from plasma (Levi et al., 1969; Litwack et at.,
1971). Kaplowitz et al. (1973) showed that ligandin
has glutathione S-transfcrase activity (EC 2.5.1.18),
and Habig et al. (\914a,b) showed that purified
ligandin had the same amino acid composition and
enzymic activities as glutathione S-transferase B.
Bile acid transport is one aspect of liver function
which, although quantitatively important, is poorly
understood. In the rat (total bile acid pool about
40/rmol) approx. 400/miol of bile acid is removed
from the portal vein and is transported across the
liver each day. The uptake of sodium taurocholate
from the extracellular fluid into the liver follows
Michaelis-Menten kinetics both in the intact dog
liver (Glasinovic et al., 1975) and in isolated rat
hepatocytes (Schwarz et al., 1975). This suggests that
bile acid transport is a carrier-mediated process.
Proteins having binding sites for cholic acid, glyco-
cholic acid, chenodeoxycholic acid and lithocholic
acid were demonstrated in 100OOOg supernatants from
rat livers by an equilibrium-dialysis technique
(Strange et al., 1976, 1977). The large values for both
the dissociation constants of binding of these bile
acids (approx. 1 pu) and the concentration of binding
sites (approx. l/rmol/g of supernatant protein)
suggested that these binding proteins might be acting
as carrier proteins in the transport of bile acids
across the hepatocyte.
We now describe (I) the partial purification of two
lithocholic acid-binding components, (2) their
examination for glutathione S-transferase activity
and (3) the effect of bile acids on the glutathione S-





acid), chenodeoxycholic acid (3a,7a-dihydroxy-5/?-
cholan-24-oic acid), deoxycholic acid (3 a, 12a-
dihydroxy-5/?-cholan-24-oic acid), cholic acid (3a,-
7a,12a-trihydroxy-5/?-cholan-24-oic acid) and the
glycine conjugate of cholic acid were purchased from
Maybridge Chemical Co., Tintagel, Cornwall, U.K.,
and were purified as described by Strange et al. (1977).
[24-14C]Lithocholic acid (59Ci/mol) was purchased
from The Radiochemical Centre, Amersham, Bucks.,
U.K., and shown to be 99% pure by t.l.c. Calcium
phosphate gel was obtained from BDH Chemicals,
Poole, Dorset, U.K. Sephadex G-75, DEAE-
Sephadex A-50 and CM-Sephadex C-50 were from
Pharmacia Fine Chemicals Ltd., London W5 5SS,
U.K. Ethacrynic acid [2,3-dichloro-4-(2-methylene-
butyryl)phenoxyacetic acid] was generously given
by Merck, Sharp and Dohme, Hoddesdon, Herts.,
U.K.
Analytical methods
Enzyme assays were performed as described by
Habig et al. (1974b) except that a temperature of 37°C
was used. The conjugation of glutathione with 1,2-
dichloro-4-nitrobenzene and l-chloro-2,4-dinitro-
benzene was studied at 340nm at pH7.5 and 6.5
respectively. Conjugation with ethacrynic acid was
studied at 270nm at pH7.5. Reaction rates were
corrected for small rates (less than 5% of total rate)
of non-enzyme-catalysed conjugation of glutathione
with l-chloro-2,4-dinitrobenzene and ethacrynic
acid.
To identify the lithocholic acid-binding compo¬
nents radioactive lithocholic acid (l6nmol; 1 /zCi)
was added to portions (2ml) of the partially purified
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preparations described below. The mixtures were
eluted from a column (30cmx2cm; void volume
50ml) of Sephadex G-75 at 4°C by using sodium/
potassium phosphate buffer (20mm; pH7.4) con¬
taining NaCl (lOOmM) (Strange et al., 1976, 1977).
This buffer is referred to as phosphate/NaC! buffer.
The flow rate was 22ml/h and the fraction volume
was 3.5ml. Radioactive lithocholic acid was eluted
with proteins of mol.wt. approx. 40000 and the
[14C]lithocholic acid-binding activity was expressed
as the ratio between the peak radioactivity (d.p.s./ml)
and the protein concentration (mg/ml) in the fraction.
All buffers were prepared at 20°C. Radioactive
counting and protein assays were performed as
described by Strange et al. (1976). Agarose-gel elec¬
trophoresis was performed in sodium barbiturate/
barbituric acid buffer (50mM; pH8.6) on Universal
agarose plates obtained from Corning-Eel (Evans
Electroselenium Ltd., Halstead, Essex, U.K.). Poly-
acrylamide-gel electrophoresis was performed at
room temperature (20°C) on discs of 10% gel pre¬
pared from acrylamide and AW'-methylenebisacryl-
amide (30:1, w/w) with (VAWTV'-tetramethylethylene-
diamine as catalyst. Na+ concentrations in column
fractions were measured by flame photometry with
an 1L 343 photometer [Instrumentation Laboratory
(U.K.) Ltd., Altrincham, Cheshire, U.K.],
Purification of lithocholic acid-binding components
Solution I. Male Wistar rats (300-350g) were
anaesthetized with diethyl ether and their livers were
perfused in situ with the phosphate/NaCl buffer to
which sucrose was added to a final concentration of
250mM. The livers were homogenized and lOOOOOg
supernatants were prepared as described by Strange
et al. (1976). Portions (40ml; approx. 40mg of
protein/ml) of supernatant were transferred to a
column (5.5 cm x 24cm) of Sephadex G-75 which was
equilibrated and eluted with the phosphate/NaCl
buffer at 4°C. The flow rate was 60ml/h, the fraction
volume was 10ml and the void volume was 160ml.
Fractions eluted between 250 and 350ml contained
proteins of mol.wt. 30000-60000. They were col¬
lected and combined (solution 1).
Solution 2. Solid (NH4)2S04 was added at room
temperature with stirring to solution 1 until 55 %
saturation was obtained (Dixon & Webb, 1964). The
solution was left without stirring for 30min then
centrifuged (2500g\ 15min, 20°C) and the precipitate
discarded. More (NH4)2S04 was added to the super¬
natant until 85 % saturation was reached, and the
solution was left for 30min then centrifuged (50000^,
25min, 10°C) and the supernatant discarded. The pre¬
cipitate was redissolved in sodium/potassium phos¬
phate buffer (20mm; pH7.4; 10ml) and the solution
was dialysed at 4°C for 15h against four changes
(each of 2 litres) of the same buffer, giving solution 2.
Solution 3. Calcium phosphate gel was washed with
sodium/potassium phosphate buffer (20mM; pH7.4)
and added to solution 2 (1 mg of gel/mg of protein) at
room temperature. The solution was stirred for I h,
centrifuged (2500g, 15min, 20°C) and the precipitate
discarded. The supernatant was dialysed against four
changes (each of 2 litres) of Tris/HCI buffer (20itim;
pH8.1) at 4°C for 15h, giving solution 3.
Solution 4. Solution 3 was added to a column
(0.9cmx 15cm) of DEAE-Sephadex A-50 equili¬
brated and eluted at 4°C with Tris/HCI buffer
(20itim; pH8.1). The flow rate was 6.5ml/h and the
fraction volume was 1.5 ml. A NaCl gradient was
established after 30ml. To obtain the gradient a solu¬
tion of NaCl (500mM) in Tris/HCI buffer (20mM;
pH8.1) was used. This solution was added (6.5ml/h),
with mixing, to 40ml of Tris/HCI buffer (20mM;
pH8.1) contained in the eluent reservoir. Eluent was
pumped (6.5ml/h) from this reservoir to the DEAE-
Sephadex column. Fractions eluted between 3.0 and
18.0ml were combined and dialysed against four
changes (each of 2 litres) of sodium/potassium
phosphate buffer (lOmM; pH7.4) at 4°C for 20h
giving solution 4. Fractions eluted between 37.5 and
45.0ml were also combined and dialysed against
sodium/potassium phosphate buffer (10mM; pH7.4).
Solution 4 was mixed with 50p\ of [14C]lithocholic
acid (16nmol; 1 /zCi) and was added to a column
(0.9cmxl5cm) of CM-Sephadex C-50, equilibrated
and eluted with sodium/potassium phosphate buffer
(10mM; pH7.4). After 27ml had been collected
a NaCl gradient was established. NaCl was added to
phosphate buffer (lOmM; pH7.4) to give a final con¬
centration of 50mM. This solution was added (6.5ml/
h), with mixing, to 50ml of phosphate buffer (lOmM;
pH7.4) in the eluent reservoir. Eluent was pumped
(6.5ml/h) from the reservoir to the CM-Sephadex
column. The fraction volume was 1.5ml. The frac¬
tions eluted between 9.0 and 30.0ml, 31.5 and 39 ml
(peak 1) and 45.0 and 58.5ml (peak 2) were
separately combined and the three solutions were
examined for the presence of lithocholic acid-binding
components.
Peak 1 and peak 2 were concentrated by dialysis at
1°C against poly(ethylene glycol) (mol.wt. 25000) and
were run in agarose-gel and polyacrylamide-gel
electrophoresis systems.
Bile acid inhibition of glutathione S-transferase
activity
The effects of cholic acid, glycocholic acid, cheno-
deoxycholic acid, deoxycholic acid and lithocholic
acid on glutathione S-transferase activity in peak 1
and peak 2 from the CM-Sephadex column were
studied by using reduced glutathione and 1-chloro-
2,4-dinitrobenzene as substrates. Portions (5/d;
1.5//g of protein) of peak 1 and peak 2 were added to
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reaction mixtures containing sodium/potassium
phosphate buffer (1.3ml; lOOtnM; pH7.45), the bile
acid (0-300//m) under study and l-chloro-2,4-dinitro-
benzene (I niM). Since lithocholic acid is only slightly
soluble in aqueous solution concentrations up to 40/m
were used. The reaction was initiated by adding either
0.5 or 1 .OmM-glutathione. Since binding of litho¬
cholic acid to supernatant proteins had been studied
only at pH 7.4 the effects of bile acids on glutathione
5-transferase activity were studied at this pH. Initial
experiments confirmed that the reaction rate was not
altered by changing the pH of the reaction mixture
from 6.5 to 7.45. The non-enzymicrate, however, was
increased to 20% of the total reaction rate in the
absence of lithocholic acid. It was subtracted from
the total measured reaction rate in all cases. Assays
were performed in quadruplicate.
Results
Purification of lithocholic acid-binding components
The protein contents, [l4C]lithocholic acid-binding
activities and specific enzyme activities for lOOOOOg
supernatant from rat liver and for each of the partially
purified preparations from it are shown in Table 1.
At each stage of the purification procedure the
discarded solutions were also tested for [l4C]litho-
cholic acid-binding activity and glutathione 5-trans-
ferase activity. Except for low [14C]lithocholic acid-
binding activity (less than 350d.p.s./mg of protein)
and glutathione 5-transferase activity (less than 10
A340 units change/min per mg of protein) found in
both the redissolved precipitate formed by adding
(NH4)2S04 to 55% saturation to solution 1 and in a
sodium/potassium phosphate buffer (500niM; pH 7.4)
wash of the discarded calcium phosphate gel, none
was found.
When solution 3 was added to a DEAE-Sephadex
A-50 column, a broad peak of protein was eluted at
3.0-18.0ml which was partly resolved into two peaks
of glutathione 5-transferase activity (Fig. 1). These
fractions were combined and shown to contain
lithocholic acid-binding activity. A second group of
protein-containing fractions was eluted with the
NaCl gradient at 36.0-60.0ml. Some of these
showed glutathione 5-transferase activity, but com¬
bined fractions 37.5-45.0ml did not contain [14C]-
lithocholic acid-binding activity.
Solution 4 was applied to a CM-Sephadex C-50
column (Fig. 2). Some protein was eluted between
9.0 and 30.0ml before the start of the NaCl gradient.
These fractions contained little glutathione 5-
transferase activity or [14C]lithocholic acid-binding
activity. Two peaks of protein (peak 1 and peak 2)
were eluted with the NaCl gradient; both contained
[14C]lithocholic acid-binding activity and gluta¬
thione 5-transferase activity with l-chloro-2,4-
dinitrobenzene and ethacrynic acid as substrates, but
wereunabletocatalysetheconjugation of glutathione
with l,2-dichloro-4-nitrobenzene. A similar elution
pattern was obtained when solution 4 was added
without lithocholic acid to the CM-Sephadex column.
On agarose-gel and polyacrylamide-gel electro¬
phoresis, samples of both peak 1 and peak 2 showed
single bands of protein.
Bile acid inhibition ofglutathione S-transferase activity
Cholic acid, glycocholic acid, chenodeoxycholic
acid and deoxycholicacid had no effect on glutathione
5-transferase activity in either peak 1 or peak 2 from
the CM-Sephadex column. Lithocholic acid had no
effect on enzyme activity in peak 2, but did inhibit
activity in peak I. Straight lines were obtained by
plotting the reciprocal of the maximum velocity
Table 1. Purification of the lithocholic acid-binding proteins
Supernatant fractions (100OOOg) were prepared from liver homogenates and two lithocholic acid-binding proteins were
isolated by using (NH4)2S04 and Ca3(P04)2-gel fractionation and ion-exchange chromatography (see the Materials
and Methods section). At each stage of the purification procedure the preparations were examined for lithocholic acid-
binding activity and glutathione 5-transferase activity.
Conjugation of glutathione with
Lithocholic 1 -chloro-2,4-dinitrobenzene
Protein acid binding (change in /f340/min per
(mg) (d.p.s./mg) mg of protein)
100000# supernatant 1600 1200 27
Sephadex G-75 500 2000 50
(NH4)2S04 fractionation 120 4000 70
Calcium phosphate gel 50 6000 100
DEAE-Sephadex 10 10000 200
CM-Sephadex
Peak 1 5.5 13000 250
Peak 2 3.5 8000 230
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Elution volume (ml)
Fig. 1. Elution pattern ofsolution 3 of the partially purified
lithocholic acid-binding proteins from DEAE-Sephadex
Solution 3 of the partially purified lithocholic acid-
binding proteins, isolated from rat liver 100000,g
supernatants by gel-exclusion chromatography,
(NH4)2S04 and Ca3(P04)2 gel fractionation (see the
Materials and Methods section) was eluted from a
DEAE-Sephadex A-50 column with Tris/HCl buffer
(20mM; pH8.1). Fractions (1.5ml) were collected
and the A28o (*), Na+ concentration (■) and
glutathione .^-transferase activity with ethacrynic
acid (a) and l-chloro-2,4-dinitrobenzene (o) as
substrates were measured.
against the concentration of lithocholic acid. At
glutathione concentrations of 0.5 and l.OmM the
intercepts (±s.e., n = 5) were 18.5 ± 3.5/rM and 20.4±
3.8/tm respectively. The confidence interval for the
difference between the two estimates of the intercept
is —1.03 to +1.41. Since this interval includes 0, the
intercepts are not significantly different, suggesting
that the inhibition is non-competitive
Discussion
The experiments described show the presence of at
least two proteins in hepatic lOOOOOg supernatants
able to bind lithocholic acid. Although exhaustive
criteria of protein purity were not applied, agarose-
and polyacrylamide-gel electrophoresis of the two
protein-containing solutions obtained from the CM-
Sephadex column demonstrated the presence of only
a single protein band in each solution. Both these
lithocholic acid-binding components had glutathione
5-transferase activity. The system used to detect
lithocholic acid binding is a non-equilibrium one, and
was used in preference to an equilibrium system (such
as equilibrium dialysis), since it was known to be less
likely to detect non-specific binding of lithocholic acid
(Strange et al., 1977).
Ligandin is one of a group of several enzymes that
have glutathione 5-transferase activity (Habig et al.,
1974/t). These workers have determined the relative
Fig. 2. Elationpatternofsolution 4 ofthepartiallypurified lithocholic acid-bindingproteinsfrom CM-Sephadex
Fractions eluted between 3.0 and 18.0ml from the DEAE-Sephadex column were collected, combined and after
dialysis against sodium/potassium phosphate buffer (10mM; pH7.4) were mixed with [14C]lithocholic acid (16nmol;
1/rCi) and eluted from a column of CM-Sephadex C-50. Fractions (1.5ml) were collected and the A2so (•), [14C]-
lithocholic acid (□), Na+ concentration (■) and glutathione 5-transferase activity with cthacrynic acid (a) and 1-
Chloro-2,4-dinitrobenzene (o) as substrates were measured,
1977
L1TKOCHOLIC ACID-BINDING PROTEINS FROM LIVER SUPERNATANTS 429
specific activities of purified glutathione S-transfer-
ases A, B, C and E for various substrates, but, since
other glutathione S-transferases are known to exist
although not yet purified, identification of the pro¬
tein solutions from the CM-Sephadex column is
difficult. Habig et al. (1974b) showed that the ratio of
glutathione-l-chloro-2,4-dinitrobenzene-conjugating
activity to glutathione-ethacrynic acid-conjugating
activity of 1 igand in was 45:1. Peak 1 and peak 2 from
the CM-Sephadex column have ratios of 1000:1 and
250:1 respectively. Since peak 2 exhibited the highest
activity for conjugating ethacrynic acid and gluta¬
thione, but had virtually no activity for conjugating
glutathione and l,2-dichloro-4-nitrobenzene, it is
suggested that it is ligandin. The difference between
the ratios obtained in these experiments and those of
Habig et al. (1974a,b) may be a result of the use of
lithocholic acid binding as a primary marker during
the purification procedure; no attempt was made to
ensure retention of enzyme activity. Glutathione
S-transferase activity of the two lithocholic acid-
binding proteins was not affected by cholic acid,
glycocholic acid, chenodeoxycholic acid or deoxy-
cholic acid in concentrations up to 300/.im. Okishio &
Nair (1966) have shown that the concentration of
cholic acid, the predominant bile acid in rat liver
lOOOOOg- supernatants, is approx. 100pM. Although
lithocholic acid in concentrations up to 60pM had no
effect on enzyme activity in the protein provisionally
identified as ligandin (peak 2), inhibition of gluta¬
thione S-transferase activity of peak 1 did occur.
Since the concentration of lithocholic acid in the liver
is unknown the relevance of this finding is not clear.
Both of the lithocholic acid-binding proteins
described here have glutathione S-transferase activity
and one of these may be the non-specific anion-
binding protein ligandin. Although purified ligandin
can bind cholic acid and its taurine and glycine con¬
jugates (Tipping et al., 1976) it is not known whether
hepatic transport of bile acids is mediated by a
mechanism similar to that of the transport of bromo-
sulphthalein and bilirubin. O'Maille et al. (1966)
showed two effects when they studied the excretion
of sodium taurocholate and bromosulphthalein into
bile. Although infusions of sodium taurocholate to
anaesthetized dogs increased the maximum rate of
bromosulphthalein excretion into bile the maximum
excretion rate of sodium taurocholate was decreased
by bromosulphthalein infusion. They concluded that
the increased excretion of bromosulphthalein was
secondary to the increased bile flow stimulated by
infusion of sodium taurocholate, and further that the
inhibition ofsodium taurocholate excretion suggested
a common pathway for the hepatic transport of bile
acids and bromosulphthalein. Since lithocholic acid
binding to proteins in lOOOOOg supernatants is
inhibited by other bile acids (Strange et al., 1977),
ligandin (or other glutathione 5-transferase enzymes)
may act as a non-specific bile acid-binding protein
involved in the transport of bile acids as well as other
anions.
We thank Dr. I. A. Nimmo, Dr. P. F. Rebello and Dr.
R. Hume for advice and Miss P. MacDonald for consider¬
able help in these experiments.
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SEPARATION OF LIGANDIN FROM GLUTATHIONE ^-TRANSFERASE B
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Royal Infirmary, Edinburgh EH 3 9YW, Scotland, U.K.
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1. Two lithocholic acid-binding proteins in rat liver cytosol, previously shown to have
glutathione .S-transferase activity, were resolved by CM-Sephadex chromatography. 2.
Phenobarbitone administration resulted in induction of both binding proteins. 3. The
two proteins had distinct subunit compositions indicating that they are dimers with
mol.wts. 44000 and 47000. 4. The two lithocholic acid-binding proteins were identified
by comparing their elution volumes from CM-Sephadex with those of purified ligandin
and glutathione .S-transferase B prepared by published procedures. Ligandin and gluta¬
thione ^-transferase B were eluted separately, as single peaks of enzyme activity, at
volumes equivalent to the two lithocholic acid-binding proteins. 5. Peptide 'mapping'
revealed structural differences between the two proteins.
Intravenous injection of unconjugated bilirubin
into rats results in rapid hepatic clearance of the
anion from the blood, its passage across the hepato-
cyte and its excretion into bile. Subcellular fractiona¬
tion showed that most of the bilirubin in these livers
was in cytosol (Brown et al., 1964). Further, gel-
exclusion chromatography of cytosol from similarly
treated animals or of hepatic cytosol mixed with
bilirubin in vitro resulted in three peaks of protein-
bound bilirubin (Levi et al., 1969b). These peaks
were called X (eluted in the void volume), Y (mol.wt.
approx. 45000) and Z (mol.wt. approx. 12000). The
binding component in the Y fraction was shown to be
a protein and was called ligandin because of its
ability to bind, non-covalently, a variety of organic
anions (Litwack et al., 1971). Circumstantial evidence
obtained from phylogenetic studies and investigations
into neonatal jaundice led to the hypothesis that
ligandin is involved in the hepatic transport of many
different anions (Levine et al., 1971; Levi et al.,
1969a, 1970).
Kaplowitz et al. (1973) showed that ligandin from
rat liver possessed glutathione S-transferase activity,
and Habig et al. (1974a) reported that ligandin was
identical with glutathione S-transferase B, one of a
group of at least seven enzymes that catalyse the
conjugation of glutathione to a number of electro-
philic compounds (Jakoby et al., 1976a). Ligandin
can therefore be defined by its enzymic activity, the
ability to conjugate glutathione with different
substrates, including l-chloro-2,4-dinitrobenzene and
Abbreviations used: GSH, reduced glutathione; SDS,
sodium dodecyl sulphate.
ethacrynic acid, and by its ability to bind non-
substrate anions.
Preparation of purified ligandin has been described
by several groups using different purification techni¬
ques (Morey & Litwack, 1969; Habig et al., 19746;
Kamisaka et al., 1975; Tipping et al., 1976). Present
evidence shows ligandin to be a basic protein (pi 8.7-
9.0), which comprises 4.0-4.5% of the total protein
in rat liver cytosol; it has a mol.wt. of 46000 and
consists of two subunits, Ya (mol.wt. 22000) and
Yc (mol.wt. 25000). However, there is now doubt
about whether the different purified preparations of
ligandin contain only one protein or indeed if they
comprise the same protein. These doubts arise partly
because of the wide range of pi values (8.4-9.8)
obtained by different groups (Litwack et al., 1971;
Jakoby et al., 19766) and also because these prepara¬
tions exhibit properties compatible either with their
containing contaminating glutathione S-transferases
or that preparations of ligandin, originally pure, are
modified during storage to a mixture of ligandin and
other proteins (Habig et al., 19746; Ketterer et al.,
1976; Listowsky et al., 1976). For example Carne
et al. (1979) have demonstrated that ligandin can be
further resolved by ion-exchange chromatography
into dimeric proteins comprising YaYa and YaYc
monomers.
We have isolated two lithocholic acid-binding
proteins from the Y fraction of rat liver cytosol
(Strange et al., 1977). Although neither protein has
been identified, both had glutathione S-transferase
activity and substrate specificities compatible with
their being ligandin.
We now describe experiments to identify these
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two proteins. Their monomeric composition, peptide
'maps' and the effect of phenobarbitone on their
concentrations have been investigated: pheno¬
barbitone has been reported to increase the synthesis
of ligandin (Reyes et al., 1971; Fleischner et al.,
1972; Arias et al., 1976). Further, glutathione S-
transferase B was prepared by the procedure of
Habig et al. (1976a) and ligandin by that described
by Arias et al. (1976), and these two purified proteins




[24-14C]Lithocholic acid (59Ci/mol) was from The
Radiochemical Centre, Amersham, Bucks., U.K.,
and was shown to be 99 % pure by t.l.c. (Hamilton &
Muldrey, 1961) before use. Acrylamide, NN'-
methylenebisacrylamide, AWTVA'-tetramethylethyl-
enediamine and l-chloro-2,4-dinitrobenzene of
analytical grade were obtained from BDH Chemicals
Ltd., Poole, Dorset, U.K., and l,2-dichloro-4-
nitrobenzene was from Eastman Kodak Co.,
Rochester, NY, U.S.A., and was twice recrystallized
from ethanol before use. GSH, rat albumin, ovalbu¬
min, a-chymotrypsinogen, a-chymotrypsin, ribo-
nuclease A, TEAE (triethylaminoethyl)-cellulose
and Coomassie Brilliant Blue G were from Sigma,
Poole, Dorset, U.K. CM-Sephadex C-50 and
QAE (quaternary aminoethyl)-Sephadex A-50 were
from Pharmacia Fine Chemicals, London W5 5SS,
U.K. CM-cellulose (Whatman CM52) and DEAE-
cellulose (Whatman DE52) were purchased from
Whatman, Maidstone, Kent, U.K., and Bio-Gel
A-0.5m (200-400 mesh) was from Bio-Rad Labora¬
tories, Bromley, Kent, U.K. Poly(ethylene glycol)
(mol.wt. 25000) was from Union Carbide, Southamp¬
ton, Hants., U.K., and Spectrapor dialysis membrane
(mol.wt. cut-off of 12000-14000) was from Spectra¬
por, Spectrum Medical Industries, Los Angeles, CA,
U.S.A. Bromosulphophthalein was from Hynson,
Westcott and Dunning, Baltimore, MD, U.S.A.
Analytical methods
Glutathione ^-transferase activity was measured
at 37°C by following the conjugation of GSH with
either l,2-dichloro-4-nitrobenzene or l-chloro-2,4-
dinitrobenzene at 340nm (Habig et al., 19746).
Bromosulphophthalein concentrations were mea¬
sured by the /f580 after addition of NaOH (100/d;
10m) to 250/d portions of column fractions. Protein
concentrations in samples eluted from columns were
calculated from the A2So values. Radioactivity and
Na+ concentrations were measured as described by
Strange et al. (1977).
Animals
Male Wistar rats (230-290g) fed ad libitum were
used. Phenobarbitone-treated rats were given sub¬
cutaneous injections of sodium phenobarbitone in
sterile water (0.5ml; approx. lOOmg/kg body wt.)
for 7 successive days and were killed on the eighth
day. Phenobarbitone administration resulted in a
30-50% increase in liver weight compared with
untreated animals.
Buffers
The compositions of the buffers used, and the
temperatures at which they were prepared, were;
buffer A, lOmM-sodium phosphate, pH7.4 (20°C);
buffer B, 10mM-Tris/HCl, pH8.1 (4°C); buffer C,
lOmM-sodium phosphate, pH6.7 (20°C); and buffer
D, 10mM-Tris/HCl, pH8.8 (4°C).
Preparation of cytosol
Rats were anaesthetized with ether and the livers
perfused in situ through a portal-vein cannula with
approx. 20ml of ice-cold buffer A containing sucrose
(250itim), until free of blood. The liver was removed,
homogenized in 20ml of the perfusion buffer and
the homogenate centrifuged (30min, 4°C, 18000g-).
The supernatant was decanted off, re-centrifuged
(120min, 4°C, lOOOOOg) and after removal of the
lipid layer the clear supernatant was stored on ice.
Separation of the glutathione S-transferases in cytosol
Cytosol from two rats was dialysed (4°C, 9h)
against two changes, each of 2 litres, of buffer A.
The dialysed solution (12ml; approx. 325mg of
protein) was eluted (4°C, 16ml/h) from a column of
CM-Sephadex (2.2cmxl5cm) which was equili¬
brated with buffer A. The fraction volume was 2.7 ml.
After 70ml had been eluted the glutathione S-
transferases, which were retained by the ion-ex¬
changer, were eluted with a continuous 0-80mM-
NaCl gradient in buffer A (Strange et al., 1977).
Discontinuous polyaerylamide-gel electrophoresis
This was performed in the presence of 0.1 % SDS
by using vertical slab gels (0.075cmx 12cmx20cm)
(Laemmli, 1970) in an RGA/500 electrophoresis
apparatus obtained from Raven Scientific Ltd.,
Haverhill, Suffolk, U.K. Samples were prepared for
electrophoresis by heating at 85°C for lOmin in an
aqueous solution containing SDS (1%, w/v), 2-
mercaptoethanol (0.1%, v/v), Bromophenol Blue
(0.002%, w/v) and sucrose (10%, w/v) as described
by Maizel (1971). Portions (40/d) of these mixtures
were run through the stacking gel [(3%, w/v) poly-
acrylamide in Tris/HCi buffer (0.125m, pH6.8)] at
6W and through the resolving gel [12.5% (w/v) poly-
acrylamide in Tris/HCl buffer (0.375m, pH8.9)] at
2-4W. The gels were stained (2h, 20°C) in a 0.2%
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(w/v) solution of Coomassie Brilliant Blue in water/
methanol/acetic acid (50: 50:7, by vol.) and destained
in water/methanol/acetic acid (88:5:7, by vol.).
After slicing, the gels were scanned at 580 nm by
using a Vitatron TLD 100 flying-spot densitometer
from Fisons Scientific Apparatus, Loughborough,
Leics., U.K.
The Ya, Yb and Yc monomers present in the Y
fraction (Bass et al., 1977) were identified as follows.
Cytosol (3 ml, 40mg of protein) was eluted (4°C,
22ml/h) from a column (2.5 cm x 38 cm) of Bio-Gel
A-0.5m. The fraction volume was 3.7ml. The void
volume (Dextran Blue) was 75 ml and the salt volume
(Na+) was 195 ml. The three fractions which contained
the maximum glutathione S-transferase activities
(eluted between 127 and 138ml) were combined and
examined by discontinuous polyacrylamide-gel elec¬
trophoresis. Densitometry of the electrophoretic
pattern demonstrated that 85 % of the total protein
present was recovered in three bands (Ya, Yb and
Yc).
Peptide 'mapping' of lithocholic acid-binding proteins
by limitedproteolytic digestion in the presence ofSDS
The method used was that described by Cleveland
et al. (1977). The two purified lithocholic acid-
binding proteins (approx. 1 mg of protein/ml) were
each heated to 95°C for 2min in the presence of
0.2% SDS and lmM-EDTA. These mixtures were
cooled (37°C, lOmin) and proteolytic digestion was
carried out at 37°C by addition of various amounts
of a-chymotrypsin (10/rl, containing 14, 1.4, 0.14,
0.014 or 0.0014/rg of protein) to portions (50/rl,
approx. 50pg of protein) of the purified lithocholic
acid-binding proteins. After 45min, 2-mercapto-
ethanol, SDS, sucrose and Bromophenol Blue were
added to final concentrations of 1, 2, 10 and 0.002%
respectively and the digestions were terminated by
heating (95°C, lOmin). Portions (50//I) of the digest,
which contained 25pg of digested lithocholic acid-
binding protein and 7-0.0007pg of either proteolytic
enzyme, were analysed by discontinuous SDS/
polyacrylamide-gel electrophoresis on slabs
(0.075cmx 12cmx20cm) by using a 3% stacking
gel and 16.5% polyacrylamide resolving gel as
described above. As a control, chymotrypsin was
incubated alone at the highest concentration used
for digestion (140//g/ml).
Preparation of lithocholic acid-bindingproteins 1 and 2
These were prepared by the method of Strange
et al. (1977).
Preparation ofglutathione S-transferase B
This was prepared as described by Jakoby et al.
(1976a). Livers from two rats were frozen in a beaker
placed in a mixture of solid C02 and ethanol (approx.
—72°C). After 30min the frozen livers were removed,
added to 40ml of water (4°C) and crushed with a
pestle. This preparation was blended for 30s in a
Sunbeam liquidizer model PB-P (Sunbeam Corp.,
Maribyrnong, Victoria, Australia) and the resulting
solution was centrifuged (lh, lOOOOg). The lipid
layer was removed and 16 ml of the supernatant
applied to a DEAE-cellulose column (2.2cm x 15cm)
which was equilibrated and eluted (22ml/h, 4°C)
with buffer B. The enzyme-containing fractions
eluted between 29 and 65 ml were combined. Solid
(NH4)2S04 was added with stirring at 20°C until
90% saturation was reached (Dixon & Webb, 1964).
After standing (30min, 20°C) the solution was
centrifuged (lOOOOg, 45min, 20°C). The supernatant
was discarded, the precipitate redissolved in 10ml of
buffer C and the solution dialysed (16h, 4°C) against
2 litres of the same buffer. The dialysed solution was
applied to a CM-cellulose column (2.2cmxl5cm)
equilibrated and eluted (22ml/h, 4°C) with buffer C.
The fraction volume was 3.7ml. After 120ml of
eluate had been collected a continuous 0-80mM-
NaCl gradient in the same buffer was initiated (Habig
et al., 19746). Five peaks of enzyme activity, able to
catalyse the conjugation of GSH with l-chloro-2,4-
dinitrobenzene, were eluted at Na+ concentrations
of 15, 37, 50, 59 and 70mM. Only the enzyme-
containing peaks eluted at Na+ concentrations of 37
and 59 mM were able to catalyse the conjugation of
GSH and l,2-dichloro-4-nitrobenzene, indicating
that these peaks contain transferases C and A
respectively (Habig et al., 19746). The enzyme-
containing peak eluted between these two trans¬
ferases at 50mM-Na+ concentration is glutathione
S-transferase B (Habig et al., 19746).
Preparation of ligandin
Ligandin was prepared essentially by the method
of Arias et at. (1976). After perfusion in situ with
approx. 20ml of ice-cold buffer A, lOOg of liver was
homogenized in 300ml of buffer A containing 250mM-
sucrose. The homogenate was centrifuged (100000g-,
90min, 4°C) and the resulting supernatant was
dialysed against 5 litres of buffer D (16 h, 4°C).
The dialysed material (approx. 80 ml) was eluted
(25ml/h) from a column (2.5cmx 100cm) of TEAE-
cellulose equilibrated with buffer D. The first protein
peak, eluted between 350 and 500ml, was combined,
concentrated to 10ml by dialysis against poly-
(ethylene glycol) and redialysed (16h, 4°C) against
2 litres of buffer A. The resulting solution was
incubated (60min, 4°C) with 20mg of bromosul-
phophthalein and eluted (24ml/h) with buffer A
from a column (2.5cm x 100cm) of Sephadex G-100
(Kirsch et al., 1975). The six fractions (elution volume
265-300mI, approx. mol.wt. 45000) containing the
maximum amount of protein-bound bromosul-
phophthalein were combined and concentrated to
approx. 5 ml by dialysis against poly(ethylene glycol).
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After dialysis (16h, 4°C) against 2 litres of buffer D
this solution was eluted (30ml/h) from a column
(1.5cm x 60cm) of QAE-Sephadex A-50 equilibrated
with buffer D. Fractions eluted between 30 and
60 ml contained ligandin (Bass et al., 1977).
Results
Elution of the glutathione S-transferases from CM-
Sephadex
CM-Sephadex resolved rat liver cytosol into five
peaks of glutathione ^-transferase activity (measured
by the conjugation of l-chloro-2,4-dinitrobenzene
and GSH) (Fig. 1). These peaks were designated
1-5 by their elution volumes: peak 1, 15-40ml;
peak 2, 43-85ml; peak 3, 91-120ml; peak 4, 130—
180ml; and peak 5, 197-241 ml. Enzyme activity in
peak 4 included a shoulder, indicating the presence
of at least two enzymes.
Material in peaks 1, 2 and part of peak 4 (elution
volume 155-180ml) was able to catalyse the conjuga¬
tion of GSH with l,2-dichloro-4-nitrobenzene. A
small peak, containing l,2-dichloro-4-nitrobenzene-
GSH-conjugating activity, was eluted between peaks
3 and 4 (elution volume 115-130ml). Enzyme activity
in peak 4 was partially resolved by CM-Sephadex
chromatography, since the initial fractions (elution
volume 130-154ml) were unable to catalyse the
conjugation of GSH with l,2-dichloro-4-nitro-
benzene, whereas the later fractions (elution volume
155-180ml) were able to catalyse the conjugation
of GSH with both l-chloro-2,4-dinitrobenzene and
1,2-dichIoro-4-nitrobenzene.
The combined elution profile of the 1-chloro-
2,4-dinitrobenzene-GSH- and l,2-dichIoro-4-nitro-
benzene-GSH-conjugating activities from CM-
Sephadex demonstrated the presence of at least seven
glutathione ^-transferases in hepatic cytosol, six of
which were able to catalyse the conjugation of 1-
chloro-2,4-dinitrobenzene and GSH.
To identify the lithocholic acid-binding proteins,
cytosol (12ml; approx. 325mg of protein) was
incubated (60min, 4°C) with [14C]lithocholic acid
(1/rCi; 17nmol) and the mixture eluted from CM-
Sephadex. Two peaks of radiolabeled lithocholic
acid were eluted with the NaCl gradient at Na+
concentrations of 40 mM and 57mM, corresponding
to the elution volumes of peak 3 (91-!20ml) and the
initial fractions of peak 4 (elution volume 130-154ml).
Peak 3 contained 55% and the first part of peak 4
contained 30% of the added radioactivity.
Jakoby et al. (1976a) have prepared six of the
glutathione S-transferases and termed them E and D
(eluted together) and C, B, A and AA by their order
of elution from CM-cellulose. Transferases B, A
and AA were eluted with a NaCl gradient. On the
basis of elution volume and substrate specificities,
either of the two lithocholic acid-binding proteins
could be ligandin.
Effect of phenobarbitone on the glutathione S-trans¬
ferases
Phenobarbitone administration has been reported
to increase the concentration of hepatic ligandin
(Arias et al., 1976), and the effect of this agent on the
elution profile of the glutathione ^-transferases from
CM-Sephadex was studied (Fig. 2). A comparison





















Fig. 1. Elution pattern from CM-Sephadex of cytosol from normal rats
Rat liver cytosol (approx. 325 mg of protein) from normal rats was dialysed against buffer A and eluted from a column
(2.2cm x 15 cm) of CM-Sephadex C-50. Fractions (2.7 ml) were collected and the Na+ concentrations (■) determined.
Glutathione S-transferase activity was also measured with l-chloro-2,4-dinitrobenzene (a) or l,2-dichloro-4-nitro-
benzene (O) as substrate.
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Fig. 2. Elution pattern from CM-Sephadex of cytosol from phenobarbitone-treated rats
Rat liver cytosol (approx. 325 mg of protein) from phenobarbitone-treated rats was dialysed against buffer A and
eluted from a column (2.2cm x 15 cm) of CM-Sephadex C-50. Fractions (2.7ml) were collected and the Na+ concentra¬
tions (■) determined. Glutathione S-transferase activity was also measured with l-chloro-2,4-dinitrobenzene (a) or




(Fig. 1) and from phenobarbitone-treated rats(Fig. 2)
shows that the elution volumes of the glutathione
S-transferase peaks were not changed by pheno-
barbitone treatment. Transferase activity in peaks 1
and 2, measured by using either l-chloro-2,4-
dinitrobenzene or l,2-dichloro-4-nitrobenzene, was
unaffected by phenobarbitone treatment. Trans¬
ferase activity in peak 3 was increased approx.
3.5-fold when measured with l-chloro-2,4-dinitro-
benzene. Transferase activity in peak 4 towards both
substrates was increased approx. 2-fold. Transferase
activity in peak 5, measured with l-chloro-2,4-
dinitrobenzene and GSH, was similar in both groups
of animals. The enzyme activities in both the first
Fig. 3. SDSIpolyacrylamide-gel electrophoresis of peaks
3 and A
Peaks 3 and 4 were prepared by CM-Sephadex
chromatography of hepatic cytosol (approx. 325mg
of protein) from normal rats. Fractions (2.7ml) were
collected and assayed for glutathione 5-transferase
activity. The three fractions (elution volume 99-
107ml) that were eluted in peak 3 and had maximum
enzyme activity were combined, and fractions that
were eluted at 136, 141, 147, 157, 165 and 173ml
across peak 4 were collected, and 15//1 (approx. 10//g
of protein) was removed from each fraction and
prepared for electrophoresis. The samples were
applied from left to right as follows: whole hepatic
cytosol, the three combined fractions (eluted at
99-107ml) from peak 3, and fractions eluted at 136,
141, 147, 157, 165 and 173ml. The origin is at the
top of the gel and samples were run down towards
the anode. The Ya (mol.wt. 22000), Yb (mol.wt.
23 500) and Yc (mol.wt. 25000) bands are indicated.
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and second parts of peak 4 appear to be increased by
phenobarbitone treatment.
Effects ofphenobarbitone on the subunit composition
of the glutathione S-transferases
To identify the Ya, Yb and Yc bands, the Y fraction
was prepared. Discontinuous SDS/polyacrylamide-
gel electrophresis of a portion (approx. 20pg of
protein) of this preparation demonstrated that 85%
of the total protein was recovered in three bands,
each containing approximately equal amounts of
protein. The mol.wts. of these bands were calculated
to be 22000, 23 500 and 25000 by comparing their
electrophoretic mobilities against rat albumin
(mol.wt. 68000), ovalbumin (mol.wt. 45000), a-






Fig. 4. Phenobarbitone induction ofpeak-4 proteins
Peak 4 was prepared by CM-Sephadex chromato¬
graphy of whole cytosol. Electrophoresis of samples
(20//1) from fractions that were eluted at 136, 141,
147, 157, 165 and 173ml from both phenobarbitone-
treated and untreated rats was performed as de¬
scribed for Fig. 3. The relative concentrations in the
peak-4 fractions of Ya (▲), Yb (■) and Yc (•)
subunits in untreated rats and Ya (a), Yb (□) and
Yc (O) subunits in phenobarbitone-treated rats were
determined by densitometry and expressed as a
percentage of the total protein in each fraction.
Equal portions of cytosol (approx. 325mg of
protein) from control and phenobarbitone-treated
rats were chromatographed on columns of CM-
Sephadex. Electrophoresis of portions (15/tl, approx.
10//g of protein) of fractions of peak 3 obtained from
control animals indicated that 80% of the protein
Fig. 5. SDS/polyacrylainide-gel electrophoresis of the two
lithocholic acid-binding proteins
The two lithocholic acid-binding proteins were
purified from CM-Sephadex by the method of
Strange et al. (1977) and prepared for discontinuous
SDS/polyacrylamide-gel electrophoresis as described
by Maizel (1971). Portions of each protein (15/rg)
were applied to the gels (12.5% polyacrylamide re¬
solving gel) and were run from the cathode (top) to
the anode (bottom). Purified protein which was
eluted from CM-Sephadex at 40mM-Na+ was
applied to the left-hand side of the gel and protein
eluted at 57mM-Na+ was applied to the right-hand
side of the gel.
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Fig. 6. Partial proteolytic digestion of the lithocholic acid-
binding proteins
Portions (50//g) of the lithocholic acid-binding
proteins were digested with various amounts of
a-chymotrypsin as described in the Materials and
Methods section. After 45 min digestion, the reaction
mixtures were applied to discontinuous SDS/
polyacrylamide gels and run from the cathode (top)
to the anode (bottom). The samples applied were:
(1) chymotrypsin (7//g); (2)—(6) lithocholic acid
binding-protein (YaYa) (25//g) and 0.0007//g,
0.007fig, 0.07/tg, 0.7//g or 7/tg of chymotrypsin re¬
spectively; (7)—(11 > lithocholic acid-binding protein
(YaYc) (25//g) and 7/;g, 0.7pg 0.07pg, 0.007pg or
0.0007pg of chymotrypsin respectively; (12) chymo¬
trypsin (7//g). Chymotrypsin treated in the same way
as the lithocholic acid-binding proteins was
dissociated into its subunits (mol.wts. approx.
17 000 and 11 000; Schroeder, 1968) and was used as a
molecular-weight marker (channels 1 and 12).
migrated with the Ya band, indicating that the YaYa
dimer is responsible for the enzyme activity of peak
3 (Fig. 3). Phenobarbitone treatment resulted in a
3-fold increase in the amount of the Ya monomer.
Only small amounts of the Yb and Yc monomers were
found in control animals, and these were not changed
by phenobarbitone treatment.
For normal rats, electrophoresis of portions
(15/rl, approx. 15//g of protein) of fractions from
peak 4 (136, 141, 147, 157, 165 and 173ml) (Fig. 3)
demonstrated a change in the Ya, Yb, Yc subunit
composition (Fig. 4). The initial fractions contained
primarily Ya and Yc subunits, in equal concen¬
trations, whereas the later fractions contained
predominantly Yb subunit. The Yb content changed
from approx. 16% (elution volume 136ml) to 55%
(elution volume 173 ml) of the total YaYbYc protein;
this suggested that a YaYc dimer is responsible for
the enzyme and lithocholic acid-binding activities
in the initial fractions of peak 4, and a YbYb dimer
for the enzyme activity in the later fractions. After
phenobarbitone treatment the concentrations of the
Ya, Yb and Yc bands were each increased approx.
2-fold in all the fractions across peak 4 (Fig. 4). The
concentrations of other bands were unchanged.
Phenobarbitone treatment therefore appears to
induce both of the two partially resolved glutathione
■S-transferases in peak 4.
Peak 3 and the initial fractions of peak 4, which
contain the two lithocholic acid-binding proteins,
are both induced by phenobarbitone treatment and
could therefore be ligandin. Ligandin has been
described as a YaYc dimer (Daniel et at., 1977;
Bhargava et at., 1978), which is consistent with its
Fig. 7. CM-Sephadex chromatography ofglutathione S-transferase B and ligandin
Glutathione S-transferase B and ligandin were prepared and 5 ml (approx. I nig) of each preparation was eluted
(16.0ml/h) from CM-Sephadex C-50. Fractions (2.67ml) were collected and the Na+ concentrations (■) determined.
The results from the separate chromatography of the two protein preparations are combined. GSH-l-chloro-2,4-
dinitrobenzene-conjugating activities in the eluate from chromatographed glutathione S-transferase B (a) and ligandin
(a) were measured.
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being eluted in peak 4. However, Bass et al. (1977)
have shown that their preparation of ligandin
contained predominantly YaYa protein, which is
consistent with it being eluted in peak 3, and Carne
et al. (1979) prepared ligandin which could be
resolved into YaYa protein and a YaYc protein.
The identity of the two bile acid-binding proteins
was therefore established by preparing ligandin and
glutathione .S-transferase B and eluting the two
purified proteins from CM-Sephadex.
Peptide 'mapping' of lithocholic acid-binding proteins
Before proteolytic digestion, portions of the two
binding proteins were examined by discontinuous
SDS/polyacrylamide-gei electrophoresis. Fig. 5 shows
that the protein eluted in peak 3 from CM-Sephadex
migrated as a single band, which was identified as
the Ya monomer, and that eluted in the initial
fractions of peak 4 migrated as two bands, identified
as the Ya and Yc monomers.
Limited proteolysis of these two proteins with
chymotrypsin followed by SDS/polyacrylamide-gel
electrophoresis revealed two major digestion
products, which were common to both proteins
(Fig. 6). Comparison of the mobility of these products
with that of the subunits of chymotrypsin showed
them to have mol.wts. about 10000 and 13000.
Fig. 6, however, also revealed digestion products
of mol.wts. about 19000 and 17000, which are
found in the protein from the initial fractions of
peak 4 (glutathione S-transferase B), but not in the
other protein.
Elation of ligandin and glutathione S-transferase B
from CM-Sephadex
Chromatography of ligandin from CM-Sephadex
resulted in elution of a peak (85-120ml) of protein
and enzyme activity (measured with l-chloro-2,4-
dinitrobenzene and GSH) at a Na+ concentration
of 40mM (Fig. 7). Glutathione S-transferase B was
eluted (130-155ml) from CM-Sephadex as a single
peak of protein and enzyme activity (measured with
l-chloro-2,4-dinitrobenzene and GSH) at a Na+
concentration of 57mM (Fig. 7). The glutathione
S-transferase activity of ligandin and glutathione
S-transferase B with l,2-dichloro-4-nitrobenzene
was less than 0.3 % of that with l-ch!oro-2,4-dinitro-
benzene. When either ligandin or glutathione
S-transferase B was incubated (4°C, 60min) with
[14C]lithocholic acid (1/tCi; 17nmol) before elution
from CM-Sephadex. single peaks of radioactivity
were eluted with the protein peaks, indicating that
both ligandin and glutathione S-transferase B bind
lithocholic acid.
Discussion
Our experiments show that seven glutathione
S-transferases in liver cytosol can be resolved by
CM-Sephadex chromatography: of these six were
able to catalyse the conjugation of GSH with 1-
chloro-2,4-dinitrobenzene. Both peak 3 and the
initial fractions of peak 4, which contain the two
previously described lithocholic acid-binding pro¬
teins, contain proteins that could be ligandin on
the basis of substrate specificity, phenobarbitone
induction, subunit composition and anion binding.
To identify these two protein peaks, ligandin and
glutathione .S-transferase B were purified and
examined by CM-Sephadex chromatography. The
two proteins were eluted separately as single peaks
of protein and enzyme activity at volumes equivalent
to peak 3 and the initial fractions of peak 4 respecti¬
vely. Neither protein exhibited the 'microhetero¬
geneity' described by Ketterer et al. (1976) or Carne
et al. (1979). These results demonstrate that ligandin,
prepared by the procedure described by Arias et al.
(1976) and Bass et al. (1977), and glutathione S-
transferase B, purified by the method of Habig
et al. (1976a), are separate proteins and that they can
be prepared to a degree of purity such that they are
eluted from CM-Sephadex as single peaks of protein.
The suggestion that ligandin is a protein which
exhibits 'microheterogeneity' is based on the finding
that apparently pure preparations of ligandin can be
resolved into two similar but separate proteins that
have similar amino acid compositions and are
composed of either YaYa or YaYc monomers
(Carne et al., 1979). Other workers, however, have
described ligandin preparations that do not demon¬
strate 'microheterogeneity'. In the present study and
in that of Bass et al. (1977), ligandin, prepared by
the method of Arias et al. (1976), was shown
by discontinuous SDS/polyacrylamide-gel electro¬
phoresis to contain predominantly the Ya monomer,
indicating that the dimeric protein comprises a
YaYa dimer. Since Bhargava et al. (1978) also used
the purification procedure described by Arias et al.
(1976), it is surprising that their ligandin was a
YaYc dimer. The procedure of Bhargarva et al.
(1978) was, however, slightly different from that
originally described by Arias et al. (1976); the pH
of the buffer used in their ion-exchange-chromato-
graphy steps was lower and the purification was
carried out in the presence of phenylmethane-
sulphonyl fluoride. The YaYa and YaYc dimers are
very similar, and this change in the pH of the eluting
buffer may have been sufficient to result in purification
of a YaYc dimer rather than the YaYa dimer.
The name ligandin was originally used to describe
three apparently homogeneous protein preparations
which, on the basis of molecular-weight studies,
amino acid compositions and immunological cross-
reactivities, were considered to be one protein
(Litwack et a!., 1971). The subunit composition of
these preparations of ligandin is not known, and,
since subsequent preparations of this protein were
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found to contain either YaYa or YaYc dimers or
even a mixture of these proteins, it is not possible to
define the subunit composition of ligandin on the
basis of the original preparation. Our preparation of
ligandin contains Ya monomers. Our experiments
also indicate that the YaYc dimer can be prepared
to a degree of purity such that it is eluted from CM-
Sephadex as a single peak of enzyme activity; it also
demonstrated no evidence of 'microheterogeneity'.
This protein, prepared by the procedure of Habig
et al. (1976a), is glutathione S-transferase B.
The finding that ligandin and glutathione S-
transferase B are separate proteins is in contrast
with the work of Habig et al. (1974a), who reported
that ligandin, prepared by the method of Arias
et al. (1976), and glutathione S-transferase B were
identical; the two proteins were immunologically
indistinguishable, were induced by phenobarbitone
and had identical amino acid compositions and
similar substrate specificities. The subunit composi¬
tion of this preparation of ligandin is not known;
it may have been a YaYc dimer and therefore been
identical with glutathione S-transferase B. However,
even if this preparation was a YaYa dimer, it is not
surprising that the two proteins were thought to be
identical. These two proteins are similar (Carne
et al., 1979), and it is not surprising that antiserum
raised against one protein cross-reacts with the other
or that their substrate specificities are similar. How¬
ever, we have previously reported that lithocholic
acid inhibits the enzyme activity of the protein now
known to be ligandin, but not that of glutathione
S-transferase B (Strange et al., 1977). Further,
although their amino acid compositions have been
reported to be identical, we have now shown differ¬
ences in their peptide 'maps'. We confirm that both
proteins are induced by phenobarbitone.
A variety of glutathione S-transferases have been
described in both human and rat liver. Five ionically
distinct glutathione S-transferases have been iso¬
lated from human liver; all have the same amino
acid composition, suggesting that they are coded for
by a single gene and that the different enzymes arise
as a result of deamidation in vivo or some other
post-synthetic modification (Habig et al., 19766).
In rat liver seven glutathione S-transferases, having
similar physical properties and overlapping substrate
specificities, have been reported; it is not clear how
many genes code for these enzymes. Although not
all the glutathione S-transferases in rat liver have
been purified, the amino acid compositions of at
least some of the enzymes (transferases C, B, A
and AA) are similar, indicating that some of these
enzymes may be coded for by the same gene (Habig
et al., 19746, 1976a). However, the enzymes in
peak 3 and peak 4 may be coded separately, since
they are the only ones that are induced by pheno¬
barbitone. The number of enzymes actually tran¬
scribed may be therefore less than the seven so far
found. This would account for the presence of only
three separate monomer bands (Ya, Yb and Yc) in
the Y fraction. The relationship between the two
lithocholic acid-binding proteins is unclear. It is
unlikely that they arise as a result of non-specific
degradation, since they can be prepared separately
from each other. Possibly a product-precursor
relationship exists between the two proteins. They
may be coded for by a single gene and synthesized as
a YcYc precursor (mol.wt. 50000), which is sub¬
sequently converted into either YaYc (mol.wt.
47000) or YaYa (mol.wt. 44000) protein by the
cleavage and removal of approx. 25 terminal amino
acids.
Our results suggest that the two previously
described lithocholic acid-binding proteins are, in
fact, ligandin and glutathione S-transferase B. These
two proteins are both induced by phenobarbitone
and have similar substrate specificities, but are
eluted differently from CM-Sephadex and possess
different subunit compositions. It is not clear whether
the two proteins are coded for by the same gene and
represent alternative forms of the same protein, or
by different genes and therefore represent isoenzymes.
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Cholic Acid Binding by Glutathione A-Transferases from Rat Liver Cytosol
John D. HAYES, Richard C. STRANGE and Iain W. PERCY-ROBB
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(Received 16 July 1979)
Cholic acid-binding activity in cytosol from rat livers appears to be mainly associated
with enzymes having glutathione 5-transferase activity; at least four of the enzymes in
this group can bind the bile acid. Examination of the subunit compositions of different
glutathione 5-transferases indicated that cholic acid binding and the ability to conjugate
reduced glutathione with 1,2-dichloro-4-nitrobenzene may be ascribed to different
subunits.
The removal of bile acids from the blood and their
secretion into bile is an important aspect of hepatic
function. Transport across the hepatocyte from the
sinusoidal membrane to the canalicular membrane
may involve cytosolic bile acid-binding components
whose molecular weight (about 45000) and lack of
specificity towards different bile acids (Strange et al.,
1977a) suggested the involvement of ligandin, a
non-specific anion-binding protein (Litwack et al.,
1971). Although the identity of ligandin may now be
in doubt (Hayes et al., 1979), it is one of at least seven
enzymes found in rat liver cytosol which have
glutathione 5-transferase activity.
The glutathione 5-transferases comprise a group
of enzymes with overlapping substrate specificities,
some of which can also bind non-substrate ligands
(Jakoby, 1978). They have molecular weights of
about 46000 and comprise two of three possible
subunits: Ya (mol.wt. 22000), Yb (mol.wt. 23 500)
and Yc (mol.wt. 25000) (Bass et al., 1977). Ligandin
has been described as a YaYa dimer (Bass et al.,
1977; Hayes et al., 1979), a YaYc dimer (Listowsky
et al., 1976) or as a mixture of two proteins com¬
prising YaYa and YaYc dimers (Carne et a!., 1979).
In the present study, we have defined ligandin (pre¬
pared by the method of Arias et al., 1976) as a YaYa
dimer.
We have purified two lithocholic acid-binding pro¬
teins from rat liver cytosol (Strange et al., 19776;
Hayes et al., 1979); both proteins possessed gluta¬
thione 5-transferase activity, and they were identified
as ligandin and glutathione 5-transferase B (Hayes
et al., 1979). We now describe experiments firstly to
determine if these and other glutathione 5-trans-
ferases can bind the quantitatively more important
primary bile acid, cholic acid, and secondly to corn-
Abbreviations used: GSH, reduced glutathione; SDS,
sodium dodecyl sulphate.
pare the subunit composition of the enzymes that




oic acid) was from Maybridge Chemical Co.,
Tintagel, Cornwall, U.K., and [2,4-3H]choIic acid
(14Ci/mmol) was from New England Nuclear,
Dreieichenhain, West Germany. They were shown
to be 99% pure by t.l.c. (Hamilton & Muldrey, 1961).
Bio-Gel A-0.5m (200-400mesh) was from Bio-Rad
Laboratories, Bromley, Kent, U.K.
Analytical methods
Glutathione 5-transferase activity was measured
at 37°C by following the conjugation of glutathione
with either l,2-dichloro-4-nitrobenzene or 1-chloro-
2,4-dinitrobenzene at 340nm (Habig et al., 1974).
Radioactivity counting, determination of Na+ and
protein concentrations were performed as described
by Strange et al. (19776).
Buffers
The compositions of the buffers used, and the
temperatures at which they were prepared, were:
buffer A, lOmM-sodium phosphate, pH7.4 (20°C);
buffer B, 20mM-sodium phosphate/100mM-NaCl,
pH7.4 (20°C); and buffer C, 20mM-Tris/HCl, pH8.6
(4°C).
Experimental and Results
Separation of glutathione S-transferases in cytosol
and examination of their cholic acid-binding activity
Cytosol prepared from two rat livers (Strange et al.,
1977a) was dialysed (4°C, 9h) against two changes,
each of 2 litres, of buffer A and eluted from a CM-
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Table 1. Elution characteristics, submit compositions andcholic acidbinding byglutathione S-transferasesfrom rat liver cytosol
The glutathione S-transferases in rat liver cytosol were separated by a combination of CM-Sephadex and DEAE-
Sephadex chromatography. Their monomer composition was determined by SDS/poIyacrylamide-gel electrophoresis
















Ya Yb Yc binding
5 25 70 Yes
5 95 0 No
90 5 5 Yes
50 0 50 Yes
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Fig. 1. DEAE-Sephadex chromatography ofpeak 4
Cytosol was eluted from a CM-Sephadex column and
peak 4 (elution vol. 130-180ml) was combined and
concentrated. After dialysis against buffer C, peak 4
was eluted from a DEAE-Sephadex column. Frac¬
tions (3.4ml) were collected and the glutathione
S-transferase activity with l-chloro-2,4-dinitroben-
zene (a) and 1,2-dichloro-4-nitrobenzene (o) and
the Na+ concentration (■) were measured.
Sephadex column (2.2cmxl5cm) (Hayes et al.,
1979). Five peaks with GSH-l-chloro-2,4-dinitro-
benzene-conjugating activity were eluted and
designated 1-5 by their elution volumes (Table 1)
(Hayes et al., 1979). They were each combined and
peaks 2-5 were concentrated, to about 5ml, by
dialysis at 4°C against poly(ethylene glycol). Peaks 1,
2, 3 and 5 were dialysed against two changes, each of
2 litres, of buffer B (4°C, 15 h).
After concentration the glutathione S-transferases
in peak 4 were dialysed against two changes, each of
2 litres, of buffer C. This solution was applied to a
DEAE-Sephadex A-50 column (2.2 cm x 15 cm), which
was equilibrated and eluted (20ml/h, 4°C) with buffer
C. A NaCl gradient (0-500 ntM) in buffer C was
established after 95ml of the buffer had passed
through (Strange et al., 19776). Fractions (3.3 ml)
were collected and analysed for glutathione S-trans-
ferase activity by measuring the conjugation of GSH
with either l-chloro-2,4-dinitrobenzene or 1,2-di-
chloro-4-nitrobenzene. Peak 4 was resolved into two
peaks of enzyme activity (Fig. 1); these were desig¬
nated peak 4(i) and peak 4(ii) (Table 1). Both peaks
were concentrated to about 5ml by dialysis at 4°C
against poly(ethylene glycol) and then dialysed
against two changes, each of 2 litres, of buffer B
(4°C, 15 h).
The glutathione S-transferases have previously
been classified by their order of elution from CM-
cellulose (Habig et al., 1974; Jakoby et al., 1976),
which suggests that transferases D, E and M are
eluted in peak 1, transferase C is eluted in peak 2,
ligandin and glutathione ^-transferase B are eluted in
peaks 3 and 4(i) respectively (Hayes et al., 1979),
transferase A is eluted in peak 4(ii) and transferase
AA in peak 5. The presence of transferase C in peak
2 and transferase A in peak 4(ii) is supported by
the substantial GSH-l,2-dichloro-4-nitrobenzene-
conjugating activity found in these two peaks (Habig
et al., 1974).
The binding of cholic acid by whole cytosol and the
separate transferase peaks was studied by using an
equilibrium chromatographic method (Wood &
Cooper, 1970). A Bio-Gel A-0.5m column (2.5cm x
38cm) was equilibrated and eluted at 4°C with buffer
B containing [3H]cholic acid (10nM; 150d.p.s./ml).
The flow rate was 20.5ml/h and the fraction volume
was 3.4ml. The elution volume of Blue Dextran was
75ml and of [3H]cholicacid 200ml. Portions (3ml) of
cytosol and glutathione S-transferase peaks 1, 2, 3,
4(i), 4(ii) or 5, containing approx. 80, 100,15,15,15 or
15mg of protein respectively, were diluted with an
equal volume of buffer B containing [3H]cholic acid
(20iim; 300d.p.s./ml). After incubation (60min,
4°C), this mixture was eluted from the Bio-Gel
column with buffer B containing [3H]cholic acid
(10nM; 150d.p.s./ml). The elution of cytosol from
the Bio-Gel column showed that the cholic acid-
1980


































































Fig. 2. Elution patterns of individual glutathione S-trans-
ferase peaks from Bio-Gel equilibrated with [3H]cholic acid
The transferase peaks [1, 2, 3, 4(i), 4(ii) and 5] ob¬
tained after ion-exchange chromatography were con¬
centrated and dialysed against buffer B. These were
eluted from a Bio-Gel A-0.5m column equilibrated
with [3H]choIic acid as follows: peak 1, (a); peak 2,
(6); peak 3, (c); peak 4(i), (<i); peak4(ii), (e); and peak
5, (/). Fractions (3.4ml) were collected and the A2so
(■), the radioactivity (•) and glutathione 5-trans-
ferase activity with l-chloro-2,4-dinitrobenzene (a)
binding activity was eluted as a single peak, which was
associated with glutathione S-transferase activity.
The elution of peaks 1-5 from the Bio-Gel column
also showed that cholic acid binding by peaks 1, 3,
4(i) and 5 was associated with enzyme activity
(Fig. 2). Cholic acid binding by peak 1 was not
restricted to enzyme-containing fractions, but was
also found in fractions with the same elution volume
as rat albumin (110ml). Peak 1 also contained a
component of mol.wt. about 15000 which bound
cholic acid. This may be the lithocholic acid-binding
protein previously described by Strange et al. (1977a),
which was shown to be eluted from CM-Sephadex
in peak 1 (J. D. Hayes, R. C. Strange & I. W. Percy-
Robb, unpublished work). Ketterer et al. (1976) have
also described a binding component ofmol.wt. 14000
which binds cholic acid. No cholic acid binding was
demonstrated in peaks 2 or 4(ii), despite the recovery
of substantial enzyme activity.
Subunit composition of the glutathione S-transferases
Before discontinuous SDS/polyacrylamide-gel
electrophoresis, the glutathione ^-transferases were
partially purified. Two portions of cytosol (each
5ml; approx. 180mg of protein) were eluted (22 ml/h)
with buffer B from the Bio-Gel column (2.5cm x
38cm). The enzyme-containing solutions, eluted
between 120 and 145ml, were combined. Examination
of a small portion of this mixture by SDS/polyacryl¬
amide-gel electrophoresis showed that about 85 %
of the protein in this mixture migrated with the Ya,
Yb or Yc monomer bands (Bass et al., 1977; Hayes
et al., 1979). (NH4)2S04 was added to the combined
enzyme-containing eluate, and the precipitate formed
between 55 and 85% saturation was collected,
redissolved in 12ml of buffer A and dialysed against
two changes, each of 2 litres, of the same buffer (4°C,
15h) (Dixon & Webb, 1964; Strange et al., 19776).
The dialysed solution was eluted from CM-Sephadex
and five peaks of glutathione ^-transferase activity
were obtained. Peak 4 was rechromatographed on
DEAE-Sephadex as described above. Portions
(lO/tg of protein) of each peak were examined by
discontinuous SDS/polyacrylamide-gel electropho¬
resis (Laemmli, 1970; Hayes et al., 1979). The gels
were scanned at 580nm as previously described
(Hayes et al., 1979) and the percentage monomer
composition of each peak was determined (Table 1).
Peak 1 probably comprises a mixture of transferases,
since it contains mainly unequal amounts of the Yb
and Yc monomers. Peak 2 appears to comprise a
YbYb dimer. Peaks 3 and 4(i) have previously been
were measured. The solid horizontal line represents
the radioactivity in the elution buffer.
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purified and shown to comprise YaYa and YaYc
dimers respectively (Hayes et al., 1979). Peak 4(ii)
comprised a YbYb dimer and peak 5 a YcYc dimer.
Discussion
We have previously described two lithocholic acid-
binding proteins in rat liver cytosol which possessed
glutathione S-transferase activity (Strange et al.,
19776). These two enzymes were eluted in peaks 3 and
4(i) and have been identified as ligandin (prepared by
the method of Arias et al., 1976) and glutathione
^-transferase B respectively (Hayes et al., 1979).
Ligandin has variously been described as a YaYa
dimer (Bass et al., 1977; Hayes et al., 1979), a YaYc
dimer (Listowsky et al., 1976) or as a mixture of two
proteins comprising YaYa and YaYc dimers (Carne
et al., 1979). Since the subunit composition of the
original ligandin preparations (Litwack et al., 1971)
is unknown, the term ligandin should perhaps be
abandoned and the proteins redefined according to
their subunit composition as YaYa or YaYc protein.
The experiments now described show that the YaYa
protein and YaYc protein as well as glutathione
^-transferase AA and one or more of the transferases
in peak 1 can bind cholic acid. SDS/polyacrylamide-
gel electrophoresis indicated that cholic acid binding
was associated with either the Ya or the Yc mono¬
mer. The proteins that catalysed the conjugation of
GSH with l,2-dichloro-4-nitrobenzene [in peaks 1,
2 and 4(ii)] all possessed the Yb band.
Although at least seven ionically distinct gluta¬
thione S-transferases exist in rat liver, SDS/poly-
acrylamide-gel electrophoresis has demonstrated
that they each comprise two of three known mono¬
mers (Ya, Yb, Yc). Habig et al. (1974, 1976) have
shown that transferases C and A, and B and AA,
have similar amino acid compositions: significant
differences exist between the alanine and valine
contents of these two groups of transferases. The
compositions suggest that transferases B and AA
may be the product of a single gene, and transferases
C and A may also be coded for by a single but
separate gene. Habig et al. (1974) have reported that
both transferases C and A cross-react with antisera
raised against each other, which supports the hypo¬
thesis that these two enzymes are the product of a
single gene. The elution position and substrate
specificity of peaks 2 and 4(ii) suggested that they
contained transferase C and transferase A respec¬
tively. Both of these enzymes comprise YbYb dimers
and therefore they may be formed by post-synthetic
modification involving minor structural changes.
Peak 4(i) has been shown to contain transferase B
(YaYc protein) (Hayes et al., 1979), and the elution
position and substrate specificity of peak 5 suggested
that it contained transferase AA. Both of these
transferases possess a Yc monomer. We have
previously shown (Hayes et al., 1979) that ligandin
(YaYa protein) and glutathione 5-transferase B
(YaYc protein) are separate proteins, and we
postulated that they may be synthesized as a YcYc
protein, which is subsequently converted into YaYc
or YaYa protein by the specific removal of 26
terminal amino acids. Our subunit data show that
transferase AA comprises a YcYc dimer. This may
represent the putative precursor protein.
Listowsky et al. (1976) have described a preparation
of glutathione S-transferase A which had the same
monomer composition (YaYc) as glutathione S-
transferase B. Our results do not agree with this
finding, since only peak 4(i) has this composition and
this peak has been identified as glutathione S-trans-
ferase B (Hayes et al., 1979). Further, this peak
possesses no GSH-l,2-dichloro-4-nitrobenzene-con-
jugating activity, which indicates that it does not
contain transferase A (Fig. 1).
The physiological importance of bile acid binding
by the transferases is not clear. It appears unlikely
that the bile acids are transported across the hepato-
cyte bound to glutathione S-transferases, since the
observed bile acid transit times across the liver appear
to be too rapid for the bile acids to diffuse across the
hepatocyte bound to protein (Strange et al., 1979).
The transferases may keep bile acids in cytosol, and
so restrict their partitioning into membrane lipid,
thereby promoting their rapid clearance into bile.
J. D. H. thanks the University of Edinburgh for a
Faculty of Medicine Scholarship.
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